Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
19402 |
4. Check minimum number of eventsNone |
19402 |
5. Include endpointsNone |
19402 |
6. Filter based on genotype QC (FinnGen only) |
18829 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G30-G32
- Name in latin
- Morbus Alzheimer
Similar endpoints
↥List of similar endpoints to
Alzheimer disease
based on the number of shared cases.
Similar with more cases:
- Alzheimer disease, excluding more controls
- Degenerative diseases of the nervous system
- Alzheimer disease, including avohilmo
- Other degenerative diseases of the nervous system
- Unspecific neurodegenerative disorder
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 227475 | 144794 | 80971 |
| Only index persons | 189864 | 122913 | 66951 |
| Unadjusted period prevalence (%) | |||
| Whole population | 3.46 | 4.15 | 2.26 |
| Only index persons | 3.83 | 4.52 | 2.56 |
| Median age at first event (years) | |||
| Whole population | 82.31 | 83.07 | 81.01 |
| Only index persons | 82.76 | 83.50 | 81.40 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 18829 | 9138 | 9691 |
| Unadjusted period prevalence (%) | 3.86 | 3.24 | 4.44 |
| Median age at first event (years) | 81.04 | 81.10 | 80.98 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 17348
- Matched controls
- 123976
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TAB00
NOMESCO Finland
Lumbar puncture
4.5
320.9
923
1545
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
101.3
318.6
224
16
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
44.6
307.7
4610
997
F009, G309,
ICD-10 Finland
1077.3
307.7
435
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.8
307.7
1950
4006
F03
ICD-10 Finland
Unspecified dementia
6.0
307.7
3157
4419
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
6.3
307.7
5563
8619
SPAT1053
SPAT
Memory test
3.6
307.7
6579
17979
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
154.4
307.7
784
38
R53
ICD-10 Finland
Malaise and fatigue
2.2
307.7
5745
23114
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
307.7
7482
34355
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.0
307.7
3264
8946
R41.3
ICD-10 Finland
Other amnesia
4.9
307.7
1398
2162
P70
ICPC
Dementia
16.4
307.7
2399
1200
G30.1
ICD-10 Finland
Alzheimer disease with late onset
116.8
307.7
10310
1536
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
206.5
307.7
5553
282
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
47.0
307.7
1326
218
N06DA02
ATC
donepezil; oral
36.7
307.7
8203
2954
N06DA04
ATC
galantamine; oral
16.9
307.7
2420
1179
N05BA04
ATC
oxazepam; oral
2.2
307.7
5541
21585
P20
ICPC
Memory disturbance
7.7
307.7
9212
15822
N05AH04
ATC
quetiapine; oral
3.8
307.7
3958
8925
SPAT1234
SPAT
Support of social functional capacity
3.0
307.7
1880
4779
F0019, G301,
ICD-10 Finland
2611.4
307.7
716
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
307.7
4336
16718
G30.8
ICD-10 Finland
Other Alzheimer disease
76.6
307.7
3399
393
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
36.3
307.7
787
162
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.7
307.7
2373
6983
N06DA03
ATC
rivastigmine; oral, transdermal
23.3
307.7
5305
2296
G30
ICD-10 Finland
Alzheimer disease
49.1
307.7
1399
221
SPAT1216
SPAT
Assessment of functional ability
2.2
307.7
4671
17449
R41.0
ICD-10 Finland
Disorientation, unspecified
3.5
307.7
1283
2730
G30.0
ICD-10 Finland
Alzheimer disease with early onset
431.5
307.7
1234
22
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
71.4
307.7
5282
755
N05AX08
ATC
risperidone; systemic
9.8
307.7
5242
5256
N06DX01
ATC
memantine; oral
59.6
307.7
10990
3492
WYA20
NOMESCO Finland
Home visit
6.0
307.7
975
1218
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
40.1
307.7
554
102
F05.1
ICD-10 Finland
Delirium superimposed on dementia
12.8
307.7
592
342
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
27.5
307.7
2970
924
F06.7
ICD-10 Finland
Mild cognitive disorder
4.3
307.7
1503
2681
A28
ICPC
Limited function/disability NOS
2.9
307.7
6964
23404
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
305.2
5561
24384
N03AG01
ATC
valproic acid; systemic, rectal
3.4
282.7
1169
2557
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
49.2
274.5
211
31
N06AX11
ATC
mirtazapine; oral
1.8
268.0
6011
27919
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
265.7
4055
16596
AA1AD
NOMESCO Finland
CT of head and brain
1.8
265.7
6785
32754
SPAT1254
SPAT
Administration of medicine
2.0
253.4
3695
14848
N05AH03
ATC
olanzapine; systemic
3.5
248.6
990
2108
OAB76
NOMESCO Finland
General guidance on nutrition and food
17.0
247.5
256
109
N02AA05
ATC
oxycodone; systemic
1.9
246.4
4748
20920
N06AX26
ATC
vortioxetine; oral
3.2
242.5
1116
2609
AXX01
NOMESCO Finland
Memory assessment
8.0
236.4
378
343
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
4.5
226.5
634
1034
F001, G301,
ICD-10 Finland
88.2
223.2
159
13
OAB41
NOMESCO Finland
Guidance and counselling related to ageing
9.6
223.1
314
238
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
73.0
222.8
162
16
XA800
NOMESCO Finland
Neuropsychological investigation
4.0
213.3
700
1296
N05AD01
ATC
haloperidol; systemic
3.2
211.3
968
2253
A04
ICPC
Weakness/tiredness general
1.9
210.6
3477
14464
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.6
207.8
1452
4269
F0009, G300,
ICD-10 Finland
+∞
206.4
226
*
OAB48
NOMESCO Finland
Lifestyle advice and guidance
13.6
205.0
235
125
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
202.2
6520
32893
L28
ICPC
Limited function/disability (L)
1.7
198.1
4802
22395
AXX01, ,
SPAT
2.6
195.9
1297
3708
N06AB10
ATC
escitalopram; oral
2.0
192.7
2459
9326
F00
ICD-10 Finland
Dementia in Alzheimer disease
14.1
187.6
211
108
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
39.3
177.1
142
26
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.0
176.6
2264
8581
S72.0
ICD-10 Finland
Fracture of neck of femur
2.4
173.9
1436
4554
A06AD11
ATC
lactulose; oral
1.7
167.4
3943
18098
Z75.5
ICD-10 Finland
Holiday relief care
5.1
166.1
405
584
U04
ICPC
Incontinence urine
2.2
164.5
1651
5687
R1250
NOMESCO Finland
Evaluation of functional capability
3.7
164.4
591
1168
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
160.6
1236
3791
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.7
159.8
982
2695
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
158.4
3302
14608
N02BE01
ATC
paracetamol; systemic, rectal
1.8
156.3
14793
94476
F0014, G301,
ICD-10 Finland
150.1
156.2
187
9
SPAT1301
SPAT
No procedures
1.6
152.9
5990
31127
F0029, G308,
ICD-10 Finland
1234.3
149.4
166
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
149.1
3212
34552
SPAT1101
SPAT
Orthostatic test
2.3
148.7
1318
4302
SPAT1246
SPAT
Screening of depression or other psychiatric problem
3.8
143.6
506
985
S01.0
ICD-10 Finland
Open wound of scalp
2.0
143.4
1788
6677
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
3.9
140.8
472
886
I95.1
ICD-10 Finland
Orthostatic hypotension
2.2
132.0
1265
4261
SPAT1304
SPAT
Counselling and guidance related to ageing
1.8
129.6
2227
9245
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.2
129.5
1199
3980
A29
ICPC
General symptom/complaint other
1.7
126.7
2767
12318
F05.9
ICD-10 Finland
Delirium, unspecified
2.8
125.9
718
1890
SPAT1252
SPAT
Overall medication plan or its review
2.0
125.2
1651
6275
130
Kela drug reimbursment
Malignant tumour
0.3
124.8
445
9233
F0011, G301,
ICD-10 Finland
55.7
123.3
93
12
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.5
122.7
1338
17667
R55
ICD-10 Finland
Syncope and collapse
1.7
122.3
2624
11613
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
117.8
3395
16216
F21, ,
ICPC
4.4
115.3
328
541
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
113.4
2520
11240
S06.0
ICD-10 Finland
Concussion
1.8
110.8
1867
7679
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
34.4
110.2
91
19
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.5
109.2
754
2188
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
27.0
107.0
94
25
SPAT1360
SPAT
Extensive global examination
1.9
106.4
1459
5607
Z29
ICPC
Social problem NOS
3.3
104.1
448
998
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
4.4
99.2
285
474
SPAT1229
SPAT
Assessment of need for aid
1.8
94.2
1806
7699
F00.12
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations
50.9
92.8
71
10
H02AB02
ATC
dexamethasone; systemic
0.4
91.6
539
8994
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
91.4
1368
5402
W19
ICD-10 Finland
Unspecified fall
1.7
91.3
1899
8280
IHZ08
NOMESCO Finland
Provision of support and information for patient’s relatives
14.0
91.3
103
53
N06AB06
ATC
sertraline; oral
1.9
88.5
1258
4882
S70.0
ICD-10 Finland
Contusion of hip
2.1
87.0
925
3234
SPAT1139
SPAT
Nutrition survey
2.2
80.1
722
2361
ICB01, ,
SPAT
5.6
79.3
171
219
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.7
79.2
1830
8190
E86
ICD-10 Finland
Volume depletion
2.3
78.8
679
2178
R42
ICD-10 Finland
Dizziness and giddiness
1.4
77.4
4573
25027
3310A
ICD-9 Finland
Other cerebral degenerations, Alzheimer's disease
+∞
75.7
83
*
N06AB04
ATC
citalopram; systemic
1.5
73.3
3070
15726
SPAT1172
SPAT
Guidance concerning hydration
2.2
72.3
686
2290
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
72.2
1250
5153
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.2
71.2
693
2338
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
3.2
71.0
311
701
N27
ICPC
Fear of neurological disease other
2.7
70.9
432
1176
F002, G308,
ICD-10 Finland
27.3
69.6
61
16
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.7
69.6
2541
25242
N05AD03
ATC
melperone; systemic
3.0
68.7
337
814
N30.0
ICD-10 Finland
Acute cystitis
1.5
68.5
2914
14947
A03FA01
ATC
metoclopramide; systemic, rectal
0.6
68.2
1843
19488
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.6
67.6
2034
9691
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.2
66.6
592
1923
F00.21
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism
27.7
66.5
58
15
EB4VA, ,
NOMESCO Finland
0.4
65.1
337
5967
SPAT1251
SPAT
Organisation of medication
2.0
65.0
773
2813
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.1
64.8
300
700
N02AJ06
ATC
codeine and paracetamol; systemic
0.7
64.7
3611
33354
EB1VA, ,
NOMESCO Finland
0.5
64.0
723
9618
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.6
63.0
1549
7022
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
4.0
62.5
196
350
C10AA01
ATC
simvastatin; oral
1.3
62.2
8911
55300
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
62.1
2414
12137
F0024, G308,
ICD-10 Finland
494.3
61.1
69
*
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
2.3
60.0
492
1544
N07AA05, ,
ATC
129.2
59.8
72
*
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
59.2
1295
5694
W0A10
NOMESCO Finland
Mapping of psychosocial situation
8.5
58.3
88
74
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.0
58.2
719
2652
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
57.6
949
3848
IHA21
NOMESCO Finland
Mini-intervention for hazardous and harmful alcohol use
12.4
57.6
69
40
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
27.6
57.2
50
13
F00.29
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms
29.3
56.9
49
12
AA1AD, ,
SPAT
3.5
56.9
219
454
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.7
56.1
1193
5202
A04AA02
ATC
granisetron; systemic, transdermal
0.3
55.6
208
4277
WYA20, ,
SPAT
3.4
53.5
210
441
G04CA02
ATC
tamsulosin; oral
1.3
53.5
5298
31044
G04CB01
ATC
finasteride; oral
1.4
53.4
2821
14991
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.7
53.2
1863
18810
R33
ICD-10 Finland
Retention of urine
1.5
52.9
1920
9494
R1210, ,
SPAT
4.3
52.0
148
245
SDA04
NOMESCO Finland
Demanding periodontal treatment
0.7
51.6
1529
15971
AA1CG, ,
SPAT
3.8
51.4
175
333
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
51.2
2235
21690
TQW40, ,
SPAT
0.5
50.7
479
6772
J01CA08
ATC
pivmecillinam; oral
1.3
49.8
5579
33164
WZC30
NOMESCO Finland
Teaching
0.6
49.6
1217
13244
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
18.5
49.1
49
19
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.3
48.7
109
2940
SPAT1167
SPAT
Insertion of urinary catheter
1.8
48.5
795
3216
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
47.2
1581
7679
SPAT1050
SPAT
Extensive neurological examination
2.3
46.9
406
1304
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
46.8
1772
8825
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.3
46.5
111
2888
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
70.5
46.2
59
6
R5110, ,
SPAT
1.5
46.2
1671
8245
WW200, ,
SPAT
0.7
46.0
2621
24409
IHZ08, ,
SPAT
4.2
45.6
134
228
A10AB05
ATC
insulin aspart; parenteral
1.6
45.4
1231
5699
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
45.4
4770
28037
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.5
44.6
1461
7058
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
44.1
3017
16668
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.8
43.9
783
3248
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.8
43.8
786
3265
Z28
ICPC
Limited function/disability (Z)
3.8
43.8
147
277
WX402
NOMESCO Finland
General anaesthesia
0.7
43.5
1416
14560
JN4AD
NOMESCO Finland
Body CT examination
0.6
43.3
1005
11102
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
43.1
2382
12709
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.0
43.1
475
1681
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.5
42.5
299
875
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
12.8
42.5
50
28
F00.22
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations
16.6
42.2
44
19
G31.0
ICD-10 Finland
Circumscribed brain atrophy
3.8
42.2
141
265
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.0
42.1
522
1928
J01EA01
ATC
trimethoprim; systemic
1.3
41.9
4292
25090
C10AX09
ATC
ezetimibe; oral
0.7
41.6
1390
14235
J01DB01
ATC
cefalexin; oral
1.3
41.5
12132
80183
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.4
41.1
316
964
A04AA01
ATC
ondansetron; systemic, rectal
0.5
41.1
435
5938
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.0
41.0
471
1692
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.4
40.8
239
4036
-2, ,
ICPC
3.5
40.6
155
320
P29
ICPC
Psychological sympt/compl other
2.0
40.2
485
1773
Z51.5
ICD-10 Finland
Palliative care
1.4
39.2
1959
10260
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
38.4
4778
28558
F0012, G301,
ICD-10 Finland
59.8
38.4
50
6
LAITO, ,
NOMESCO Finland
8.9
38.3
56
45
Z2445
NOMESCO Finland
Psychologist
2.4
38.3
290
879
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.7
38.3
780
3357
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.9
37.8
549
2137
WZC00
NOMESCO Finland
Treatment plan or consultation
0.8
37.8
3445
30175
SPAT1263
SPAT
Sampling
1.2
37.5
6238
38528
XF606, ,
SPAT
2.9
37.5
196
492
F22.0
ICD-10 Finland
Delusional disorder
2.6
37.5
237
659
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.5
37.5
1401
6947
AA1BG, ,
SPAT
2.5
37.2
252
725
WX212
NOMESCO Finland
Femoral plexus blockade
1.9
36.1
500
1917
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
65.9
35.8
46
5
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.3
35.7
140
2818
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
2.1
35.6
346
1167
F0013, G301,
ICD-10 Finland
+∞
35.5
39
*
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
5.2
35.5
82
113
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
35.3
1698
16344
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.3
34.7
2559
14245
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.0
34.7
415
1514
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.4
34.3
1543
7922
XX3DW
NOMESCO Finland
Time consuming IT work
0.6
34.1
787
8728
P05
ICPC
Senility, feeling/behaving old
3.1
33.7
157
369
S00.0
ICD-10 Finland
Superficial injury of scalp
1.9
33.6
434
1626
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
9.7
33.3
46
34
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.4
33.3
1719
9040
A10BK03
ATC
empagliflozin; oral
0.6
33.3
758
8434
A27
ICPC
Fear of other disease NOS
1.6
33.2
842
3830
C03DA01
ATC
spironolactone; oral
0.7
33.2
1527
14822
XQ855, ,
SPAT
2.5
33.2
217
614
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.4
33.1
156
2887
F05.8
ICD-10 Finland
Other delirium
2.7
32.9
193
517
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
32.8
1126
5484
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
3.6
32.5
116
229
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
3.7
32.5
115
226
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
32.3
5102
31201
C10AA07
ATC
rosuvastatin; oral
0.8
32.1
3303
28626
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
32.1
54
1727
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
31.9
2490
13956
XQ858, ,
SPAT
3.2
31.8
140
318
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
93.1
31.6
39
*
SPAT1307
SPAT
Psychosocial counselling and guidance
2.0
31.5
360
1292
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
0.7
31.3
1087
11092
N02AX02
ATC
tramadol; systemic, rectal
0.8
31.1
5188
42663
F0022, G308,
ICD-10 Finland
132.5
31.0
37
*
R06.0
ICD-10 Finland
Dyspnoea
0.8
30.9
3446
29608
F0021, G308,
ICD-10 Finland
90.7
30.8
38
*
SPAT1231
SPAT
Assessment of adjustments needed in living environment
1.9
30.8
410
1553
L01BC06
ATC
capecitabine; oral
0.4
30.7
142
2651
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
30.7
1116
5497
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.3
30.5
2442
13728
N17
ICPC
Vertigo/dizziness
1.3
30.2
2234
12421
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.8
29.9
476
1908
F01.2
ICD-10 Finland
Subcortical vascular dementia
2.8
29.8
164
425
H02AB06
ATC
prednisolone; systemic
0.8
29.7
5966
48237
SPAT1153
SPAT
Removal of sutures
0.8
29.2
3658
31058
IHA10
NOMESCO Finland
Structured mapping of problematic alcohol use
3.2
29.1
127
287
W06
ICD-10 Finland
Fall involving bed
2.4
29.1
210
624
E0000UV, ,
ATC
1.2
29.0
5777
36086
R4110, ,
SPAT
0.7
28.9
1050
10635
M01AH05
ATC
etoricoxib; oral
0.8
28.7
5741
46493
SDA03
NOMESCO Finland
Periodontal treatment
0.8
28.6
2860
24936
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
0.7
28.6
1735
16159
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
28.6
6104
38373
UGC12
NOMESCO Finland
Flexible bronchoscopy
0.6
28.5
730
7928
F00, F03,
ICD-10 Finland
7.2
28.5
49
49
D12
ICPC
Constipation
1.6
28.5
698
3148
SPAT1284
SPAT
Extensive health certificate
2.0
28.5
329
1186
F00.23
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression
32.6
28.5
41
9
Z03
ICPC
Housing/neighbourhood problem
3.1
28.4
126
288
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
1.9
28.2
385
1470
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
2.9
28.0
145
363
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.3
27.9
226
707
J01MA02
ATC
ciprofloxacin; systemic
1.2
27.9
6461
40903
WPA10, ,
SPAT
3.9
27.8
90
166
P04
ICPC
Feeling/behaving irritable/angry
5.0
27.7
66
94
N28
ICPC
Limited function/disability (N)
2.0
27.5
304
1079
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
3.4
27.5
109
232
F0024, G301,
ICD-10 Finland
118.1
27.4
33
*
SPAT1014
SPAT
Treatment of eyes
1.9
27.2
345
1285
Z60.8
ICD-10 Finland
Other problems related to social environment
3.9
27.0
87
160
A10AE04
ATC
insulin glargine; parenteral
1.4
26.9
1476
7828
L15
ICPC
Knee symptom/complaint
0.8
26.9
2288
20370
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
4.0
26.9
85
154
HA1RA, ,
SPAT
0.3
26.5
77
1796
F009, F03,
ICD-10 Finland
9.5
26.4
37
28
D82
ICPC
Teeth/gum disease
0.8
26.1
2514
22055
S18
ICPC
Laceration/cut
0.8
25.8
5915
47465
S28
ICPC
Limited function/disability (S)
2.6
25.8
159
438
A10BK01
ATC
dapagliflozin; oral
0.6
25.5
543
6148
F0004, G300,
ICD-10 Finland
+∞
25.5
28
*
F0023, G308,
ICD-10 Finland
+∞
25.5
28
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
25.5
4751
29391
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
1.7
25.5
455
1889
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.3
25.2
1709
9366
J96.1
ICD-10 Finland
Chronic respiratory failure
0.4
25.0
120
2200
Y94.1
ICD-10 Finland
Accident in connection with service housing
6.7
24.9
45
48
G47.3
ICD-10 Finland
Sleep apnoea
0.7
24.7
1557
14449
R03AC02
ATC
salbutamol; inhalant
0.8
24.7
5863
46966
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.5
24.5
758
3608
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.3
24.4
2113
11980
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.2
24.3
6458
41242
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.7
24.2
511
2222
WF002
NOMESCO Finland
Radical radiotherapy
0.6
24.1
383
4660
N29
ICPC
Neurological sympt/complt other
1.9
24.1
307
1147
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.7
24.0
1273
12121
SPAT1262
SPAT
Handing over of treatment supplies
1.3
23.9
2780
16343
U13
ICPC
Bladder symptom/complaint other
1.7
23.8
481
2066
K03.64
ICD-10 Finland
Dental calculus supragingival
0.8
23.7
1983
17730
WZC30, ,
SPAT
0.6
23.6
526
5893
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
0.7
23.5
664
7073
R11
ICD-10 Finland
Nausea and vomiting
1.4
23.5
1296
6876
R45.1
ICD-10 Finland
Restlessness and agitation
4.6
23.2
61
95
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
23.1
6809
43808
M04AA01
ATC
allopurinol; systemic
0.8
23.1
1831
16484
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.4
22.9
976
4954
A78
ICPC
Infectious disease other/NOS
2.4
22.8
169
509
H02AA02
ATC
fludrocortisone; oral
2.3
22.8
176
540
N07AA06, ,
ATC
+∞
22.8
25
*
N03AX14
ATC
levetiracetam; systemic
1.8
22.6
377
1534
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.3
22.6
1770
9891
F01.9
ICD-10 Finland
Vascular dementia, unspecified
1.7
22.6
437
1855
R01AD58
ATC
fluticasone, combinations; nasal
0.7
22.6
1115
10745
XF606
NOMESCO Finland
Ortostatic test
2.3
22.6
179
556
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.7
22.3
1398
13002
F009, G301,
ICD-10 Finland
186.4
22.3
26
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
22.3
2453
14316
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.4
22.2
98
1862
N02BF01
ATC
gabapentin; oral
0.7
22.1
681
7131
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.7
22.1
882
8802
ZYY02, ,
SPAT
8.1
21.8
34
30
GD1AD
NOMESCO Finland
Thorax CT examination
0.6
21.8
454
5167
T03
ICPC
Loss of appetite
3.3
21.6
88
191
WW500
NOMESCO Finland
Blood transfusion
0.5
21.6
232
3156
P18
ICPC
Medication abuse
3.7
21.5
74
143
JN4BD
NOMESCO Finland
Extensive body CT
0.7
21.4
995
9682
L75
ICPC
Fracture: femur
1.9
21.4
295
1133
S32.8
ICD-10 Finland
Fracture of other and unspecified parts of lumbar spine and pelvis
2.0
21.0
238
854
C03CA01
ATC
furosemide; systemic
1.2
20.8
7541
49188
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
1.9
20.7
268
1007
4289X
ICD-9 Finland
Heart failure, unspecified
0.1
20.7
9
564
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.5
20.7
188
2700
ZXY02
NOMESCO Finland
Neuropsychologist
4.4
20.6
57
93
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.5
20.6
699
3395
R01AD59
ATC
mometasone, combinations; nasal
0.4
20.5
80
1609
250, ,
Kela drug reimbursment
0.4
20.5
101
1829
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.8
20.4
2365
20394
R54
ICD-10 Finland
Senility
2.4
20.2
152
462
A10BJ06
ATC
semaglutide; parenteral
0.4
20.0
129
2095
L03AA13
ATC
pegfilgrastim; parenteral
0.5
20.0
164
2439
S82
ICPC
Naevus/mole
0.7
20.0
1044
9978
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
0.6
19.9
338
4043
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.2
19.9
21
911
K08.3
ICD-10 Finland
Retained dental root
1.4
19.9
1072
5665
Z01.2
ICD-10 Finland
Dental examination
0.8
19.8
3798
31176
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
2.3
19.8
158
493
Z51.88
ICD-10 Finland
Other specified medical care
1.8
19.8
321
1297
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.7
19.8
762
7658
ZXA00
NOMESCO Finland
Right side
1.2
19.8
4308
26915
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
4.8
19.7
49
73
E000001, ,
ATC
1.2
19.6
2440
14420
S01.8
ICD-10 Finland
Open wound of other parts of head
1.9
19.6
242
895
TDA90, ,
SPAT
0.7
19.6
558
5937
R44.1
ICD-10 Finland
Visual hallucinations
2.6
19.6
125
351
Y94.0
ICD-10 Finland
Accident at home
1.8
19.6
314
1264
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
4.5
19.6
53
85
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.3
19.5
45
1185
F00.02
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions
85.9
19.5
24
*
K59.0
ICD-10 Finland
Constipation
1.4
19.4
1001
5252
HA1AA
NOMESCO Finland
X-ray mammography
0.6
19.3
476
5216
F0019, G309,
ICD-10 Finland
+∞
19.1
21
*
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.8
19.1
3587
29521
P28
ICPC
Limited function/disability (P)
3.0
19.1
92
222
L08
ICPC
Shoulder symptom/complaint
0.8
19.1
2088
18130
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
0.6
18.8
393
4469
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
1.8
18.7
284
1125
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
1.4
18.7
778
3930
ZX120, ,
SPAT
2.0
18.7
220
801
R03AK07
ATC
formoterol and budesonide; inhalant
0.8
18.7
1425
12922
KMAK, ,
NOMESCO Finland
1.2
18.6
5304
33855
A04AA55
ATC
palonosetron, combinations; systemic
0.3
18.6
50
1211
SPAT1125
SPAT
Stoma care and guidance
1.7
18.5
357
1516
R1250, ,
SPAT
1.6
18.5
425
1889
C04AE01
ATC
ergoloid mesylates; systemic
2.2
18.5
159
513
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.2
18.5
28
950
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.7
18.2
523
5554
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
3.0
18.1
85
202
I67.4
ICD-10 Finland
Hypertensive encephalopathy
6.0
18.1
36
43
ZXA05
NOMESCO Finland
Left side
1.2
18.0
4021
25134
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
1.7
18.0
336
1415
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
3.7
18.0
61
117
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.4
18.0
709
3546
G72.8
ICD-10 Finland
Other specified myopathies
1.8
17.9
293
1189
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
42.9
17.8
24
*
B01AB10
ATC
tinzaparin; parenteral
0.7
17.8
859
8316
EBA30
NOMESCO Finland
Extraction of root of tooth
1.4
17.7
790
4044
T05
ICPC
Feeding problem of adult
2.7
17.6
99
261
GD1AA, ,
SPAT
0.7
17.6
615
6289
S01BC05
ATC
ketorolac; ophthalmic
1.4
17.6
781
3994
A69.2
ICD-10 Finland
Lyme disease
0.6
17.6
325
3802
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.5
17.5
661
3280
R74
ICPC
Upper respiratory infection acute
0.8
17.4
1638
14486
G04BD08
ATC
solifenacin; oral
1.3
17.3
1154
6297
WF003
NOMESCO Finland
Adjuvant radiotherapy
0.5
17.3
156
2243
K59.09
ICD-10 Finland
Constipation, unspecified
1.3
17.2
1195
6559
E66.01
ICD-10 Finland
Obesity due to excess calories
0.6
17.2
239
3012
R45.5
ICD-10 Finland
Hostility
8.5
17.2
26
22
XF600, ,
SPAT
1.5
17.2
584
2838
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
1.6
17.2
374
1642
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
0.7
17.0
458
4928
K02.0
ICD-10 Finland
Caries limited to enamel
0.7
16.9
831
8023
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.8
16.7
3341
27402
ZX120
NOMESCO Finland
Intravenous
0.7
16.6
768
7491
TPX10
NOMESCO Finland
Implantation of vascular injection port
0.4
16.6
105
1714
L03AA02
ATC
filgrastim; parenteral
0.4
16.5
111
1769
A98
ICPC
Health maint/preventive medicine
1.2
16.5
13601
93566
G04CB02
ATC
dutasteride; oral
1.3
16.5
1507
8584
Z75.0
ICD-10 Finland
Medical services not available in home
3.4
16.4
65
139
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.5
16.4
197
2587
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
0.6
16.4
222
2815
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
0.7
16.4
433
4674
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
0.4
16.3
108
1733
R44
ICPC
Respiratory, Preventive immunization/medic
1.7
16.3
281
1157
H04AA01
ATC
glucagon; nasal, parenteral
2.3
16.3
133
420
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
1.9
16.2
208
781
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.2
16.2
1945
11433
M70.6
ICD-10 Finland
Trochanteric bursitis
0.8
16.2
1231
11177
T08
ICPC
Weight loss
1.8
16.2
261
1055
F32
ICD-10 Finland
Depressive episode
1.6
16.1
373
1663
SPAT1058
SPAT
PEF monitoring instruction
0.7
16.1
604
6102
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
1.8
16.1
262
1062
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
1.8
16.1
249
994
A01
ICPC
Pain general/multiple sites
1.3
16.1
1445
8212
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.3
16.1
1105
6058
R44.3
ICD-10 Finland
Hallucinations, unspecified
2.5
16.0
102
287
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.5
16.0
149
2119
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
3.8
16.0
53
100
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
2.4
16.0
112
330
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
0.6
16.0
343
3873
D19
ICPC
Teeth/gum symptom/complaint
0.8
15.8
2076
17718
PJA12
NOMESCO Finland
Sentinel node biopsy
0.7
15.7
499
5196
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
4.6
15.7
41
64
A10AE05
ATC
insulin detemir; parenteral
1.4
15.6
682
3476
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
3.6
15.6
56
112
D07AA02
ATC
hydrocortisone; topical
1.3
15.6
1547
8897
M25.5
ICD-10 Finland
Pain in joint
0.8
15.6
2617
21817
R63.4
ICD-10 Finland
Abnormal weight loss
1.4
15.5
630
3169
F009, G308,
ICD-10 Finland
+∞
15.5
17
*
F000, G300,
ICD-10 Finland
+∞
15.5
17
*
U28
ICPC
Limited function/disability (U)
1.9
15.5
202
764
F0020, G301,
ICD-10 Finland
31.5
15.4
22
5
WX290
NOMESCO Finland
Other blockage of nerve
0.8
15.4
3050
25065
WYA30, ,
SPAT
2.7
15.3
86
227
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.6
15.3
225
2789
R2110
NOMESCO Finland
Giving the first information
1.4
15.3
653
3317
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.4
15.3
760
3964
L90
ICPC
Osteoarthrosis of knee
0.7
15.2
596
5974
W0A10, ,
SPAT
7.2
15.2
26
26
G91.0
ICD-10 Finland
Communicating hydrocephalus
2.6
15.1
90
245
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.6
15.1
378
1718
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
0.4
15.1
74
1338
A10BB12
ATC
glimepiride; oral
1.3
15.1
1397
7968
I95.9
ICD-10 Finland
Hypotension, unspecified
1.7
15.0
274
1148
Z11
ICPC
Compliance/being ill problem
2.4
14.9
106
315
X59
ICD-10 Finland
Exposure to unspecified factor
1.2
14.9
2268
13661
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
1.9
14.7
187
701
F09
ICD-10 Finland
Unspecified organic or symptomatic mental disorder
4.9
14.7
36
53
L03
ICPC
Low back symptom/complaint
0.8
14.7
2692
22286
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
0.3
14.7
40
958
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
0.7
14.7
666
6515
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
0.4
14.7
74
1321
N06AX21
ATC
duloxetine; oral
1.3
14.6
1183
6630
SPAT1260
SPAT
Consultation of another employee
1.2
14.6
2512
15311
Z10.1
ICD-10 Finland
Routine general health check-up of inhabitants of institutions
5.1
14.5
34
48
R32
ICD-10 Finland
Unspecified urinary incontinence
1.5
14.5
463
2224
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
0.7
14.4
423
4472
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
2.8
14.3
75
191
L57.0
ICD-10 Finland
Actinic keratosis
0.8
14.3
1581
13744
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
3.6
14.2
50
99
WX722
NOMESCO Finland
PEEP
0.6
14.1
285
3263
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
0.7
14.0
359
3902
OAB43, ,
SPAT
0.5
14.0
108
1636
T93
ICPC
Lipid disorder
0.7
14.0
534
5380
G04BD07
ATC
tolterodine; oral
1.3
14.0
883
4782
ZYY02
NOMESCO Finland
Contact between professionals and family members
7.5
13.9
23
22
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
0.4
13.9
63
1177
S01.9
ICD-10 Finland
Open wound of head, part unspecified
1.7
13.9
249
1039
C09CA06
ATC
candesartan; oral
0.8
13.9
2394
19937
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
4.4
13.8
38
62
SPAT1285
SPAT
Provision of consultation response
1.4
13.8
710
3723
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.6
13.8
307
3439
N05AX12
ATC
aripiprazole; systemic
2.1
13.8
143
499
ZYB04, ,
SPAT
2.8
13.8
74
191
N06AX16
ATC
venlafaxine; oral
1.3
13.7
1075
6000
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
0.4
13.7
59
1126
F0001, G300,
ICD-10 Finland
+∞
13.7
15
*
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.3
13.7
953
5236
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.2
13.7
2130
12855
R03BA08
ATC
ciclesonide; inhalant
0.7
13.6
494
5019
N05CD07
ATC
temazepam; oral
1.2
13.5
2216
13434
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
0.2
13.5
18
661
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
0.5
13.5
119
1719
I50.1
ICD-10 Finland
Left ventricular failure
0.7
13.5
634
6166
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.1
13.5
128
432
F00.03
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression
114.4
13.4
16
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
0.7
13.3
437
4521
F01.34
ICD-10 Finland
Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type
4.4
13.3
36
58
N05AH02
ATC
clozapine; systemic
2.6
13.2
80
220
L02BG04
ATC
letrozole; oral
0.7
13.2
394
4152
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
0.4
13.2
74
1263
WF004
NOMESCO Finland
Palliative radiotherapy
0.5
13.2
117
1686
NG1AA, ,
SPAT
0.5
13.2
163
2118
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
13.1
4094
26170
S09.9
ICD-10 Finland
Unspecified injury of head
1.7
13.1
228
944
HA1AA, ,
SPAT
0.4
13.1
58
1092
N80
ICPC
Head injury other
1.7
13.0
269
1167
R40.2
ICD-10 Finland
Coma, unspecified
2.0
13.0
143
510
Z60.9
ICD-10 Finland
Problem related to social environment, unspecified
3.0
13.0
61
146
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
0.4
13.0
56
1067
XA400
NOMESCO Finland
EEG
2.5
12.9
83
236
115
Kela drug reimbursment
Breast cancer
0.7
12.8
592
5771
D06BB10
ATC
imiquimod; topical
0.7
12.8
419
4333
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.0
12.7
150
549
R18
ICD-10 Finland
Ascites
0.4
12.7
85
1354
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.4
12.7
672
3541
S22.3
ICD-10 Finland
Fracture of rib
1.3
12.7
976
5433
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
0.6
12.7
263
2989
T82
ICPC
Obesity
0.4
12.7
57
1066
ZXD35
NOMESCO Finland
Usual procedure
1.5
12.6
425
2064
K86
ICPC
Hypertension uncomplicated
0.8
12.6
1669
14259
S52.5
ICD-10 Finland
Fracture of lower end of radius
1.3
12.6
1350
7830
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
0.6
12.6
227
2668
A11CC03
ATC
alfacalcidol; systemic
0.5
12.6
124
1726
F0021, G301,
ICD-10 Finland
40.5
12.6
17
*
S42.0
ICD-10 Finland
Fracture of clavicle
1.6
12.6
308
1395
R01AD12
ATC
fluticasone furoate; nasal
0.8
12.5
1856
15687
SGA01
NOMESCO Finland
Emergency treatment
0.7
12.5
634
6096
I49.3
ICD-10 Finland
Ventricular premature depolarization
0.7
12.5
553
5431
R50.9
ICD-10 Finland
Fever, unspecified
1.2
12.5
2043
12382
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
0.7
12.4
389
4060
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
1.7
12.4
226
948
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
0.6
12.4
175
2192
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
1.8
12.4
191
763
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
0.4
12.4
73
1221
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
0.8
12.4
1323
11557
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
0.2
12.4
21
657
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.1
12.3
6889
45711
K05.30
ICD-10 Finland
Periodontitis complex
0.8
12.3
1193
10533
SPAT1138
SPAT
Guidance concerning bowel function
1.7
12.3
247
1065
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
0.2
12.3
14
569
XF600
NOMESCO Finland
Bloodpressure measurement
1.3
12.2
906
5019
S01
ICD-10 Finland
Open wound of head
1.8
12.2
175
684
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
0.5
12.2
122
1688
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.9
12.2
2953
23941
N07
ICPC
Convulsion/seizure
4.0
12.1
37
66
UJF30
NOMESCO Finland
Ileoscopy through colon
0.8
12.1
801
7413
KED22
NOMESCO Finland
Transurethral resection of prostate
1.3
12.1
1221
7037
R31
ICD-10 Finland
Unspecified haematuria
1.2
12.0
1914
11565
R03AK03
ATC
[U] fenoterol and ipratropium bromide
0.8
12.0
716
6724
EBA15
NOMESCO Finland
Extraction of multiple teeth
1.4
12.0
489
2467
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
2.6
11.9
70
190
Z08
ICPC
Social welfare problem
2.0
11.9
131
468
OAB41, ,
SPAT
2.0
11.8
137
499
Z74.1
ICD-10 Finland
Need for assistance with personal care
6.8
11.8
21
22
L03AA14
ATC
lipegfilgrastim; parenteral
0.3
11.8
32
765
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
2.9
11.8
57
139
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
0.9
11.8
3989
31590
A10BH05
ATC
linagliptin; oral
1.3
11.8
952
5337
C10AA02
ATC
lovastatin; oral
1.3
11.8
810
4443
SPAT1042
SPAT
Guidance concerning balance maintenance
2.2
11.8
98
314
G04BD12
ATC
mirabegron; oral
1.2
11.8
2096
12798
OAB44, ,
SPAT
0.7
11.7
517
5079
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
0.3
11.7
31
749
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
0.4
11.6
71
1169
A05
ICPC
Feeling ill
1.4
11.6
512
2619
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
2.1
11.6
118
410
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.8
11.6
1060
9420
N99
ICPC
Neurological disease other
1.8
11.6
166
650
M03BX02
ATC
tizanidine; oral
0.9
11.5
5784
44702
P19
ICPC
Drug abuse
3.5
11.5
43
89
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
0.8
11.5
2064
17158
S06.3
ICD-10 Finland
Focal brain injury
1.8
11.5
181
729
SPAT1111
SPAT
Planning of analgesia
1.8
11.5
163
636
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
0.6
11.5
273
3008
L01CA04
ATC
vinorelbine; systemic
0.2
11.4
15
553
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.2
11.3
1463
8659
M02AA07
ATC
piroxicam; topical
1.1
11.3
5498
36121
NF1AA
NOMESCO Finland
Hip X-ray examination
1.2
11.3
1600
9558
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
0.5
11.3
136
1776
G04CA01
ATC
alfuzosin; oral
1.2
11.2
2061
12614
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
0.3
11.2
38
809
WX404
NOMESCO Finland
Intravenous generell anesthesy
0.8
11.2
1665
14073
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
0.3
11.2
29
708
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
1.9
11.1
139
520
M54.4
ICD-10 Finland
Lumbago with sciatica
0.8
11.1
1333
11510
K91
ICPC
Cerebrovascular disease
1.6
11.1
244
1077
WX723
NOMESCO Finland
CPAP therapy
0.5
11.1
119
1609
ZXD20
NOMESCO Finland
Day surgery
1.2
11.1
1487
8837
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
1.7
11.1
217
931
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.7
11.1
636
6000
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.3
11.0
770
4232
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
0.7
11.0
345
3598
QDB10, ,
SPAT
0.6
11.0
154
1930
SFA20
NOMESCO Finland
Two-surface restoration
0.9
11.0
5045
39232
SPAT1236
SPAT
Informing family of child’s disability
1.6
11.0
259
1164
L13
ICPC
Hip symptom/complaint
0.8
11.0
2229
18345
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
0.2
11.0
13
513
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
0.8
11.0
776
7117
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.2
11.0
2320
14373
A12AA04
ATC
calcium carbonate; oral
0.4
10.9
62
1050
F0009, G309,
ICD-10 Finland
+∞
10.9
12
*
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.2
10.9
1648
9909
N05AB03
ATC
perphenazine; systemic, rectal
1.5
10.9
317
1496
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
0.4
10.9
48
902
T90.5
ICD-10 Finland
Sequelae of intracranial injury
2.1
10.8
110
383
G03DC02
ATC
norethisterone; oral
0.7
10.8
550
5280
S00.8
ICD-10 Finland
Superficial injury of other parts of head
1.6
10.8
224
976
SPAT1313
SPAT
Guidance and counselling related to accident prevention
2.1
10.8
99
331
F06.0
ICD-10 Finland
Organic hallucinosis
2.9
10.8
53
131
NG2AA
NOMESCO Finland
Patella X-ray examination
0.6
10.7
156
1934
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
1.8
10.7
156
614
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
0.7
10.7
573
5463
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
2.6
10.7
64
176
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
0.6
10.7
147
1849
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.2
10.7
1841
11204
S32.5
ICD-10 Finland
Fracture of pubis
1.8
10.6
175
715
G40
ICD-10 Finland
Epilepsy
2.3
10.6
85
268
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
0.3
10.6
21
597
-1, ,
ICPC
1.4
10.6
432
2180
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
10.6
2407
14998
XX2RW, ,
NOMESCO Finland
0.3
10.5
32
719
R03BB04
ATC
tiotropium bromide; inhalant
0.8
10.5
1299
11184
JN4CD
NOMESCO Finland
Very extensive body CT
0.7
10.5
267
2900
S01.7
ICD-10 Finland
Multiple open wounds of head
2.1
10.5
97
325
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.9
10.5
2409
19641
TK800
NOMESCO Finland
Hemodialysis
0.5
10.5
81
1220
128
Kela drug reimbursment
Cancers of female genital organs
0.4
10.5
59
1001
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
0.7
10.4
347
3576
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
0.1
10.4
*
273
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
0.7
10.4
336
3481
SPAT1081
SPAT
Cardiorespiratory global assessment
1.3
10.4
896
5066
NFB10
NOMESCO Finland
Primary partial prosthetic replacement of hip joint not using cement, other or unspecified
2.3
10.4
79
244
TPH04, ,
SPAT
1.8
10.4
156
621
M76.6
ICD-10 Finland
Achilles tendinitis
0.6
10.3
208
2377
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
0.2
10.3
7
319
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
1.9
10.3
136
520
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.4
10.2
440
2242
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
5.8
10.2
21
26
JN3AD
NOMESCO Finland
Abdominal CT examination
0.8
10.2
1282
11020
WX199
NOMESCO Finland
Other local analgesia
0.7
10.2
263
2848
D10
ICPC
Vomiting
1.5
10.2
322
1547
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
0.6
10.1
167
2003
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
0.6
10.1
205
2340
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.9
10.1
5010
38837
R03BB01
ATC
ipratropium bromide; inhalant
0.7
10.1
482
4673
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.4
10.1
547
2898
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
1.5
10.1
278
1298
R00.2
ICD-10 Finland
Palpitations
0.7
10.0
435
4283
Z02.8
ICD-10 Finland
Other examinations for administrative purposes
2.1
10.0
94
317
SPA02
NOMESCO Finland
Preparation for dental prosthetics
0.6
10.0
155
1889
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.4
10.0
410
2073
TGC00
NOMESCO Finland
Bronchial lavation
0.6
10.0
143
1777
NK6AN
NOMESCO Finland
Total body bone isotope imaging
0.6
10.0
182
2127
M96.6
ICD-10 Finland
Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate
2.0
10.0
110
395
AA1ED
NOMESCO Finland
Trauma CT of head and neck
2.1
10.0
91
304
4148X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]
0.4
9.9
45
835
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
2.5
9.9
64
183
S20.2
ICD-10 Finland
Contusion of thorax
1.3
9.9
612
3307
K80
ICPC
Cardiac arrhythmia NOS
0.8
9.9
791
7146
K31
ICPC
Cardiovascular, Medical examin/health eval partial
2.0
9.9
109
391
WVA40, ,
SPAT
2.1
9.9
98
338
WZA30
NOMESCO Finland
Assessment of driving capacity and statement
9.4
9.9
21
16
Q90.9
ICD-10 Finland
Down syndrome, unspecified
85.8
9.9
12
*
F0002, G300,
ICD-10 Finland
85.8
9.9
12
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.6
9.9
255
1173
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
0.2
9.8
8
324
NA3BG, ,
SPAT
0.5
9.8
79
1171
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
0.6
9.8
144
1777
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.9
9.8
2199
17964
J01FA10
ATC
azithromycin; systemic
0.9
9.7
5086
39318
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
0.5
9.7
108
1441
L01CB01
ATC
etoposide; systemic
0.2
9.7
7
304
S21
ICPC
Skin texture symptom/complaint
0.8
9.7
1581
13260
SGC00
NOMESCO Finland
Medication, disinfection of root canals
0.7
9.7
429
4207
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
0.4
9.6
43
803
D70.82
ICD-10 Finland
Drug-induced neutropenia
0.4
9.6
46
834
NFJ52
NOMESCO Finland
Internal fixation of fracture of upper femur with screws and sideplate
1.8
9.6
153
620
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
2.4
9.6
69
208
AA1AA
NOMESCO Finland
Head X-ray examination
1.9
9.6
116
431
SPAT1377
SPAT
Polysomnography
0.5
9.6
105
1407
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
0.2
9.5
15
489
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
3.4
9.5
37
79
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
0.5
9.5
87
1235
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
0.1
9.5
6
287
JN6AD
NOMESCO Finland
CT of torso and neck
0.4
9.5
63
1000
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
0.3
9.5
28
636
Z27
ICPC
Fear of a social problem
2.8
9.5
48
121
N03AF02
ATC
oxcarbazepine; oral
1.5
9.4
326
1596
DFF00, ,
SPAT
0.4
9.4
56
928
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
2.0
9.4
103
369
K03.00
ICD-10 Finland
Approximal wear
0.7
9.4
326
3332
N84.0
ICD-10 Finland
Polyp of corpus uteri
0.7
9.4
390
3865
L01
ICPC
Neck symptom/complaint
0.8
9.4
1235
10568
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.3
9.4
809
4575
XJH00
NOMESCO Finland
Transanal ultrasonography
1.2
9.4
1140
6705
P03
ICPC
Feeling depressed
1.3
9.3
532
2842
R12
ICD-10 Finland
Heartburn
0.8
9.3
536
5055
SPAT1104
SPAT
Monitoring of emergency patient
1.3
9.3
899
5153
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
0.8
9.3
765
6888
A23
ICPC
Risk factor NOS
1.3
9.3
834
4739
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
2.3
9.3
75
238
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
0.6
9.3
152
1822
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
2.3
9.3
72
225
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
0.5
9.2
62
980
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
2.2
9.2
83
276
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.3
9.2
921
5302
HAB40
NOMESCO Finland
Wedge excision of mammary gland
0.7
9.2
305
3142
ZX080
NOMESCO Finland
Image guided radiotherapy
0.5
9.2
79
1144
AA1FD
NOMESCO Finland
Trauma CT of head and face
3.3
9.2
37
81
A04AD12
ATC
aprepitant; systemic
0.4
9.2
40
753
F30.1
ICD-10 Finland
Mania without psychotic symptoms
4.9
9.2
22
32
U08
ICPC
Urinary retention
1.4
9.1
360
1808
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.8
9.1
1051
9112
F0010, G308,
ICD-10 Finland
+∞
9.1
10
*
R03AK08
ATC
formoterol and beclometasone; inhalant
0.7
9.1
227
2471
T68
ICD-10 Finland
Hypothermia
2.3
9.1
72
227
F0001, G301,
ICD-10 Finland
42.9
9.1
12
*
SDA05
NOMESCO Finland
Very demanding periodontal treatment
0.7
9.1
271
2846
WVA30, ,
SPAT
0.7
9.1
500
4741
NF3AA
NOMESCO Finland
Femur X-ray examination
1.4
9.0
349
1746
G04BX04, ,
ATC
1.5
9.0
299
1452
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
2.3
9.0
71
223
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.3
9.0
618
3391
V252A
ICD-9 Finland
Contraceptive management, Sterilisation
0.7
9.0
308
3156
C45.0
ICD-10 Finland
Mesothelioma of pleura
0.1
9.0
*
226
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
0.5
9.0
61
960
F0014, G309,
ICD-10 Finland
78.7
9.0
11
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
0.3
9.0
28
618
N18
ICPC
Paralysis/weakness
1.5
9.0
299
1454
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.2
9.0
1416
8546
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
1.5
9.0
289
1396
R02
ICPC
Shortness of breath/dyspnoea
0.8
8.9
1594
13272
W10
ICD-10 Finland
Fall on and from stairs and steps
1.3
8.9
641
3542
HAMTE, ,
NOMESCO Finland
2.1
8.9
81
271
SPAT1255
SPAT
Intravenous administration of medicine
1.2
8.9
925
5351
R05
ICPC
Cough
0.9
8.9
2397
19331
GD1AA
NOMESCO Finland
Thorax X-ray examination
0.9
8.8
7149
54108
ZYY01
NOMESCO Finland
Contact between professionals
3.8
8.8
29
55
WX111
NOMESCO Finland
Local infiltration anesthesia
0.7
8.8
249
2642
R5120
NOMESCO Finland
Preparation of an aid
1.4
8.7
468
2477
OAB72, ,
SPAT
0.2
8.7
6
270
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.9
8.7
2085
16966
S12
ICPC
Insect bite/sting
0.8
8.7
791
7037
R4190
NOMESCO Finland
Nutritional therapy
0.6
8.7
124
1541
CS494
NOMESCO Finland
Other visual field testing
0.6
8.7
156
1828
SGB30
NOMESCO Finland
Other complicated root filling
0.7
8.7
288
2966
H25.8
ICD-10 Finland
Other senile cataract
0.9
8.7
1908
15624
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
1.4
8.7
352
1778
F0022, G301,
ICD-10 Finland
23.2
8.7
13
*
SFA30
NOMESCO Finland
Three-surface restoration
0.9
8.7
3685
28873
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
1.4
8.7
384
1970
N43
ICPC
Neurological, Other diagnostic procedure
2.2
8.7
77
255
A01AB09
ATC
miconazole; local oral
1.2
8.7
1211
7226
K04.5
ICD-10 Finland
Chronic apical periodontitis
0.9
8.7
2341
18881
OAB48, ,
SPAT
0.6
8.6
149
1763
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.3
8.6
549
2982
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.5
8.6
286
1390
S01EX03, ,
ATC
1.4
8.6
425
2222
H02.3
ICD-10 Finland
Blepharochalasis
0.8
8.6
580
5348
T11
ICPC
Dehydration
3.1
8.5
37
85
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.8
8.5
1370
11510
L04AX01
ATC
azathioprine; systemic
0.6
8.5
182
2047
L01AX03
ATC
temozolomide; systemic
0.1
8.5
*
218
N05AL01
ATC
sulpiride; systemic
1.7
8.5
164
704
EP1AE
NOMESCO Finland
Neck ultrasound examination
0.7
8.5
400
3880
6271A
ICD-9 Finland
Menopausal and postmenopausal disorders, Postmenopausal bleeding
1.6
8.5
200
903
S72.9
ICD-10 Finland
Fracture of femur, part unspecified
2.0
8.4
92
330
S15
ICPC
Foreign body in skin
0.8
8.4
513
4797
G46.8
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
5.2
8.4
19
26
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.4
8.4
450
2382
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
0.9
8.4
2309
18607
R44.0
ICD-10 Finland
Auditory hallucinations
2.3
8.4
63
194
WX302
NOMESCO Finland
Thoracal epidural anesthesy
0.7
8.4
384
3745
W18
ICD-10 Finland
Other fall on same level
2.0
8.4
97
355
F38
ICPC
Eye, Other laboratory test NEC
0.5
8.4
85
1165
ZYY01, ,
SPAT
2.6
8.4
49
134
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
1.7
8.3
138
567
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.1
8.3
5072
33617
AA1AG, ,
SPAT
4.5
8.3
22
35
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
0.9
8.3
5183
39782
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
0.7
8.3
409
3942
R053, ,
ICD-10 Finland
0.5
8.3
86
1170
B81
ICPC
Anaemia vit B12/folate deficiency
1.3
8.3
625
3477
180
Kela drug reimbursment
Interferon alfa
0.1
8.3
*
229
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.3
8.3
793
4545
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
1.5
8.3
256
1228
L02BG06
ATC
exemestane; oral
0.5
8.2
58
898
E66
ICD-10 Finland
Obesity
0.6
8.2
105
1342
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
1.9
8.2
102
384
G03FB05
ATC
norethisterone and estrogen; systemic
0.8
8.2
812
7149
GD1QA, ,
SPAT
2.6
8.2
50
140
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
0.6
8.1
143
1683
HMAK, ,
NOMESCO Finland
0.8
8.1
674
6060
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.3
8.1
493
2661
G03CA04
ATC
estriol; systemic, vaginal
1.2
8.1
1285
7758
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
0.7
8.1
426
4067
ZX070
NOMESCO Finland
Intensity modified radiotherapy
0.5
8.1
84
1141
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
0.3
8.1
17
462
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
0.7
8.0
271
2780
B01AA03
ATC
warfarin; systemic
1.1
8.0
4278
28141
SAD02, ,
SPAT
7.6
8.0
19
18
G04BD10
ATC
darifenacin; oral
1.9
8.0
109
422
U29
ICPC
Urinary symptom/complaint other
1.4
8.0
443
2358
N81.6
ICD-10 Finland
Rectocele
0.8
8.0
474
4448
S22.4
ICD-10 Finland
Multiple fractures of ribs
1.4
8.0
292
1449
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
0.3
7.9
26
558
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
0.8
7.9
527
4867
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
0.8
7.9
538
4953
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
1.5
7.9
245
1177
H02BX01
ATC
methylprednisolone, combinations; systemic
1.2
7.9
807
4663
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
0.8
7.9
711
6325
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
0.5
7.8
75
1045
B04AB02, ,
ATC
1.4
7.8
381
1988
N02BF02
ATC
pregabalin; oral
0.7
7.8
418
3978
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
1.5
7.8
276
1361
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
0.5
7.8
68
975
UKC02
NOMESCO Finland
Cystoscopy
1.1
7.8
2959
19088
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
0.5
7.7
66
955
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
0.4
7.7
38
676
SGA02
NOMESCO Finland
Opening and preparing the root canals
0.8
7.7
762
6711
S72.2
ICD-10 Finland
Subtrochanteric fracture
1.7
7.7
151
652
J01FA09
ATC
clarithromycin; systemic
0.9
7.7
2601
20679
PD5AD
NOMESCO Finland
CT of aorta
0.6
7.7
177
1954
L04AX03
ATC
methotrexate; systemic
0.8
7.6
643
5768
L16
ICPC
Ankle symptom/complaint
0.8
7.6
888
7691
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
0.6
7.6
137
1602
SAD01, ,
SPAT
4.0
7.6
23
41
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.8
7.6
957
8224
QBB10, ,
SPAT
0.5
7.6
53
822
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.4
7.6
309
1564
XCH00
NOMESCO Finland
Eye pressure measurement
0.8
7.6
454
4253
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
0.3
7.6
16
433
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
0.5
7.6
89
1164
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
2.9
7.5
37
92
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
4.7
7.5
19
29
Z43.5
ICD-10 Finland
Attention to cystostomy
1.8
7.5
121
494
SAE01, ,
NOMESCO Finland
0.4
7.5
37
657
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
1.9
7.5
95
360
N05CD08
ATC
midazolam; nasal, systemic
1.4
7.5
329
1689
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
0.3
7.5
18
452
G03AC03
ATC
levonorgestrel; oral, implant
0.7
7.5
223
2337
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
0.4
7.5
33
614
FN2AB
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon
0.6
7.4
100
1259
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
0.7
7.4
206
2191
V613A
ICD-9 Finland
Other family circumstances, Problems with aged parents or in-laws
8.8
7.4
16
13
QXB99, ,
SPAT
0.6
7.4
153
1732
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
0.9
7.4
1721
14042
N05CF01
ATC
zopiclone; oral
1.1
7.4
5228
34868
R5140
NOMESCO Finland
Monitoring the use of the aid
0.8
7.4
864
7480
L89
ICPC
Osteoarthrosis of hip
0.7
7.4
306
3029
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
0.3
7.4
16
427
K90
ICPC
Stroke/cerebrovascular accident
1.3
7.4
508
2793
G56.0
ICD-10 Finland
Carpal tunnel syndrome
0.8
7.4
1059
8990
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.1
7.4
3338
21745
R81
ICPC
Pneumonia
1.3
7.4
482
2633
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
0.3
7.3
25
525
Z74.2
ICD-10 Finland
Need for assistance at home and no other household member able to render care
4.0
7.3
22
39
B01AC24
ATC
ticagrelor; oral
0.7
7.3
245
2515
F0003, G300,
ICD-10 Finland
+∞
7.3
8
*
F0024, G309,
ICD-10 Finland
+∞
7.3
8
*
HA1AE, ,
SPAT
0.4
7.3
38
659
QCB10, ,
SPAT
0.5
7.3
50
779
F02.80
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without additional symptoms
4.8
7.3
18
27
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
0.7
7.3
378
3611
IGP01
NOMESCO Finland
Psychiatric family contact
2.8
7.3
38
98
TQW40
NOMESCO Finland
Remowal of suture of skin
0.8
7.3
486
4484
S52.6
ICD-10 Finland
Fracture of lower end of both ulna and radius
1.5
7.3
232
1122
F0023, G301,
ICD-10 Finland
64.4
7.3
9
*
Z51.0
ICD-10 Finland
Radiotherapy session
0.5
7.2
58
856
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
2.1
7.2
69
236
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
0.3
7.2
23
499
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
1.6
7.2
188
870
R10.1
ICD-10 Finland
Pain localized to upper abdomen
0.9
7.2
1582
12960
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.8
7.2
643
5726
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
0.6
7.2
169
1857
U70
ICPC
Pyelonephritis/pyelitis
1.6
7.2
175
798
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
0.6
7.2
117
1399
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.2
7.2
1013
6054
E87.6
ICD-10 Finland
Hypokalaemia
1.3
7.2
475
2600
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
2.0
7.1
77
276
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
0.8
7.1
560
5064
H91.1
ICD-10 Finland
Presbycusis
1.2
7.1
1486
9186
K03.11
ICD-10 Finland
Abrasion dentifrice of teeth
0.6
7.1
103
1271
R03DA04
ATC
theophylline; systemic, rectal
0.8
7.1
704
6201
C08CA13
ATC
lercanidipine; oral
0.9
7.1
1928
15562
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
1.5
7.1
206
976
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
0.4
7.1
29
559
Z49.1
ICD-10 Finland
Extracorporeal dialysis
0.5
7.1
48
751
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
0.4
7.1
44
711
F01.21
ICD-10 Finland
Subcortical vascular dementia without additional symptoms, mainly paranoidism
4.1
7.1
21
37
L04AA06
ATC
mycophenolic acid; systemic
0.4
7.1
37
640
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
0.8
7.1
903
7747
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.2
7.1
1290
7890
S01.2
ICD-10 Finland
Open wound of nose
1.6
7.0
179
824
SPAT1244
SPAT
Occupational therapy
1.7
7.0
136
585
L02BA01
ATC
tamoxifen; oral
0.7
7.0
210
2198
S29
ICPC
Skin symptom/complaint other
0.9
7.0
2268
18093
F07.8
ICD-10 Finland
Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
4.4
7.0
19
31
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
0.6
7.0
156
1734
WX780
NOMESCO Finland
Remote monitoring CPAP
0.6
7.0
150
1681
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.6
7.0
88
1126
M05BA02
ATC
clodronic acid; systemic
0.3
7.0
14
389
A57
ICPC
General and Unspecified, Physical medicine/rehabilitation
3.5
6.9
25
51
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
0.8
6.9
393
3707
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
0.7
6.9
225
2320
8306
FHL
Hysterectomy (related to abortion 8516, prolapse correction 8436)
0.7
6.9
194
2057
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
0.5
6.9
55
813
DFF00
NOMESCO Finland
Pure tone audiometry
0.8
6.9
1143
9582
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.3
6.9
396
2122
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
0.6
6.9
160
1763
C01BD01
ATC
amiodarone; systemic
0.7
6.9
256
2578
ACC51
NOMESCO Finland
Release of median nerve
0.8
6.9
476
4371
SPF30
NOMESCO Finland
Relining of denture
1.4
6.9
280
1419
SPAT1281
SPAT
Other administrative function
1.2
6.9
920
5469
C01DA14
ATC
isosorbide mononitrate; oral
1.1
6.9
3833
25245
OAA80, ,
SPAT
0.3
6.9
18
431
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
0.2
6.9
9
272
IGV01
NOMESCO Finland
Psychiatric network contact
2.5
6.9
42
118
B02
ICD-10 Finland
Zoster [herpes zoster]
0.7
6.9
302
2957
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.2
6.9
56
180
G91.1
ICD-10 Finland
Obstructive hydrocephalus
2.4
6.9
48
144
M76.0
ICD-10 Finland
Gluteal tendinitis
0.5
6.8
75
999
DAX08
NOMESCO Finland
Fitting of hearing aid
0.8
6.8
736
6422
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.5
6.8
69
942
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
1.8
6.8
94
367
R35
ICD-10 Finland
Polyuria
1.2
6.8
1025
6163
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
0.4
6.8
29
547
G03FB06
ATC
medroxyprogesterone and estrogen; systemic
0.8
6.8
930
7927
R21
ICPC
Throat symptom/complaint
0.8
6.8
1093
9179
U05
ICPC
Urination problems other
1.2
6.8
840
4957
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
0.4
6.8
33
587
NG1BG, ,
SPAT
0.3
6.8
20
449
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
0.8
6.8
460
4232
A49
ICPC
General and Unspecified, Other preventive procedure
1.8
6.7
101
405
L02BB04
ATC
enzalutamide; oral
0.5
6.7
52
775
N18.0
ICD-10 Finland
End-stage renal disease
0.5
6.7
52
775
C09AA05
ATC
ramipril; oral
1.1
6.7
4594
30564
EC1VA, ,
NOMESCO Finland
0.7
6.7
206
2145
Z71.8
ICD-10 Finland
Other specified counselling
1.1
6.7
3801
25053
B01AC07
ATC
dipyridamole; systemic
1.2
6.7
1040
6271
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
0.3
6.7
16
402
J01
ICD-10 Finland
Acute sinusitis
0.7
6.7
176
1888
F16
ICPC
Eyelid symptom/complaint
0.7
6.7
336
3223
NFJ62
NOMESCO Finland
Internal fixation of fracture of other parts of femur with plate
1.6
6.7
134
583
TFP20
NOMESCO Finland
Cardiodefibrillation
0.8
6.7
858
7354
S16
ICPC
Bruise/contusion
1.3
6.7
453
2490
A02BC04
ATC
rabeprazole; oral
0.8
6.6
553
4963
SPAT1127
SPAT
Enema
1.6
6.6
142
628
TFP34
NOMESCO Finland
Electrophysiological investigation
0.6
6.6
115
1353
G41.9
ICD-10 Finland
Status epilepticus, unspecified
2.0
6.6
74
269
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
1.7
6.6
117
492
T83
ICPC
Overweight
0.4
6.6
30
550
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
0.5
6.6
52
770
E66.00
ICD-10 Finland
Metabolic syndrome
0.7
6.6
281
2765
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
0.5
6.6
73
969
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
1.6
6.6
159
724
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
0.6
6.6
99
1207
F22.8
ICD-10 Finland
Other persistent delusional disorders
3.1
6.6
28
64
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
0.8
6.6
477
4353
JAH01
NOMESCO Finland
Laparoscopy
0.7
6.6
194
2035
N02AJ13
ATC
tramadol and paracetamol; systemic
0.6
6.6
101
1224
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
0.6
6.6
128
1464
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.3
6.6
357
1900
QXA70, ,
SPAT
0.4
6.6
34
589
G03FA14
ATC
dydrogesterone and estrogen; systemic
0.7
6.5
189
1990
D25.1
ICD-10 Finland
Intramural leiomyoma of uterus
0.7
6.5
180
1913
A58
ICPC
General and Unspecified, Therapeutic counselling/listening
3.3
6.5
26
57
A10BX01
ATC
guar gum; oral
1.2
6.5
647
3728
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
0.6
6.5
142
1584
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
0.4
6.5
35
597
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
0.7
6.5
256
2550
P99
ICPC
Psychological disorders other
1.6
6.5
138
610
137
Kela drug reimbursment
Uraemia requiring dialysis
0.3
6.5
15
383
H01
ICPC
Ear pain/earache
0.8
6.5
723
6284
XX9LA
NOMESCO Finland
Complementary kinetic X-ray examination without contrast
1.8
6.5
101
410
G03FB08
ATC
dydrogesterone and estrogen; systemic
0.6
6.5
149
1642
A31
ICPC
General and Unspecified, Medical examin/health eval partial
1.4
6.5
305
1587
NF3BA
NOMESCO Finland
Femur extensive X-ray examination
2.2
6.4
56
185
B03XA02
ATC
darbepoetin alfa; parenteral
0.6
6.4
142
1580
PJA10
NOMESCO Finland
Exploration of lymph nodes
0.5
6.4
43
675
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.3
6.4
588
3356
ZXC96
NOMESCO Finland
Robot assisted procedure
0.6
6.4
106
1262
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
0.5
6.4
77
998
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
0.7
6.4
176
1872
Z49.0
ICD-10 Finland
Preparatory care for dialysis
0.4
6.4
28
522
191
Kela drug reimbursment
Erlotinib
0.1
6.4
*
158
S52.0
ICD-10 Finland
Fracture of upper end of ulna
1.5
6.4
182
860
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
0.4
6.4
37
614
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
0.5
6.4
69
923
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.2
6.4
648
3742
WZC15, ,
NOMESCO Finland
0.3
6.4
17
403
F0014, G308,
ICD-10 Finland
57.2
6.4
8
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
0.3
6.4
22
457
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
0.2
6.4
6
221
F0009, G301,
ICD-10 Finland
+∞
6.4
7
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
0.5
6.4
68
912
L02BA03
ATC
fulvestrant; parenteral
0.2
6.4
12
345
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
0.7
6.4
185
1945
T89
ICPC
Diabetes insulin dependent
1.4
6.4
276
1416
M79.6
ICD-10 Finland
Pain in limb
0.9
6.3
4883
37220
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.2
6.3
773
4554
JAH00
NOMESCO Finland
Laparotomy
0.7
6.3
197
2045
A10AD05
ATC
insulin aspart; parenteral
1.4
6.3
322
1696
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
0.2
6.3
*
190
S42.4
ICD-10 Finland
Fracture of lower end of humerus
1.6
6.3
133
586
D11
ICPC
Diarrhoea
1.2
6.3
1054
6397
A02
ICPC
Chills
1.8
6.3
86
335
159
Kela drug reimbursment
Pazopanib
0.0
6.3
*
115
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
1.7
6.3
119
510
-31
ICPC
Medical examin/health eval partial
1.2
6.3
923
5538
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
0.8
6.3
509
4582
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.2
6.3
870
5192
XKD00
NOMESCO Finland
Uroflowmetry
1.1
6.3
2839
18481
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
1.6
6.3
151
688
A08.3
ICD-10 Finland
Other viral enteritis
2.3
6.3
49
155
A96
ICPC
Death
1.7
6.3
109
457
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
0.6
6.2
82
1035
OAB75, ,
SPAT
0.5
6.2
58
811
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
0.8
6.2
405
3745
7865A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Chest pain
1.4
6.2
296
1543
4120X
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]
0.6
6.2
141
1558
IGY99
NOMESCO Finland
Other psychiatric treatment contact
1.9
6.2
71
261
K64.0
ICD-10 Finland
First degree haemorrhoids
0.6
6.2
80
1014
XCW10, ,
SPAT
0.3
6.2
16
384
Z00.8
ICD-10 Finland
Other general examinations
1.2
6.2
873
5220
359
Kela drug reimbursment
Mirabegroni
1.8
6.2
89
353
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.9
6.2
1405
11483
L76
ICPC
Fracture: other
1.3
6.2
443
2455
A06AH03
ATC
naloxegol; oral
0.5
6.2
61
836
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
0.7
6.1
195
2016
P71
ICPC
Organic psychosis other
5.8
6.1
17
21
I21.2
ICD-10 Finland
Acute transmural myocardial infarction of other sites
0.4
6.1
27
501
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
0.2
6.1
7
227
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
3.3
6.1
24
52
M79.1
ICD-10 Finland
Myalgia
0.8
6.1
1063
8873
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
0.5
6.1
67
891
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
0.8
6.1
866
7357
XG474
NOMESCO Finland
Exhalation nntrogen oxide
0.6
6.1
75
965
C09DA01
ATC
losartan and diuretics; oral
0.9
6.1
1173
9710
H43.8
ICD-10 Finland
Other disorders of vitreous body
0.8
6.1
775
6649
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
0.3
6.1
15
369
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
0.8
6.1
697
6038
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
0.6
6.1
127
1427
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
2.2
6.0
48
153
P20
ICD-10 Finland
Intrauterine hypoxia
6.7
6.0
15
16
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
0.1
6.0
*
166
Z60.2
ICD-10 Finland
Living alone
3.6
6.0
21
42
K29.4
ICD-10 Finland
Chronic atrophic gastritis
1.3
6.0
345
1852
K85
ICPC
Elevated blood pressure
0.9
6.0
2233
17675
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
1.3
6.0
438
2432
C09DX04
ATC
valsartan and sacubitril; oral
0.4
6.0
32
547
D17
ICPC
Incontinence of bowel
1.5
6.0
156
724
R96
ICPC
Asthma
0.8
6.0
851
7227
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Alzheimer disease with late onset
G30.1 [45552521]
G30.1 [45552521]
3.3e+00
3.7e+00
5.0e+00
9.7e+00
6.0e+00
5.0e+00
4.5e+00
cases:9.39%
controls:0.39%
cases:10.10%
controls:0.29%
cases:6.34%
controls:0.05%
cases:35.00%
controls:0.00%
cases:14.11%
controls:0.04%
cases:33.67%
controls:0.33%
cases:46.73%
controls:0.98%
1820
752
17560
192968
1958
556
17421
193164
1228
92
18151
193628
6783
6
12596
193714
2466
82
15005
192605
5198
592
10239
178252
4011
1109
4573
112362
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
F00.10*G30.1 [2000501573]
F00.10*G30.1 [2000501573]
2.9e+00
2.9e+00
4.0e+00
8.8e+00
5.1e+00
4.2e+00
3.8e+00
cases:3.22%
controls:0.18%
cases:3.04%
controls:0.17%
cases:1.70%
controls:0.03%
cases:14.40%
controls:0.00%
cases:4.17%
controls:0.03%
cases:13.79%
controls:0.24%
cases:19.91%
controls:0.56%
625
347
18755
193373
589
338
18790
193382
330
63
19049
193657
2790
5
16589
193715
729
51
16742
192636
2129
422
13308
178422
1709
640
6875
112831
Alzheimer disease, unspecified
G30.9 [45591165]
G30.9 [45591165]
3.4e+00
3.4e+00
5.3e+00
—
6.4e+00
5.1e+00
5.2e+00
cases:1.56%
controls:0.06%
cases:1.32%
controls:0.05%
cases:1.44%
controls:0.01%
—
—
cases:3.20%
controls:0.01%
cases:9.41%
controls:0.06%
cases:22.04%
controls:0.16%
303
107
19077
193613
255
88
19124
193632
279
14
19100
193706
—
559
11
16912
192676
1452
108
13985
178736
1892
176
6692
113295
Alzheimer disease
G30 [45538101]
G30 [45538101]
3.8e+00
4.4e+00
6.4e+00
—
6.2e+00
4.0e+00
3.5e+00
cases:7.46%
controls:0.17%
cases:6.18%
controls:0.08%
cases:3.80%
controls:0.01%
—
—
cases:2.76%
controls:0.01%
cases:4.68%
controls:0.09%
cases:8.24%
controls:0.28%
1446
332
17934
193388
1198
154
18181
193566
736
13
18643
193707
—
482
11
16989
192676
722
168
14715
178676
707
316
7877
113155
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
307 [2001600266]
307 [2001600266]
3.8e+00
4.5e+00
6.6e+00
1.0e+50
6.2e+00
3.6e+00
1.9e+00
cases:9.04%
controls:0.23%
cases:6.77%
controls:0.08%
cases:4.36%
controls:0.01%
cases:2.16%
controls:0.00%
cases:3.22%
controls:0.01%
cases:3.43%
controls:0.09%
cases:2.21%
controls:0.32%
1751
444
17629
193276
1311
158
18068
193562
845
12
18534
193708
419
0
18960
193720
562
13
16909
192674
529
166
14908
178678
190
366
8394
113105
donepezil; oral
N06DA02 [21604795]
N06DA02 [21604795]
3.0e+00
3.3e+00
3.1e+00
5.9e+00
4.0e+00
3.9e+00
3.5e+00
cases:15.57%
controls:0.91%
cases:18.67%
controls:0.87%
cases:8.07%
controls:0.39%
cases:6.66%
controls:0.02%
cases:17.14%
controls:0.39%
cases:35.25%
controls:1.04%
cases:37.57%
controls:1.86%
3017
1762
16363
191958
3618
1683
15761
192037
1564
761
17815
192959
1290
39
18089
193681
2994
744
14477
191943
5442
1864
9995
176980
3225
2114
5359
111357
Other Alzheimer disease
G30.8 [45605532]
G30.8 [45605532]
3.1e+00
3.8e+00
5.0e+00
1.0e+50
5.6e+00
4.6e+00
4.0e+00
cases:2.65%
controls:0.12%
cases:2.66%
controls:0.06%
cases:1.51%
controls:0.01%
cases:7.83%
controls:0.00%
cases:2.41%
controls:0.01%
cases:7.55%
controls:0.08%
cases:11.51%
controls:0.23%
513
230
18867
193490
516
118
18863
193602
292
20
19087
193700
1518
0
17861
193720
421
18
17050
192669
1166
146
14271
178698
988
266
7596
113205
memantine; oral
N06DX01 [21604799]
N06DX01 [21604799]
3.0e+00
3.2e+00
3.0e+00
4.4e+00
3.3e+00
3.9e+00
4.1e+00
cases:16.21%
controls:0.94%
cases:23.07%
controls:1.19%
cases:11.87%
controls:0.64%
cases:3.24%
controls:0.04%
cases:15.83%
controls:0.67%
cases:43.23%
controls:1.53%
cases:62.84%
controls:2.70%
3142
1820
16238
191900
4471
2304
14908
191416
2300
1247
17079
192473
627
79
18752
193641
2766
1282
14705
191405
6673
2730
8764
176114
5394
3060
3190
110411
rivastigmine; oral, transdermal
N06DA03 [21604796]
N06DA03 [21604796]
2.8e+00
2.9e+00
2.8e+00
4.9e+00
3.5e+00
3.6e+00
3.2e+00
cases:8.36%
controls:0.56%
cases:10.37%
controls:0.64%
cases:4.92%
controls:0.31%
cases:1.98%
controls:0.01%
cases:8.73%
controls:0.28%
cases:22.04%
controls:0.77%
cases:25.82%
controls:1.46%
1620
1079
17760
192641
2010
1248
17369
192472
954
607
18425
193113
384
28
18995
193692
1525
542
15946
192145
3403
1385
12034
177459
2216
1652
6368
111819
Geriatric Medicine
38 [38004478]
38 [38004478]
1.0e+00
2.2e+00
3.6e+00
8.8e+00
3.7e+00
2.8e+00
1.4e+00
cases:5.38%
controls:1.99%
cases:7.97%
controls:0.98%
cases:4.76%
controls:0.14%
cases:19.23%
controls:0.00%
cases:5.84%
controls:0.16%
cases:16.40%
controls:1.19%
cases:13.82%
controls:3.93%
1043
3862
18337
189858
1544
1905
17835
191815
922
271
18457
193449
3726
7
15653
193713
1021
300
16450
192387
2531
2136
12906
176708
1186
4459
7398
109012
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
F00.20 [2000501579]
F00.20 [2000501579]
3.1e+00
3.6e+00
4.9e+00
1.0e+50
4.1e+00
3.9e+00
3.2e+00
cases:1.22%
controls:0.05%
cases:1.06%
controls:0.03%
cases:0.35%
controls:0.00%
cases:0.21%
controls:0.00%
cases:0.34%
controls:0.01%
cases:1.48%
controls:0.03%
cases:2.67%
controls:0.11%
237
103
19143
193617
206
55
19173
193665
67
5
19312
193715
40
0
19339
193720
59
11
17412
192676
229
53
15208
178791
229
121
8355
113350
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
F00.10 [2000501572]
F00.10 [2000501572]
3.1e+00
3.7e+00
3.9e+00
1.0e+50
4.0e+00
4.1e+00
3.8e+00
cases:2.04%
controls:0.09%
cases:1.48%
controls:0.04%
cases:0.34%
controls:0.01%
cases:0.31%
controls:0.00%
cases:0.42%
controls:0.01%
cases:2.38%
controls:0.04%
cases:5.82%
controls:0.13%
395
175
18985
193545
286
70
19093
193650
66
14
19313
193706
61
0
19318
193720
73
15
17398
192672
368
71
15069
178773
500
151
8084
113320
galantamine; oral
N06DA04 [21604797]
N06DA04 [21604797]
2.6e+00
2.8e+00
2.7e+00
4.8e+00
3.2e+00
3.2e+00
2.8e+00
cases:4.94%
controls:0.37%
cases:5.99%
controls:0.40%
cases:2.93%
controls:0.21%
cases:1.10%
controls:0.01%
cases:4.72%
controls:0.20%
cases:10.19%
controls:0.45%
cases:10.95%
controls:0.78%
957
718
18423
193002
1160
781
18219
192939
568
398
18811
193322
213
18
19166
193702
824
392
16647
192295
1573
799
13864
178045
940
880
7644
112591
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
F00.20*G30.8 [2000501580]
F00.20*G30.8 [2000501580]
2.8e+00
2.8e+00
4.3e+00
—
4.8e+00
4.0e+00
2.9e+00
cases:2.21%
controls:0.14%
cases:2.64%
controls:0.16%
cases:1.78%
controls:0.03%
—
—
cases:3.36%
controls:0.03%
cases:9.66%
controls:0.20%
cases:9.48%
controls:0.56%
429
275
18951
193445
512
306
18867
193414
345
50
19034
193670
—
587
56
16884
192631
1491
364
13946
178480
814
635
7770
112836
Dementia
P70 [2002000864]
P70 [2002000864]
2.3e+00
2.8e+00
3.1e+00
2.9e+00
3.1e+00
2.9e+00
2.7e+00
cases:3.05%
controls:0.32%
cases:3.08%
controls:0.20%
cases:1.19%
controls:0.06%
cases:0.26%
controls:0.01%
cases:1.29%
controls:0.06%
cases:4.85%
controls:0.28%
cases:11.23%
controls:0.84%
591
619
18789
193101
596
392
18783
193328
230
110
19149
193610
51
28
19328
193692
226
112
17245
192575
748
494
14689
178350
964
953
7620
112518
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
F00.00*G30.0 [2000501566]
F00.00*G30.0 [2000501566]
3.3e+00
4.2e+00
—
1.0e+50
—
5.6e+00
5.5e+00
cases:0.21%
controls:0.01%
cases:0.21%
controls:0.00%
—
—
cases:1.67%
controls:0.00%
—
—
cases:1.94%
controls:0.01%
cases:3.86%
controls:0.02%
40
15
19340
193705
41
6
19338
193714
—
323
0
19056
193720
—
300
13
15137
178831
331
19
8253
113452
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
R41.8 [45534452]
1.7e+00
2.9e+00
3.8e+00
5.8e+00
2.6e+00
1.6e+00
-2.0e-01
cases:10.24%
controls:1.96%
cases:15.11%
controls:0.93%
cases:5.80%
controls:0.13%
cases:2.61%
controls:0.01%
cases:1.80%
controls:0.13%
cases:4.77%
controls:1.03%
cases:2.81%
controls:3.41%
1985
3802
17395
189918
2928
1800
16451
191920
1124
258
18255
193462
506
15
18873
193705
315
254
17156
192433
736
1848
14701
176996
241
3867
8343
109604
Dementia in Alzheimer disease, unspecified
F00.9 [45561994]
F00.9 [45561994]
3.2e+00
3.6e+00
4.1e+00
1.0e+50
—
3.3e+00
3.6e+00
cases:0.64%
controls:0.03%
cases:0.45%
controls:0.01%
cases:0.24%
controls:0.00%
cases:0.10%
controls:0.00%
—
—
cases:0.62%
controls:0.02%
cases:2.41%
controls:0.07%
124
53
19256
193667
87
25
19292
193695
47
8
19332
193712
20
0
19359
193720
—
95
41
15342
178803
207
76
8377
113395
Progressive vascular leukoencephalopathy
I67.3 [45538402]
I67.3 [45538402]
1.3e+00
1.4e+00
2.0e+00
5.7e+00
2.9e+00
2.1e+00
9.6e-01
cases:1.00%
controls:0.28%
cases:0.96%
controls:0.24%
cases:0.52%
controls:0.07%
cases:1.51%
controls:0.01%
cases:1.07%
controls:0.06%
cases:2.31%
controls:0.28%
cases:1.70%
controls:0.66%
193
549
19187
193171
186
466
19193
193254
100
133
19279
193587
293
10
19086
193710
187
112
17284
192575
356
498
15081
178346
146
750
8438
112721
Unspecified dementia
F03 [45566772]
F03 [45566772]
1.9e+00
2.7e+00
3.2e+00
4.5e+00
2.1e+00
1.2e+00
6.1e-01
cases:5.94%
controls:0.93%
cases:7.52%
controls:0.53%
cases:2.06%
controls:0.08%
cases:0.89%
controls:0.01%
cases:0.84%
controls:0.10%
cases:2.52%
controls:0.75%
cases:4.61%
controls:2.56%
1152
1801
18228
191919
1458
1019
17921
192701
400
164
18979
193556
172
20
19207
193700
146
198
17325
192489
389
1346
15048
177498
396
2901
8188
110570
Alzheimer disease with early onset
G30.0 [45566868]
G30.0 [45566868]
3.7e+00
—
1.0e+50
1.0e+50
—
6.4e+00
6.2e+00
cases:0.32%
controls:0.01%
—
—
cases:0.15%
controls:0.00%
cases:3.35%
controls:0.00%
—
—
cases:3.16%
controls:0.01%
cases:6.02%
controls:0.01%
62
16
19318
193704
—
30
0
19349
193720
650
0
18729
193720
—
488
10
14949
178834
517
15
8067
113456
Delirium superimposed on dementia
F05.1 [45557150]
F05.1 [45557150]
1.4e+00
2.6e+00
3.8e+00
—
3.4e+00
2.5e+00
2.2e+00
cases:0.28%
controls:0.07%
cases:0.46%
controls:0.04%
cases:0.36%
controls:0.01%
—
—
cases:0.33%
controls:0.01%
cases:0.71%
controls:0.06%
cases:1.85%
controls:0.21%
55
131
19325
193589
90
69
19289
193651
69
15
19310
193705
—
57
22
17414
192665
110
107
15327
178737
159
239
8425
113232
Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
33203-1 [3042810]
33203-1 [3042810]
2.3e+00
4.6e+00
5.2e+00
1.0e+50
—
2.3e+00
9.5e-01
cases:1.11%
controls:0.11%
cases:2.49%
controls:0.03%
cases:0.58%
controls:0.00%
cases:0.10%
controls:0.00%
—
—
cases:0.27%
controls:0.03%
cases:0.21%
controls:0.08%
215
212
19165
193508
482
51
18897
193669
113
6
19266
193714
19
0
19360
193720
—
42
48
15395
178796
18
92
8566
113379
Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
72260-3 [43055225]
72260-3 [43055225]
2.3e+00
4.6e+00
5.2e+00
1.0e+50
—
2.3e+00
9.4e-01
cases:1.11%
controls:0.11%
cases:2.49%
controls:0.03%
cases:0.58%
controls:0.00%
cases:0.10%
controls:0.00%
—
—
cases:0.27%
controls:0.03%
cases:0.21%
controls:0.08%
215
212
19165
193508
482
51
18897
193669
113
6
19266
193714
19
0
19360
193720
—
42
49
15395
178795
18
93
8566
113378
Tau protein [Mass/volume] in Cerebral spinal fluid
30160-6 [3000242]
30160-6 [3000242]
2.3e+00
4.6e+00
5.2e+00
1.0e+50
—
2.3e+00
9.4e-01
cases:1.10%
controls:0.11%
cases:2.46%
controls:0.03%
cases:0.58%
controls:0.00%
cases:0.09%
controls:0.00%
—
—
cases:0.27%
controls:0.03%
cases:0.21%
controls:0.08%
213
213
19167
193507
477
51
18902
193669
112
6
19267
193714
18
0
19361
193720
—
42
50
15395
178794
18
93
8566
113378
Normal-pressure hydrocephalus
G91.2 [45547765]
G91.2 [45547765]
1.2e+00
1.6e+00
1.9e+00
5.0e+00
2.2e+00
1.7e+00
1.6e+00
cases:1.25%
controls:0.38%
cases:1.16%
controls:0.24%
cases:0.39%
controls:0.06%
cases:0.70%
controls:0.00%
cases:0.38%
controls:0.04%
cases:1.17%
controls:0.22%
cases:1.84%
controls:0.37%
243
739
19137
192981
225
457
19154
193263
76
109
19303
193611
135
9
19244
193711
67
79
17404
192608
180
400
15257
178444
158
419
8426
113052
Lumbar puncture
TAB00 [2001300538]
TAB00 [2001300538]
1.3e+00
3.7e+00
4.7e+00
1.0e+50
3.9e+00
1.6e+00
4.1e-01
cases:0.89%
controls:0.25%
cases:2.16%
controls:0.05%
cases:0.53%
controls:0.00%
cases:0.12%
controls:0.00%
cases:0.13%
controls:0.00%
cases:0.23%
controls:0.05%
cases:0.22%
controls:0.15%
172
477
19208
193243
419
106
18960
193614
102
9
19277
193711
23
0
19356
193720
22
5
17449
192682
35
86
15402
178758
19
167
8565
113304
Dementia in Alzheimer's disease with late onset without information about additional symptoms
F00.19 [2000501571]
F00.19 [2000501571]
3.6e+00
3.7e+00
—
1.0e+50
—
4.0e+00
3.9e+00
cases:0.18%
controls:0.01%
cases:0.14%
controls:0.00%
—
—
cases:0.05%
controls:0.00%
—
—
cases:0.16%
controls:0.00%
cases:0.42%
controls:0.01%
35
10
19345
193710
27
7
19352
193713
—
10
0
19369
193720
—
24
5
15413
178839
36
10
8548
113461
risperidone; oral, parenteral
N05AX08 [21604559]
N05AX08 [21604559]
1.5e+00
1.9e+00
2.1e+00
2.8e+00
2.1e+00
2.3e+00
2.3e+00
cases:5.47%
controls:1.31%
cases:7.48%
controls:1.15%
cases:4.30%
controls:0.56%
cases:0.40%
controls:0.03%
cases:4.42%
controls:0.55%
cases:12.79%
controls:1.40%
cases:24.81%
controls:3.10%
1061
2542
18319
191178
1450
2231
17929
191489
834
1090
18545
192630
78
49
19301
193671
773
1067
16698
191620
1974
2507
13463
176337
2130
3521
6454
109950
Neurology
13 [38004458]
13 [38004458]
5.0e-01
1.2e+00
1.9e+00
6.9e+00
2.0e+00
1.5e+00
5.2e-01
cases:22.47%
controls:15.01%
cases:16.38%
controls:5.67%
cases:5.51%
controls:0.87%
cases:21.51%
controls:0.03%
cases:6.18%
controls:0.87%
cases:21.60%
controls:5.67%
cases:22.52%
controls:14.76%
4355
29084
15025
164636
3175
10983
16204
182737
1067
1694
18312
192026
4169
53
15210
193667
1079
1682
16392
191005
3334
10141
12103
168703
1933
16753
6651
96718
Memory disturbance
P20 [2002000816]
P20 [2002000816]
1.7e+00
2.5e+00
2.3e+00
2.3e+00
2.2e+00
1.9e+00
1.5e+00
cases:23.44%
controls:5.17%
cases:24.56%
controls:2.71%
cases:5.23%
controls:0.53%
cases:1.10%
controls:0.11%
cases:4.33%
controls:0.49%
cases:16.56%
controls:2.98%
cases:27.77%
controls:8.09%
4542
10020
14838
183700
4760
5255
14619
188465
1013
1027
18366
192693
214
207
19165
193513
756
944
16715
191743
2556
5327
12881
173517
2384
9184
6200
104287
Geriatric Psychiatry
27 [38004470]
27 [38004470]
7.2e-01
1.2e+00
1.5e+00
5.7e+00
1.9e+00
1.7e+00
1.2e+00
cases:1.19%
controls:0.58%
cases:0.81%
controls:0.25%
cases:0.38%
controls:0.08%
cases:1.16%
controls:0.00%
cases:0.54%
controls:0.08%
cases:1.45%
controls:0.26%
cases:1.84%
controls:0.58%
231
1132
19149
192588
157
486
19222
193234
74
163
19305
193557
225
8
19154
193712
95
155
17376
192532
224
462
15213
178382
158
658
8426
112813
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
F00.14 [2000501570]
F00.14 [2000501570]
2.8e+00
3.7e+00
1.0e+50
1.0e+50
—
3.9e+00
3.4e+00
cases:0.15%
controls:0.01%
cases:0.14%
controls:0.00%
cases:0.08%
controls:0.00%
cases:0.04%
controls:0.00%
—
—
cases:0.34%
controls:0.01%
cases:0.80%
controls:0.03%
29
17
19351
193703
27
7
19352
193713
16
0
19363
193720
8
0
19371
193720
—
52
12
15385
178832
69
30
8515
113441
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
F00.24 [2000501577]
F00.24 [2000501577]
3.5e+00
3.5e+00
—
—
—
3.7e+00
2.7e+00
cases:0.10%
controls:0.00%
cases:0.12%
controls:0.00%
—
—
—
—
—
—
cases:0.18%
controls:0.00%
cases:0.23%
controls:0.01%
19
6
19361
193714
24
7
19355
193713
—
—
—
28
8
15409
178836
20
17
8564
113454
Dementia in Alzheimer disease, atypical or mixed type and Other Alzheimer disease
F00.2*G30.8 [2000503832]
F00.2*G30.8 [2000503832]
3.6e+00
3.6e+00
—
1.0e+50
—
3.4e+00
2.5e+00
cases:0.11%
controls:0.00%
cases:0.09%
controls:0.00%
—
—
cases:0.11%
controls:0.00%
—
—
cases:0.13%
controls:0.00%
cases:0.19%
controls:0.01%
21
6
19359
193714
18
5
19361
193715
—
21
0
19358
193720
—
20
8
15417
178836
16
17
8568
113454
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
F00.00 [2000501565]
F00.00 [2000501565]
4.1e+00
4.2e+00
1.0e+50
1.0e+50
—
—
4.4e+00
cases:0.31%
controls:0.01%
cases:0.17%
controls:0.00%
cases:0.04%
controls:0.00%
cases:0.04%
controls:0.00%
—
—
—
—
cases:0.96%
controls:0.01%
60
10
19320
193710
33
5
19346
193715
8
0
19371
193720
7
0
19372
193720
—
—
82
13
8502
113458
Severe psychotic and other severe mental disorders
112 [2001600112]
112 [2001600112]
1.5e+00
2.0e+00
—
—
3.7e+00
3.2e+00
2.0e+00
cases:0.50%
controls:0.11%
cases:0.21%
controls:0.03%
—
—
—
—
cases:0.15%
controls:0.00%
cases:0.50%
controls:0.02%
cases:0.54%
controls:0.07%
96
214
19284
193506
40
53
19339
193667
—
—
26
7
17445
192680
77
38
15360
178806
46
80
8538
113391
Other amnesia
R41.3 [45539342]
R41.3 [45539342]
1.8e+00
3.0e+00
3.7e+00
—
2.4e+00
1.3e+00
-1.2e-01
cases:2.77%
controls:0.49%
cases:3.55%
controls:0.18%
cases:0.93%
controls:0.02%
—
—
cases:0.27%
controls:0.02%
cases:0.78%
controls:0.21%
cases:0.69%
controls:0.77%
537
952
18843
192768
687
346
18692
193374
180
44
19199
193676
—
48
46
17423
192641
120
381
15317
178463
59
879
8525
112592
Memory assessment
AXX01 [2001300726]
AXX01 [2001300726]
1.5e+00
2.7e+00
3.5e+00
1.0e+50
—
2.7e+00
1.8e+00
cases:0.06%
controls:0.01%
cases:0.34%
controls:0.02%
cases:0.14%
controls:0.00%
cases:0.44%
controls:0.00%
—
—
cases:0.56%
controls:0.04%
cases:0.87%
controls:0.14%
11
25
19369
193695
65
42
19314
193678
27
8
19352
193712
85
0
19294
193720
—
87
70
15350
178774
75
163
8509
113308
General Practice
1 [38004446]
1 [38004446]
4.4e-01
8.0e-01
1.6e+00
5.9e+00
1.7e+00
9.9e-01
8.0e-01
cases:37.47%
controls:27.85%
cases:25.33%
controls:13.26%
cases:10.07%
controls:2.24%
cases:26.33%
controls:0.10%
cases:11.95%
controls:2.37%
cases:32.48%
controls:15.20%
cases:58.36%
controls:38.63%
7262
53948
12118
139772
4909
25681
14470
168039
1951
4342
17428
189378
5103
198
14276
193522
2087
4560
15384
188127
5014
27188
10423
151656
5010
43832
3574
69639
donepezil and memantine
N06DA52 [40252271]
N06DA52 [40252271]
3.7e+00
—
—
—
—
4.4e+00
4.1e+00
cases:0.15%
controls:0.00%
—
—
—
—
—
—
—
—
cases:0.22%
controls:0.00%
cases:0.41%
controls:0.01%
29
7
19351
193713
—
—
—
—
34
5
15403
178839
35
8
8549
113463
Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms
F00.29 [2000501578]
F00.29 [2000501578]
3.3e+00
3.6e+00
1.0e+50
—
—
2.3e+00
2.8e+00
cases:0.07%
controls:0.00%
cases:0.09%
controls:0.00%
cases:0.03%
controls:0.00%
—
—
—
—
cases:0.05%
controls:0.00%
cases:0.13%
controls:0.01%
14
5
19366
193715
18
5
19361
193715
5
0
19374
193720
—
—
7
8
15430
178836
11
9
8573
113462
Psychiatry
26 [38004469]
26 [38004469]
7.0e-01
1.1e+00
1.6e+00
4.9e+00
1.7e+00
1.3e+00
7.7e-01
cases:4.09%
controls:2.07%
cases:2.36%
controls:0.80%
cases:0.99%
controls:0.20%
cases:1.41%
controls:0.01%
cases:1.13%
controls:0.22%
cases:2.70%
controls:0.75%
cases:3.83%
controls:1.82%
792
4009
18588
189711
458
1553
18921
192167
192
391
19187
193329
273
21
19106
193699
198
417
17273
192270
417
1333
15020
177511
329
2066
8255
111405
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
14744-7 [3020044]
1.2e+00
2.8e+00
3.6e+00
—
3.1e+00
1.2e+00
2.4e-01
cases:1.18%
controls:0.38%
cases:2.11%
controls:0.12%
cases:0.43%
controls:0.01%
—
—
cases:0.23%
controls:0.01%
cases:0.36%
controls:0.11%
cases:0.47%
controls:0.37%
228
727
19152
192993
408
241
18971
193479
83
22
19296
193698
—
40
19
17431
192668
55
197
15382
178647
40
416
8544
113055
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
34563-7 [3044290]
1.1e+00
2.8e+00
3.6e+00
1.0e+50
3.3e+00
9.9e-01
2.9e-01
cases:1.01%
controls:0.33%
cases:1.83%
controls:0.11%
cases:0.36%
controls:0.01%
cases:0.11%
controls:0.00%
cases:0.19%
controls:0.01%
cases:0.27%
controls:0.10%
cases:0.48%
controls:0.36%
196
634
19184
193086
354
209
19025
193511
69
19
19310
193701
22
0
19357
193720
33
13
17438
192674
42
181
15395
178663
41
405
8543
113066
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
26465-5 [3016543]
1.2e+00
2.8e+00
3.6e+00
—
3.1e+00
1.1e+00
3.8e-01
cases:1.17%
controls:0.36%
cases:2.05%
controls:0.13%
cases:0.40%
controls:0.01%
—
—
cases:0.20%
controls:0.01%
cases:0.37%
controls:0.12%
cases:0.56%
controls:0.38%
227
706
19153
193014
397
253
18982
193467
77
21
19302
193699
—
35
17
17436
192670
57
212
15380
178632
48
434
8536
113037
Neuropsychological investigation
XA800 [2001300412]
XA800 [2001300412]
1.4e+00
3.0e+00
4.6e+00
1.0e+50
—
1.9e+00
8.2e-01
cases:1.07%
controls:0.25%
cases:1.26%
controls:0.06%
cases:0.55%
controls:0.01%
cases:0.10%
controls:0.00%
—
—
cases:0.29%
controls:0.04%
cases:0.37%
controls:0.16%
207
490
19173
193230
245
121
19134
193599
107
11
19272
193709
19
0
19360
193720
—
44
73
15393
178771
32
187
8552
113284
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
2880-3 [3019473]
1.1e+00
2.8e+00
3.6e+00
—
3.2e+00
1.1e+00
3.8e-01
cases:1.30%
controls:0.43%
cases:2.28%
controls:0.15%
cases:0.45%
controls:0.01%
—
—
cases:0.23%
controls:0.01%
cases:0.39%
controls:0.13%
cases:0.62%
controls:0.42%
252
842
19128
192878
441
283
18938
193437
88
25
19291
193695
—
41
18
17430
192669
60
228
15377
178616
53
479
8531
112992
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
26454-9 [3027475]
1.2e+00
2.8e+00
3.6e+00
—
3.1e+00
1.1e+00
3.7e-01
cases:1.17%
controls:0.36%
cases:2.08%
controls:0.13%
cases:0.39%
controls:0.01%
—
—
cases:0.20%
controls:0.01%
cases:0.36%
controls:0.12%
cases:0.56%
controls:0.39%
227
707
19153
193013
403
257
18976
193463
76
21
19303
193699
—
35
17
17436
192670
56
213
15381
178631
48
437
8536
113034
Dementia in Alzheimer disease, atypical or mixed type
F00.2 [45557146]
F00.2 [45557146]
3.6e+00
2.9e+00
—
—
—
2.5e+00
2.8e+00
cases:0.09%
controls:0.00%
cases:0.06%
controls:0.00%
—
—
—
—
—
—
cases:0.05%
controls:0.00%
cases:0.13%
controls:0.01%
18
5
19362
193715
11
6
19368
193714
—
—
—
7
7
15430
178837
11
9
8573
113462
Fracture of neck of femur
S72.0 [45593656]
S72.0 [45593656]
5.1e-01
5.7e-01
2.1e+00
4.7e+00
1.8e+00
1.0e+00
8.9e-01
cases:1.86%
controls:1.12%
cases:0.90%
controls:0.51%
cases:0.81%
controls:0.10%
cases:0.76%
controls:0.01%
cases:0.57%
controls:0.09%
cases:1.54%
controls:0.57%
cases:4.78%
controls:2.01%
360
2176
19020
191544
175
997
19204
192723
157
187
19222
193533
147
14
19232
193706
99
173
17372
192514
238
1022
15199
177822
410
2286
8174
111185
Malaise and fatigue
R53 [45553741]
R53 [45553741]
5.3e-01
9.3e-01
2.0e+00
5.3e+00
1.4e+00
7.8e-01
5.4e-01
cases:9.79%
controls:6.00%
cases:6.37%
controls:2.61%
cases:2.51%
controls:0.35%
cases:1.76%
controls:0.01%
cases:1.44%
controls:0.35%
cases:6.57%
controls:3.11%
cases:16.67%
controls:10.45%
1898
11622
17482
182098
1234
5063
18145
188657
487
669
18892
193051
342
17
19037
193703
252
668
17219
192019
1014
5558
14423
173286
1431
11856
7153
101615
Dementia in Alzheimer disease with late onset and Alzheimer disease with late onset
F00.1*G30.1 [2000503819]
F00.1*G30.1 [2000503819]
2.8e+00
—
—
1.0e+50
1.0e+50
4.6e+00
4.0e+00
cases:0.17%
controls:0.01%
—
—
—
—
cases:0.38%
controls:0.00%
cases:0.06%
controls:0.00%
cases:0.45%
controls:0.00%
cases:0.84%
controls:0.02%
32
20
19348
193700
—
—
74
0
19305
193720
11
0
17460
192687
70
8
15367
178836
72
18
8512
113453
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
F00.13 [2000501569]
F00.13 [2000501569]
3.1e+00
2.1e+00
—
—
—
3.2e+00
2.9e+00
cases:0.06%
controls:0.00%
cases:0.03%
controls:0.00%
—
—
—
—
—
—
cases:0.07%
controls:0.00%
cases:0.27%
controls:0.01%
11
5
19369
193715
6
7
19373
193713
—
—
—
11
5
15426
178839
23
17
8561
113454
Orthostatic hypotension
I95.1 [45605872]
I95.1 [45605872]
6.6e-01
9.7e-01
1.4e+00
5.2e+00
1.4e+00
1.0e+00
6.5e-01
cases:2.23%
controls:1.16%
cases:1.39%
controls:0.53%
cases:0.38%
controls:0.09%
cases:0.66%
controls:0.00%
cases:0.38%
controls:0.10%
cases:1.70%
controls:0.64%
cases:3.81%
controls:2.02%
432
2248
18948
191472
269
1026
19110
192694
74
175
19305
193545
127
7
19252
193713
67
185
17404
192502
263
1137
15174
177707
327
2296
8257
111175
Hydrocephalus, unspecified
G91.9 [45571835]
G91.9 [45571835]
1.2e+00
1.7e+00
2.5e+00
1.0e+50
2.1e+00
1.7e+00
1.7e+00
cases:0.15%
controls:0.05%
cases:0.10%
controls:0.02%
cases:0.03%
controls:0.00%
cases:0.06%
controls:0.00%
cases:0.03%
controls:0.00%
cases:0.09%
controls:0.02%
cases:0.19%
controls:0.03%
30
91
19350
193629
20
35
19359
193685
6
5
19373
193715
11
0
19368
193720
6
8
17465
192679
14
29
15423
178815
16
39
8568
113432
Epilepsy, unspecified
G40.9 [45562083]
G40.9 [45562083]
4.8e-01
9.5e-01
1.6e+00
4.3e+00
1.4e+00
1.1e+00
1.1e+00
cases:0.86%
controls:0.53%
cases:0.63%
controls:0.25%
cases:0.24%
controls:0.05%
cases:0.40%
controls:0.01%
cases:0.22%
controls:0.05%
cases:0.87%
controls:0.29%
cases:1.82%
controls:0.63%
166
1026
19214
192694
123
479
19256
193241
46
91
19333
193629
78
11
19301
193709
38
103
17433
192584
135
524
15302
178320
156
720
8428
112751
Emergency use of U07.1 | COVID-19, virus identified
U07.1 [45756093]
U07.1 [45756093]
3.1e-01
6.0e-01
2.0e+00
5.2e+00
1.5e+00
6.4e-01
6.4e-01
cases:1.95%
controls:1.44%
cases:1.63%
controls:0.90%
cases:0.76%
controls:0.10%
cases:1.08%
controls:0.01%
cases:0.50%
controls:0.11%
cases:2.02%
controls:1.08%
cases:7.16%
controls:3.90%
378
2788
19002
190932
316
1748
19063
191972
147
199
19232
193521
209
12
19170
193708
88
214
17383
192473
312
1927
15125
176917
615
4421
7969
109050
Holiday relief care
Z75.5 [45547342]
Z75.5 [45547342]
1.1e+00
1.4e+00
1.3e+00
—
1.9e+00
2.6e+00
2.3e+00
cases:0.39%
controls:0.13%
cases:0.28%
controls:0.07%
cases:0.07%
controls:0.02%
—
—
cases:0.16%
controls:0.02%
cases:0.91%
controls:0.07%
cases:2.31%
controls:0.23%
76
257
19304
193463
54
131
19325
193589
14
38
19365
193682
—
28
45
17443
192642
141
128
15296
178716
198
265
8386
113206
Subcortical vascular dementia without information on additional symptoms
F01.29 [2000501592]
F01.29 [2000501592]
8.8e-01
1.7e+00
2.6e+00
1.0e+50
2.3e+00
1.7e+00
1.4e+00
cases:0.15%
controls:0.06%
cases:0.18%
controls:0.03%
cases:0.07%
controls:0.01%
cases:0.17%
controls:0.00%
cases:0.09%
controls:0.01%
cases:0.29%
controls:0.05%
cases:0.42%
controls:0.11%
30
125
19350
193595
34
64
19345
193656
14
10
19365
193710
32
0
19347
193720
15
17
17456
192670
44
93
15393
178751
36
123
8548
113348
Degenerative disease of nervous system, unspecified
G31.9 [45600776]
G31.9 [45600776]
1.6e+00
2.9e+00
2.6e+00
1.0e+50
—
2.3e+00
1.2e+00
cases:0.16%
controls:0.03%
cases:0.17%
controls:0.01%
cases:0.05%
controls:0.00%
cases:0.05%
controls:0.00%
—
—
cases:0.16%
controls:0.02%
cases:0.19%
controls:0.05%
31
63
19349
193657
33
19
19346
193701
9
7
19370
193713
9
0
19370
193720
—
24
29
15413
178815
16
61
8568
113410
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
7.3e-01
1.3e+00
1.6e+00
4.0e+00
1.4e+00
9.3e-01
5.5e-01
cases:2.22%
controls:1.09%
cases:1.48%
controls:0.43%
cases:0.40%
controls:0.08%
cases:0.49%
controls:0.01%
cases:0.37%
controls:0.09%
cases:1.20%
controls:0.48%
cases:2.24%
controls:1.31%
431
2106
18949
191614
287
829
19092
192891
78
158
19301
193562
95
17
19284
193703
64
171
17407
192516
185
850
15252
177994
192
1482
8392
111989
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
14946-8 [3009466]
9.5e-01
1.4e+00
1.9e+00
—
2.8e+00
1.8e+00
1.7e+00
cases:0.74%
controls:0.29%
cases:0.56%
controls:0.15%
cases:0.14%
controls:0.02%
—
—
cases:0.35%
controls:0.02%
cases:0.98%
controls:0.16%
cases:2.04%
controls:0.39%
143
554
19237
193166
109
282
19270
193438
27
41
19352
193679
—
62
42
17409
192645
151
283
15286
178561
175
439
8409
113032
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
4.5e-01
6.9e-01
1.7e+00
5.1e+00
1.3e+00
7.3e-01
5.4e-01
cases:13.67%
controls:9.15%
cases:7.40%
controls:3.87%
cases:3.14%
controls:0.57%
cases:3.60%
controls:0.02%
cases:2.22%
controls:0.62%
cases:8.57%
controls:4.34%
cases:22.23%
controls:14.30%
2649
17718
16731
176002
1434
7491
17945
186229
608
1109
18771
192611
697
46
18682
193674
387
1191
17084
191496
1323
7766
14114
171078
1908
16224
6676
97247
Medication abuse
P18 [2002000814]
P18 [2002000814]
8.8e-01
2.0e+00
2.3e+00
—
3.0e+00
1.8e+00
1.4e+00
cases:0.06%
controls:0.03%
cases:0.13%
controls:0.02%
cases:0.05%
controls:0.00%
—
—
cases:0.06%
controls:0.00%
cases:0.11%
controls:0.02%
cases:0.22%
controls:0.06%
12
50
19368
193670
25
34
19354
193686
9
9
19370
193711
—
11
6
17460
192681
17
32
15420
178812
19
65
8565
113406
vortioxetine; oral
N06AX26 [44819158]
N06AX26 [44819158]
9.5e-01
1.3e+00
1.3e+00
2.5e+00
1.5e+00
1.5e+00
1.4e+00
cases:1.73%
controls:0.68%
cases:1.95%
controls:0.54%
cases:0.94%
controls:0.26%
cases:0.13%
controls:0.01%
cases:1.14%
controls:0.26%
cases:2.80%
controls:0.61%
cases:4.72%
controls:1.21%
335
1308
19045
192412
378
1047
19001
192673
183
497
19196
193223
26
22
19353
193698
200
507
17271
192180
433
1097
15004
177747
405
1375
8179
112096
Provision of support and information to patient’s family members
SPAT1245 [2001700346]
SPAT1245 [2001700346]
1.2e+00
1.5e+00
1.5e+00
2.2e+00
1.6e+00
1.4e+00
1.0e+00
cases:4.27%
controls:1.31%
cases:3.07%
controls:0.70%
cases:0.75%
controls:0.16%
cases:0.13%
controls:0.01%
cases:0.80%
controls:0.17%
cases:3.24%
controls:0.82%
cases:6.36%
controls:2.35%
828
2531
18552
191189
595
1364
18784
192356
146
318
19233
193402
25
28
19354
193692
139
326
17332
192361
500
1463
14937
177381
546
2671
8038
110800
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
3.2e-01
6.8e-01
2.3e+00
4.8e+00
1.0e+00
6.9e-01
5.6e-01
cases:7.46%
controls:5.54%
cases:5.13%
controls:2.66%
cases:3.35%
controls:0.36%
cases:1.85%
controls:0.02%
cases:1.10%
controls:0.39%
cases:6.30%
controls:3.27%
cases:17.60%
controls:10.92%
1445
10730
17935
182990
994
5147
18385
188573
650
701
18729
193019
359
30
19020
193690
192
757
17279
191930
973
5855
14464
172989
1511
12394
7073
101077
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism
F00.21 [2000501574]
F00.21 [2000501574]
2.8e+00
2.5e+00
—
1.0e+50
—
2.9e+00
2.0e+00
cases:0.09%
controls:0.01%
cases:0.07%
controls:0.01%
—
—
cases:0.03%
controls:0.00%
—
—
cases:0.14%
controls:0.01%
cases:0.16%
controls:0.02%
17
10
19363
193710
14
11
19365
193709
—
5
0
19374
193720
—
21
13
15416
178831
14
26
8570
113445
Inpatient Hospital
21 [8717]
21 [8717]
1.8e-01
4.9e-01
1.5e+00
5.6e+00
1.3e+00
7.1e-01
5.2e-01
cases:46.49%
controls:42.15%
cases:22.63%
controls:15.14%
cases:10.27%
controls:2.55%
cases:24.17%
controls:0.12%
cases:8.78%
controls:2.55%
cases:26.35%
controls:14.97%
cases:46.85%
controls:34.41%
9009
81649
10371
112071
4385
29321
14994
164399
1990
4945
17389
188775
4684
232
14695
193488
1534
4920
15937
187767
4067
26781
11370
152063
4022
39046
4562
74425
Dementia in Alzheimer disease
F00 [45533052]
F00 [45533052]
2.1e+00
3.4e+00
—
—
—
2.3e+00
2.4e+00
cases:0.28%
controls:0.04%
cases:0.41%
controls:0.01%
—
—
—
—
—
—
cases:0.15%
controls:0.01%
cases:0.61%
controls:0.06%
55
69
19325
193651
79
26
19300
193694
—
—
—
23
26
15414
178818
52
64
8532
113407
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
1845-7 [3023183]
7.0e-01
1.3e+00
2.8e+00
2.8e+00
2.1e+00
5.5e-01
7.6e-02
cases:0.61%
controls:0.31%
cases:0.51%
controls:0.14%
cases:0.21%
controls:0.01%
cases:0.04%
controls:0.00%
cases:0.17%
controls:0.02%
cases:0.30%
controls:0.18%
cases:0.68%
controls:0.63%
119
594
19261
193126
98
271
19281
193449
40
24
19339
193696
8
5
19371
193715
30
42
17441
192645
47
314
15390
178530
58
711
8526
112760
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
SPAT1217 [2001700318]
8.8e-01
1.3e+00
1.7e+00
2.2e+00
2.3e+00
1.2e+00
6.3e-01
cases:7.43%
controls:3.23%
cases:5.26%
controls:1.54%
cases:0.98%
controls:0.19%
cases:0.06%
controls:0.01%
cases:1.99%
controls:0.20%
cases:5.45%
controls:1.68%
cases:9.38%
controls:5.21%
1439
6248
17941
187472
1019
2988
18360
190732
190
367
19189
193353
12
13
19367
193707
348
389
17123
192298
841
3012
14596
175832
805
5917
7779
107554
Contusion of hip
S70.0 [45574306]
S70.0 [45574306]
6.0e-01
7.4e-01
2.1e+00
4.1e+00
1.2e+00
6.1e-01
7.5e-01
cases:1.39%
controls:0.77%
cases:0.59%
controls:0.28%
cases:0.23%
controls:0.03%
cases:0.15%
controls:0.00%
cases:0.10%
controls:0.03%
cases:0.61%
controls:0.33%
cases:2.68%
controls:1.29%
270
1491
19110
192229
114
547
19265
193173
44
54
19335
193666
30
5
19349
193715
18
58
17453
192629
94
594
15343
178250
230
1459
8354
112012
colecalciferol; oral
A11CC05 [21600820]
A11CC05 [21600820]
1.0e+00
1.3e+00
1.4e+00
2.0e+00
1.4e+00
1.6e+00
1.4e+00
cases:2.43%
controls:0.90%
cases:3.79%
controls:1.08%
cases:3.00%
controls:0.76%
cases:0.28%
controls:0.04%
cases:3.08%
controls:0.78%
cases:6.61%
controls:1.43%
cases:11.57%
controls:2.99%
471
1744
18909
191976
735
2096
18644
191624
581
1474
18798
192246
55
76
19324
193644
538
1496
16933
191191
1021
2555
14416
176289
993
3398
7591
110073
Observation for suspected nervous system disorder
Z03.3 [45609903]
Z03.3 [45609903]
1.1e+00
2.1e+00
3.3e+00
—
2.4e+00
1.1e+00
-3.6e-02
cases:2.25%
controls:0.76%
cases:1.84%
controls:0.22%
cases:0.57%
controls:0.02%
—
—
cases:0.25%
controls:0.02%
cases:0.68%
controls:0.22%
cases:0.80%
controls:0.83%
437
1480
18943
192240
357
432
19022
193288
111
40
19268
193680
—
44
44
17427
192643
105
391
15332
178453
69
945
8515
112526
Syncope and collapse
R55 [45568141]
R55 [45568141]
4.8e-01
7.7e-01
1.6e+00
4.9e+00
1.1e+00
8.1e-01
5.0e-01
cases:4.67%
controls:2.94%
cases:2.12%
controls:0.99%
cases:0.58%
controls:0.12%
cases:0.48%
controls:0.00%
cases:0.34%
controls:0.12%
cases:2.27%
controls:1.02%
cases:5.82%
controls:3.63%
906
5693
18474
188027
410
1926
18969
191794
112
238
19267
193482
93
7
19286
193713
60
228
17411
192459
350
1819
15087
177025
500
4115
8084
109356
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
2900A [2000402724]
2900A [2000402724]
3.0e+00
—
—
—
1.0e+50
3.5e+00
3.5e+00
cases:0.27%
controls:0.01%
—
—
—
—
—
—
cases:0.04%
controls:0.00%
cases:0.09%
controls:0.00%
cases:0.15%
controls:0.00%
52
25
19328
193695
—
—
—
7
0
17464
192687
14
5
15423
178839
13
5
8571
113466
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations
F00.22 [2000501575]
F00.22 [2000501575]
2.6e+00
2.3e+00
1.0e+50
1.0e+50
1.0e+50
3.2e+00
2.0e+00
cases:0.09%
controls:0.01%
cases:0.04%
controls:0.00%
cases:0.04%
controls:0.00%
cases:0.03%
controls:0.00%
cases:0.05%
controls:0.00%
cases:0.10%
controls:0.00%
cases:0.16%
controls:0.02%
17
13
19363
193707
7
7
19372
193713
8
0
19371
193720
5
0
19374
193720
8
0
17463
192687
15
7
15422
178837
14
26
8570
113445
Ventriculoperitoneal shunt
AAF05 [2001300295]
AAF05 [2001300295]
1.1e+00
1.8e+00
2.1e+00
—
—
2.7e+00
2.3e+00
cases:0.46%
controls:0.16%
cases:0.28%
controls:0.05%
cases:0.03%
controls:0.00%
—
—
—
—
cases:0.23%
controls:0.02%
cases:0.33%
controls:0.03%
90
303
19290
193417
54
88
19325
193632
6
7
19373
193713
—
—
36
29
15401
178815
28
37
8556
113434
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
N03AG01 [21604422]
9.0e-01
1.2e+00
1.4e+00
2.0e+00
1.3e+00
1.5e+00
1.7e+00
cases:1.58%
controls:0.65%
cases:1.81%
controls:0.54%
cases:0.90%
controls:0.23%
cases:0.09%
controls:0.01%
cases:0.80%
controls:0.22%
cases:2.60%
controls:0.60%
cases:4.73%
controls:0.88%
307
1263
19073
192457
351
1046
19028
192674
174
445
19205
193275
17
23
19362
193697
140
429
17331
192258
401
1066
15036
177778
406
998
8178
112473
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
3.6e-01
6.8e-01
1.8e+00
4.3e+00
1.7e+00
7.0e-01
4.5e-01
cases:4.64%
controls:3.29%
cases:3.69%
controls:1.91%
cases:1.59%
controls:0.26%
cases:0.94%
controls:0.01%
cases:1.43%
controls:0.28%
cases:4.66%
controls:2.37%
cases:11.16%
controls:7.45%
900
6376
18480
187344
715
3706
18664
190014
308
500
19071
193220
182
25
19197
193695
250
532
17221
192155
720
4247
14717
174597
958
8450
7626
105021
Disorientation, unspecified
R41.0 [45558469]
R41.0 [45558469]
1.2e+00
2.0e+00
3.3e+00
—
1.9e+00
9.9e-01
5.6e-01
cases:1.89%
controls:0.59%
cases:1.91%
controls:0.28%
cases:0.79%
controls:0.03%
—
—
cases:0.29%
controls:0.04%
cases:0.81%
controls:0.30%
cases:2.06%
controls:1.18%
367
1152
19013
192568
371
535
19008
193185
154
58
19225
193662
—
51
83
17420
192604
125
542
15312
178302
177
1342
8407
112129
Vascular dementia, unspecified
F01.9 [45533058]
F01.9 [45533058]
6.4e-01
9.8e-01
1.5e+00
4.8e+00
1.5e+00
4.3e-01
-1.0e-01
cases:0.63%
controls:0.34%
cases:0.60%
controls:0.23%
cases:0.22%
controls:0.05%
cases:0.38%
controls:0.00%
cases:0.22%
controls:0.05%
cases:0.62%
controls:0.40%
cases:1.13%
controls:1.25%
123
651
19257
193069
117
442
19262
193278
43
94
19336
193626
74
6
19305
193714
38
97
17433
192590
95
716
15342
178128
97
1418
8487
112053
Guidance and counselling related to ageing
OAB41 [2001308639]
OAB41 [2001308639]
1.0e+00
1.9e+00
3.1e+00
1.0e+50
—
2.8e+00
2.0e+00
cases:0.03%
controls:0.01%
cases:0.11%
controls:0.02%
cases:0.07%
controls:0.00%
cases:0.43%
controls:0.00%
—
—
cases:0.56%
controls:0.03%
cases:0.82%
controls:0.11%
6
21
19374
193699
21
31
19358
193689
13
6
19366
193714
84
0
19295
193720
—
86
60
15351
178784
70
125
8514
113346
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
94759-8 [586526]
2.0e-01
5.7e-01
1.8e+00
4.6e+00
1.6e+00
5.0e-01
4.7e-01
cases:2.03%
controls:1.66%
cases:1.18%
controls:0.67%
cases:0.52%
controls:0.09%
cases:0.32%
controls:0.00%
cases:0.44%
controls:0.08%
cases:1.22%
controls:0.74%
cases:4.46%
controls:2.82%
393
3224
18987
190496
229
1301
19150
192419
100
172
19279
193548
62
6
19317
193714
76
163
17395
192524
189
1329
15248
177515
383
3203
8201
110268
Acute tubulo-interstitial nephritis
N10 [45543856]
N10 [45543856]
3.2e-01
6.2e-01
1.7e+00
4.8e+00
1.1e+00
6.7e-01
5.4e-01
cases:4.70%
controls:3.47%
cases:2.57%
controls:1.40%
cases:1.07%
controls:0.19%
cases:1.02%
controls:0.01%
cases:0.55%
controls:0.18%
cases:3.02%
controls:1.56%
cases:9.19%
controls:5.55%
911
6727
18469
186993
499
2717
18880
191003
207
371
19172
193349
197
17
19182
193703
96
345
17375
192342
466
2794
14971
176050
789
6297
7795
107174
Depressive episode
F32 [45595904]
F32 [45595904]
6.1e-01
1.2e+00
1.6e+00
3.3e+00
1.2e+00
9.9e-01
6.9e-01
cases:0.80%
controls:0.44%
cases:0.41%
controls:0.12%
cases:0.07%
controls:0.01%
cases:0.07%
controls:0.00%
cases:0.07%
controls:0.02%
cases:0.32%
controls:0.12%
cases:0.79%
controls:0.40%
156
851
19224
192869
80
238
19299
193482
14
27
19365
193693
14
5
19365
193715
12
38
17459
192649
50
215
15387
178629
68
452
8516
113019
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
3.3e-01
6.4e-01
1.8e+00
4.2e+00
1.6e+00
6.6e-01
4.0e-01
cases:4.45%
controls:3.23%
cases:3.78%
controls:2.03%
cases:1.68%
controls:0.28%
cases:0.95%
controls:0.01%
cases:1.56%
controls:0.30%
cases:4.92%
controls:2.61%
cases:11.59%
controls:8.06%
862
6266
18518
187454
732
3938
18647
189782
325
543
19054
193177
185
27
19194
193693
272
585
17199
192102
759
4662
14678
174182
995
9145
7589
104326
Pelvis X-ray examination
NE1AA [2001307792]
NE1AA [2001307792]
1.9e-01
5.4e-01
2.3e+00
4.8e+00
7.5e-01
7.5e-01
4.1e-01
cases:2.13%
controls:1.77%
cases:1.10%
controls:0.64%
cases:0.61%
controls:0.06%
cases:0.30%
controls:0.00%
cases:0.15%
controls:0.07%
cases:1.48%
controls:0.70%
cases:3.96%
controls:2.66%
413
3425
18967
190295
213
1248
19166
192472
119
118
19260
193602
58
5
19321
193715
27
141
17444
192546
229
1259
15208
177585
340
3015
8244
110456
Psychological sympt/compl other
P29 [2002000823]
P29 [2002000823]
7.7e-01
1.1e+00
1.6e+00
2.8e+00
1.8e+00
1.1e+00
4.7e-01
cases:0.83%
controls:0.39%
cases:0.50%
controls:0.17%
cases:0.17%
controls:0.03%
cases:0.06%
controls:0.00%
cases:0.21%
controls:0.04%
cases:0.56%
controls:0.18%
cases:0.82%
controls:0.51%
161
750
19219
192970
97
326
19282
193394
33
66
19346
193654
12
7
19367
193713
37
69
17434
192618
86
321
15351
178523
70
581
8514
112890
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
1.8e-01
6.4e-01
2.0e+00
4.4e+00
1.4e+00
6.3e-01
4.1e-01
cases:2.77%
controls:2.31%
cases:1.77%
controls:0.94%
cases:0.93%
controls:0.13%
cases:0.78%
controls:0.01%
cases:0.53%
controls:0.13%
cases:2.13%
controls:1.15%
cases:6.14%
controls:4.16%
536
4482
18844
189238
343
1829
19036
191891
181
254
19198
193466
151
18
19228
193702
92
251
17379
192436
329
2053
15108
176791
527
4716
8057
108755
Delusional disorder
F22.0 [45581451]
F22.0 [45581451]
1.0e+00
1.4e+00
1.6e+00
3.5e+00
1.1e+00
1.0e+00
2.6e-01
cases:0.56%
controls:0.20%
cases:0.45%
controls:0.12%
cases:0.18%
controls:0.03%
cases:0.20%
controls:0.01%
cases:0.11%
controls:0.04%
cases:0.36%
controls:0.13%
cases:0.38%
controls:0.30%
108
397
19272
193323
88
223
19291
193497
34
67
19345
193653
38
12
19341
193708
20
70
17451
192617
55
227
15382
178617
33
338
8551
113133
Concussion
S06.0 [45582805]
S06.0 [45582805]
6.4e-01
9.0e-01
1.6e+00
4.4e+00
7.7e-01
7.6e-01
5.0e-01
cases:3.15%
controls:1.69%
cases:1.34%
controls:0.55%
cases:0.29%
controls:0.06%
cases:0.26%
controls:0.00%
cases:0.14%
controls:0.07%
cases:1.35%
controls:0.63%
cases:4.01%
controls:2.48%
611
3268
18769
190452
260
1064
19119
192656
57
112
19322
193608
50
6
19329
193714
25
128
17446
192559
208
1134
15229
177710
344
2811
8240
110660
Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations
F00.12 [2000501568]
F00.12 [2000501568]
3.4e+00
—
—
1.0e+50
—
3.4e+00
2.8e+00
cases:0.09%
controls:0.00%
—
—
—
—
cases:0.03%
controls:0.00%
—
—
cases:0.14%
controls:0.00%
cases:0.20%
controls:0.01%
18
6
19362
193714
—
—
6
0
19373
193720
—
21
8
15416
178836
17
14
8567
113457
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
14731-4 [3019309]
6.6e-01
1.5e+00
1.7e+00
3.1e+00
2.0e+00
3.7e-01
2.4e-01
cases:17.50%
controls:9.86%
cases:9.92%
controls:2.46%
cases:1.32%
controls:0.24%
cases:0.17%
controls:0.01%
cases:1.85%
controls:0.26%
cases:3.19%
controls:2.23%
cases:9.68%
controls:7.77%
3391
19108
15989
174612
1922
4773
17457
188947
255
462
19124
193258
32
14
19347
193706
323
500
17148
192187
493
3994
14944
174850
831
8814
7753
104657
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
8.2e-01
1.1e+00
1.2e+00
2.2e+00
1.0e+00
1.5e+00
1.7e+00
cases:1.29%
controls:0.57%
cases:1.38%
controls:0.47%
cases:0.84%
controls:0.24%
cases:0.07%
controls:0.01%
cases:0.65%
controls:0.24%
cases:2.19%
controls:0.50%
cases:4.38%
controls:0.87%
250
1107
19130
192613
268
907
19111
192813
162
467
19217
193253
14
15
19365
193705
113
455
17358
192232
338
901
15099
177943
376
985
8208
112486
haloperidol; oral, parenteral
N05AD01 [21604516]
N05AD01 [21604516]
9.8e-01
1.3e+00
1.7e+00
—
1.8e+00
1.9e+00
1.8e+00
cases:0.67%
controls:0.25%
cases:0.62%
controls:0.17%
cases:0.28%
controls:0.05%
—
—
cases:0.27%
controls:0.05%
cases:1.39%
controls:0.21%
cases:3.20%
controls:0.54%
130
489
19250
193231
121
322
19258
193398
54
97
19325
193623
—
48
91
17423
192596
215
372
15222
178472
275
617
8309
112854
Bacterial pneumonia, unspecified
J15.9 [45557621]
J15.9 [45557621]
2.5e-01
4.5e-01
1.6e+00
5.0e+00
1.3e+00
4.7e-01
3.6e-01
cases:2.00%
controls:1.56%
cases:0.90%
controls:0.58%
cases:0.37%
controls:0.08%
cases:0.53%
controls:0.00%
cases:0.27%
controls:0.07%
cases:1.15%
controls:0.72%
cases:3.55%
controls:2.51%
387
3015
18993
190705
175
1118
19204
192602
72
148
19307
193572
103
7
19276
193713
48
139
17423
192548
177
1287
15260
177557
305
2849
8279
110622
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
7.9e-01
1.1e+00
1.3e+00
2.1e+00
1.2e+00
1.4e+00
1.6e+00
cases:5.76%
controls:2.71%
cases:6.23%
controls:2.16%
cases:2.77%
controls:0.81%
cases:0.33%
controls:0.04%
cases:2.77%
controls:0.85%
cases:9.48%
controls:2.42%
cases:18.51%
controls:4.47%
1117
5241
18263
188479
1208
4191
18171
189529
536
1566
18843
192154
63
79
19316
193641
484
1630
16987
191057
1464
4328
13973
174516
1589
5075
6995
108396
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
2.1e-01
5.5e-01
1.8e+00
4.3e+00
1.5e+00
5.8e-01
3.9e-01
cases:6.08%
controls:4.98%
cases:4.86%
controls:2.87%
cases:2.25%
controls:0.38%
cases:1.30%
controls:0.02%
cases:1.84%
controls:0.41%
cases:6.04%
controls:3.47%
cases:14.57%
controls:10.33%
1179
9641
18201
184079
942
5554
18437
188166
436
728
18943
192992
251
33
19128
193687
321
783
17150
191904
933
6211
14504
172633
1251
11723
7333
101748
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
F00.11 [2000501567]
F00.11 [2000501567]
3.6e+00
—
—
1.0e+50
—
2.6e+00
3.1e+00
cases:0.11%
controls:0.00%
—
—
—
—
cases:0.04%
controls:0.00%
—
—
cases:0.09%
controls:0.01%
cases:0.38%
controls:0.02%
22
6
19358
193714
—
—
7
0
19372
193720
—
14
12
15423
178832
33
19
8551
113452
Lithium [Moles/volume] in Serum or Plasma
14334-7 [3024666]
14334-7 [3024666]
9.6e-01
1.5e+00
1.7e+00
—
2.9e+00
1.3e+00
9.4e-01
cases:0.15%
controls:0.06%
cases:0.17%
controls:0.04%
cases:0.05%
controls:0.01%
—
—
cases:0.07%
controls:0.00%
cases:0.15%
controls:0.04%
cases:0.20%
controls:0.08%
30
115
19350
193605
32
69
19347
193651
10
19
19369
193701
—
12
7
17459
192680
23
76
15414
178768
17
88
8567
113383
Circumscribed brain atrophy
G31.0 [45591166]
G31.0 [45591166]
8.8e-01
1.7e+00
1.8e+00
1.0e+50
1.8e+00
1.7e+00
1.3e+00
cases:0.15%
controls:0.06%
cases:0.22%
controls:0.04%
cases:0.07%
controls:0.01%
cases:0.08%
controls:0.00%
cases:0.07%
controls:0.01%
cases:0.30%
controls:0.05%
cases:0.48%
controls:0.13%
29
120
19351
193600
42
74
19337
193646
14
23
19365
193697
15
0
19364
193720
13
23
17458
192664
47
96
15390
178748
41
150
8543
113321
Assessment of need for rehabilitation and/or rehabilitation plan
SPAT1220 [2001700321]
SPAT1220 [2001700321]
3.0e-01
7.7e-01
1.1e+00
3.4e+00
2.3e+00
8.4e-01
5.6e-01
cases:2.44%
controls:1.81%
cases:1.16%
controls:0.54%
cases:0.21%
controls:0.07%
cases:0.17%
controls:0.01%
cases:0.56%
controls:0.06%
cases:1.08%
controls:0.47%
cases:2.55%
controls:1.47%
472
3504
18908
190216
224
1048
19155
192672
40
133
19339
193587
32
11
19347
193709
98
106
17373
192581
167
844
15270
178000
219
1667
8365
111804
Delirium, unspecified
F05.9 [45591078]
F05.9 [45591078]
1.2e+00
1.9e+00
3.1e+00
—
2.2e+00
6.8e-01
1.6e-01
cases:1.10%
controls:0.32%
cases:1.00%
controls:0.16%
cases:0.44%
controls:0.02%
—
—
cases:0.24%
controls:0.03%
cases:0.45%
controls:0.23%
cases:0.96%
controls:0.81%
214
624
19166
193096
193
303
19186
193417
85
37
19294
193683
—
42
49
17429
192638
70
413
15367
178431
82
921
8502
112550
Subcortical vascular dementia without additional symptoms
F01.20 [2000501587]
F01.20 [2000501587]
1.1e+00
1.4e+00
2.1e+00
—
2.5e+00
1.6e+00
5.0e-01
cases:0.50%
controls:0.17%
cases:0.55%
controls:0.13%
cases:0.25%
controls:0.03%
—
—
cases:0.33%
controls:0.03%
cases:0.84%
controls:0.18%
cases:0.83%
controls:0.50%
96
328
19284
193392
106
253
19273
193467
48
59
19331
193661
—
57
53
17414
192634
129
313
15308
178531
71
569
8513
112902
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
1.8e-01
4.5e-01
1.6e+00
5.2e+00
1.2e+00
4.1e-01
1.1e-01
cases:14.19%
controls:12.17%
cases:11.20%
controls:7.42%
cases:5.33%
controls:1.11%
cases:8.41%
controls:0.05%
cases:3.53%
controls:1.14%
cases:12.39%
controls:8.58%
cases:25.17%
controls:23.11%
2750
23576
16630
170144
2170
14376
17209
179344
1033
2150
18346
191570
1630
96
17749
193624
617
2201
16854
190486
1912
15339
13525
163505
2161
26221
6423
87250
Mild cognitive disorder
F06.7 [45605450]
F06.7 [45605450]
1.7e+00
2.3e+00
2.5e+00
—
1.7e+00
9.0e-01
-2.0e-01
cases:4.32%
controls:0.78%
cases:4.01%
controls:0.44%
cases:0.82%
controls:0.07%
—
—
cases:0.37%
controls:0.06%
cases:1.10%
controls:0.45%
cases:1.06%
controls:1.29%
838
1516
18542
192204
777
844
18602
192876
158
137
19221
193583
—
64
124
17407
192563
170
810
15267
178034
91
1460
8493
112011
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
1.1e-01
4.1e-01
1.7e+00
4.7e+00
1.1e+00
4.8e-01
4.7e-01
cases:7.80%
controls:7.02%
cases:4.50%
controls:3.04%
cases:2.43%
controls:0.45%
cases:3.22%
controls:0.03%
cases:1.47%
controls:0.48%
cases:6.11%
controls:3.87%
cases:18.30%
controls:12.33%
1512
13606
17868
180114
872
5893
18507
187827
470
873
18909
192847
624
56
18755
193664
257
917
17214
191770
943
6914
14494
171930
1571
13987
7013
99484
Fracture of upper end of humerus
S42.2 [45544677]
S42.2 [45544677]
3.5e-01
4.9e-01
1.6e+00
4.2e+00
1.3e+00
6.8e-01
4.6e-01
cases:1.25%
controls:0.89%
cases:0.50%
controls:0.30%
cases:0.23%
controls:0.05%
cases:0.23%
controls:0.00%
cases:0.19%
controls:0.05%
cases:0.59%
controls:0.30%
cases:1.67%
controls:1.06%
243
1715
19137
192005
96
589
19283
193131
44
88
19335
193632
45
7
19334
193713
34
103
17437
192584
91
536
15346
178308
143
1203
8441
112268
General guidance on nutrition and food
OAB76 [2001308654]
OAB76 [2001308654]
1.8e+00
1.7e+00
—
1.0e+50
—
2.9e+00
2.6e+00
cases:0.04%
controls:0.01%
cases:0.07%
controls:0.01%
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.43%
controls:0.02%
cases:0.72%
controls:0.05%
7
12
19373
193708
13
24
19366
193696
—
69
0
19310
193720
—
66
41
15371
178803
62
59
8522
113412
Delirium not superimposed on dementia, so described
F05.0 [45571703]
F05.0 [45571703]
1.4e+00
1.6e+00
2.3e+00
1.0e+50
2.2e+00
1.4e+00
7.5e-01
cases:0.15%
controls:0.04%
cases:0.10%
controls:0.02%
cases:0.05%
controls:0.00%
cases:0.06%
controls:0.00%
cases:0.03%
controls:0.00%
cases:0.13%
controls:0.03%
cases:0.20%
controls:0.09%
30
73
19350
193647
19
39
19360
193681
9
9
19370
193711
12
0
19367
193720
6
7
17465
192680
20
60
15417
178784
17
106
8567
113365
Urinary tract infection, site not specified
N39.0 [45548665]
N39.0 [45548665]
3.2e-01
6.1e-01
1.5e+00
4.6e+00
9.2e-01
6.1e-01
3.5e-01
cases:5.66%
controls:4.17%
cases:3.13%
controls:1.73%
cases:0.87%
controls:0.19%
cases:0.94%
controls:0.01%
cases:0.53%
controls:0.21%
cases:3.50%
controls:1.93%
cases:9.40%
controls:6.82%
1096
8074
18284
185646
606
3344
18773
190376
168
375
19211
193345
182
19
19197
193701
92
406
17379
192281
541
3450
14896
175394
807
7741
7777
105730
Unspecified nonorganic psychosis
F29 [45533099]
F29 [45533099]
1.0e+00
1.9e+00
2.6e+00
—
1.7e+00
1.5e+00
1.6e-01
cases:0.34%
controls:0.12%
cases:0.28%
controls:0.04%
cases:0.12%
controls:0.01%
—
—
cases:0.07%
controls:0.01%
cases:0.21%
controls:0.04%
cases:0.16%
controls:0.14%
66
242
19314
193478
54
79
19325
193641
24
17
19355
193703
—
13
25
17458
192662
32
80
15405
178764
14
158
8570
113313
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
95941-1 [36031861]
1.2e-01
5.2e-01
1.8e+00
4.3e+00
1.5e+00
5.7e-01
2.2e-01
cases:1.55%
controls:1.38%
cases:1.85%
controls:1.11%
cases:0.93%
controls:0.15%
cases:0.58%
controls:0.01%
cases:0.73%
controls:0.17%
cases:2.36%
controls:1.35%
cases:5.22%
controls:4.24%
301
2673
19079
191047
358
2150
19021
191570
180
288
19199
193432
112
16
19267
193704
127
326
17344
192361
364
2419
15073
176425
448
4806
8136
108665
Other delirium
F05.8 [45605447]
F05.8 [45605447]
9.2e-01
1.7e+00
3.1e+00
—
2.1e+00
1.0e+00
3.7e-01
cases:0.25%
controls:0.10%
cases:0.27%
controls:0.05%
cases:0.15%
controls:0.01%
—
—
cases:0.06%
controls:0.01%
cases:0.19%
controls:0.07%
cases:0.28%
controls:0.19%
48
192
19332
193528
52
96
19327
193624
29
13
19350
193707
—
11
15
17460
192672
29
124
15408
178720
24
220
8560
113251
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
A09 [45605189]
3.1e-01
5.2e-01
1.4e+00
5.0e+00
7.5e-01
6.2e-01
2.3e-01
cases:3.90%
controls:2.90%
cases:1.58%
controls:0.94%
cases:0.34%
controls:0.09%
cases:0.46%
controls:0.00%
cases:0.22%
controls:0.10%
cases:1.76%
controls:0.96%
cases:4.55%
controls:3.66%
756
5614
18624
188106
307
1829
19072
191891
65
168
19314
193552
90
6
19289
193714
38
199
17433
192488
272
1712
15165
177132
391
4154
8193
109317
glycopyrronium bromide; oral, parenteral, rectal
A03AB02 [21600141]
A03AB02 [21600141]
—
1.5e+00
4.1e+00
—
—
1.3e+00
1.9e+00
—
—
cases:0.07%
controls:0.02%
cases:0.21%
controls:0.00%
—
—
—
—
cases:0.14%
controls:0.04%
cases:1.14%
controls:0.17%
—
13
30
19366
193690
41
7
19338
193713
—
—
22
68
15415
178776
98
196
8486
113275
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
1.8e-01
4.5e-01
1.7e+00
4.3e+00
1.5e+00
4.3e-01
1.8e-01
cases:13.19%
controls:11.27%
cases:6.60%
controls:4.32%
cases:2.65%
controls:0.49%
cases:1.72%
controls:0.02%
cases:2.02%
controls:0.48%
cases:6.61%
controls:4.38%
cases:16.16%
controls:13.90%
2557
21839
16823
171881
1279
8364
18100
185356
514
941
18865
192779
333
45
19046
193675
353
919
17118
191768
1021
7841
14416
171003
1387
15769
7197
97702
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
2639-3 [3005895]
3.1e-01
5.4e-01
1.9e+00
4.0e+00
1.5e+00
4.1e-01
6.0e-02
cases:1.43%
controls:1.05%
cases:0.77%
controls:0.45%
cases:0.37%
controls:0.05%
cases:0.23%
controls:0.00%
cases:0.23%
controls:0.05%
cases:0.69%
controls:0.46%
cases:1.64%
controls:1.55%
277
2036
19103
191684
150
878
19229
192842
71
102
19308
193618
44
8
19335
193712
41
102
17430
192585
107
827
15330
178017
141
1757
8443
111714
periciazine; oral, parenteral
N05AC01 [21604511]
N05AC01 [21604511]
1.5e+00
2.2e+00
—
—
—
2.5e+00
2.5e+00
cases:0.08%
controls:0.02%
cases:0.08%
controls:0.01%
—
—
—
—
—
—
cases:0.11%
controls:0.01%
cases:0.20%
controls:0.02%
16
37
19364
193683
15
17
19364
193703
—
—
—
17
16
15420
178828
17
18
8567
113453
clozapine; oral, parenteral
N05AH02 [21604542]
N05AH02 [21604542]
1.4e+00
1.4e+00
1.4e+00
—
9.3e-01
1.6e+00
1.9e+00
cases:0.26%
controls:0.06%
cases:0.25%
controls:0.06%
cases:0.20%
controls:0.05%
—
—
cases:0.13%
controls:0.05%
cases:0.30%
controls:0.06%
cases:0.41%
controls:0.06%
50
123
19330
193597
48
116
19331
193604
38
94
19341
193626
—
22
96
17449
192591
47
110
15390
178734
35
70
8549
113401
Sequelae of cerebral infarction
I69.3 [45533476]
I69.3 [45533476]
2.9e-01
4.4e-01
1.1e+00
4.6e+00
1.3e+00
6.1e-01
2.5e-01
cases:3.88%
controls:2.94%
cases:2.68%
controls:1.74%
cases:1.08%
controls:0.35%
cases:2.78%
controls:0.03%
cases:1.35%
controls:0.36%
cases:3.67%
controls:2.03%
cases:6.56%
controls:5.17%
752
5686
18628
188034
520
3378
18859
190342
209
674
19170
193046
538
57
18841
193663
235
698
17236
191989
567
3627
14870
175217
563
5869
8021
107602
Feeding problem of adult
T05 [2002001069]
T05 [2002001069]
4.7e-01
1.5e+00
1.9e+00
1.3e+00
2.1e+00
1.7e+00
1.4e+00
cases:0.09%
controls:0.06%
cases:0.14%
controls:0.03%
cases:0.10%
controls:0.01%
cases:0.03%
controls:0.01%
cases:0.11%
controls:0.01%
cases:0.20%
controls:0.04%
cases:0.40%
controls:0.09%
18
112
19362
193608
27
63
19352
193657
20
29
19359
193691
5
13
19374
193707
20
26
17451
192661
31
69
15406
178775
34
106
8550
113365
sertraline; oral
N06AB06 [21604714]
N06AB06 [21604714]
9.1e-01
1.1e+00
1.2e+00
1.6e+00
1.1e+00
1.3e+00
1.3e+00
cases:1.88%
controls:0.76%
cases:1.54%
controls:0.50%
cases:0.61%
controls:0.18%
cases:0.05%
controls:0.01%
cases:0.59%
controls:0.20%
cases:1.98%
controls:0.55%
cases:3.53%
controls:0.94%
364
1477
19016
192243
298
975
19081
192745
118
346
19261
193374
9
19
19370
193701
103
381
17368
192306
305
990
15132
177854
303
1067
8281
112404
Epilepsy and comparable convulsive disorders
111 [2001600111]
111 [2001600111]
6.9e-01
1.2e+00
1.8e+00
—
2.7e+00
1.3e+00
9.1e-01
cases:0.75%
controls:0.38%
cases:0.36%
controls:0.11%
cases:0.07%
controls:0.01%
—
—
cases:0.14%
controls:0.01%
cases:0.43%
controls:0.12%
cases:0.99%
controls:0.40%
145
733
19235
192987
69
209
19310
193511
13
22
19366
193698
—
24
18
17447
192669
67
216
15370
178628
85
454
8499
113017
Emergency Medicine
93 [38004510]
93 [38004510]
1.9e-01
4.5e-01
1.6e+00
4.7e+00
9.3e-01
4.5e-01
1.9e-01
cases:28.84%
controls:25.01%
cases:20.96%
controls:14.43%
cases:10.14%
controls:2.23%
cases:9.24%
controls:0.09%
cases:5.64%
controls:2.30%
cases:22.94%
controls:15.92%
cases:40.79%
controls:36.38%
5589
48446
13791
145274
4062
27958
15317
165762
1965
4326
17414
189394
1791
178
17588
193542
985
4435
16486
188252
3542
28472
11895
150372
3501
41278
5083
72193
cyanocobalamin; nasal, oral, parenteral
B03BA01 [21601121]
B03BA01 [21601121]
7.2e-01
1.0e+00
1.3e+00
1.9e+00
1.3e+00
1.3e+00
9.6e-01
cases:2.14%
controls:1.05%
cases:2.18%
controls:0.77%
cases:1.27%
controls:0.36%
cases:0.14%
controls:0.02%
cases:1.43%
controls:0.38%
cases:3.28%
controls:0.95%
cases:5.20%
controls:2.05%
414
2027
18966
191693
422
1498
18957
192222
247
695
19132
193025
27
40
19352
193680
249
731
17222
191956
506
1706
14931
177138
446
2328
8138
111143
Cystitis, unspecified
N30.9 [45606488]
N30.9 [45606488]
2.8e-01
6.2e-01
1.4e+00
4.4e+00
9.6e-01
5.8e-01
3.1e-01
cases:1.74%
controls:1.33%
cases:0.98%
controls:0.53%
cases:0.29%
controls:0.07%
cases:0.25%
controls:0.00%
cases:0.18%
controls:0.07%
cases:1.09%
controls:0.62%
cases:2.98%
controls:2.20%
338
2574
19042
191146
190
1028
19189
192692
56
142
19323
193578
48
6
19331
193714
32
135
17439
192552
169
1104
15268
177740
256
2494
8328
110977
Dementia in Alzheimer disease, unspecified and Unspecified dementia
F00.9*F03 [2000503848]
F00.9*F03 [2000503848]
1.6e+00
2.4e+00
1.0e+50
—
—
2.5e+00
2.0e+00
cases:0.04%
controls:0.01%
cases:0.05%
controls:0.00%
cases:0.03%
controls:0.00%
—
—
—
—
cases:0.04%
controls:0.00%
cases:0.14%
controls:0.02%
8
16
19372
193704
10
9
19369
193711
5
0
19374
193720
—
—
6
6
15431
178838
12
21
8572
113450
Nausea and vomiting
R11 [45539317]
R11 [45539317]
3.4e-01
3.7e-01
1.3e+00
4.2e+00
1.2e+00
6.8e-01
3.5e-01
cases:2.16%
controls:1.54%
cases:0.80%
controls:0.55%
cases:0.23%
controls:0.06%
cases:0.22%
controls:0.00%
cases:0.22%
controls:0.07%
cases:1.15%
controls:0.59%
cases:2.96%
controls:2.11%
418
2992
18962
190728
155
1069
19224
192651
45
124
19334
193596
42
6
19337
193714
38
129
17433
192558
178
1052
15259
177792
254
2398
8330
111073
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
2.4e-01
5.6e-01
1.5e+00
4.7e+00
1.0e+00
3.7e-01
9.7e-02
cases:3.01%
controls:2.38%
cases:1.86%
controls:1.08%
cases:0.63%
controls:0.14%
cases:0.46%
controls:0.00%
cases:0.35%
controls:0.12%
cases:1.85%
controls:1.29%
cases:5.03%
controls:4.59%
583
4617
18797
189103
361
2087
19018
191633
122
269
19257
193451
89
8
19290
193712
61
238
17410
192449
286
2303
15151
176541
432
5206
8152
108265
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
94500-6 [706163]
1.2e-01
4.4e-01
1.6e+00
4.0e+00
1.4e+00
5.1e-01
3.8e-01
cases:12.31%
controls:11.02%
cases:7.92%
controls:5.24%
cases:3.20%
controls:0.67%
cases:1.63%
controls:0.03%
cases:2.80%
controls:0.68%
cases:9.06%
controls:5.63%
cases:21.42%
controls:15.74%
2385
21353
16995
172367
1535
10158
17844
183562
621
1304
18758
192416
315
61
19064
193659
489
1316
16982
191371
1399
10072
14038
168772
1839
17855
6745
95616
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
1.2e-01
4.2e-01
1.7e+00
4.1e+00
1.4e+00
4.7e-01
2.8e-01
cases:11.26%
controls:10.08%
cases:7.21%
controls:4.87%
cases:3.49%
controls:0.69%
cases:1.70%
controls:0.03%
cases:2.84%
controls:0.71%
cases:8.65%
controls:5.59%
cases:20.40%
controls:16.26%
2182
19528
17198
174192
1397
9440
17982
184280
676
1330
18703
192390
329
58
19050
193662
497
1361
16974
191326
1336
9993
14101
168851
1751
18449
6833
95022
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
3.6e-01
5.6e-01
1.6e+00
4.2e+00
1.2e+00
3.8e-01
1.6e-01
cases:3.09%
controls:2.18%
cases:1.55%
controls:0.89%
cases:0.58%
controls:0.11%
cases:0.42%
controls:0.01%
cases:0.41%
controls:0.12%
cases:1.48%
controls:1.01%
cases:3.83%
controls:3.30%
599
4221
18781
189499
300
1721
19079
191999
112
218
19267
193502
81
12
19298
193708
72
238
17399
192449
228
1815
15209
177029
329
3741
8255
109730
Other specified degenerative diseases of nervous system
G31.8 [45542879]
G31.8 [45542879]
1.1e+00
1.3e+00
1.8e+00
—
1.4e+00
1.5e+00
1.3e+00
cases:0.20%
controls:0.06%
cases:0.21%
controls:0.06%
cases:0.08%
controls:0.01%
—
—
cases:0.07%
controls:0.02%
cases:0.37%
controls:0.08%
cases:0.59%
controls:0.17%
38
125
19342
193595
41
114
19338
193606
16
26
19363
193694
—
12
33
17459
192654
57
150
15380
178694
51
189
8533
113282
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 [3014973]
22133-3 [3014973]
3.9e-01
2.2e+00
3.1e+00
—
3.0e+00
2.4e-01
-2.9e-01
cases:0.26%
controls:0.18%
cases:0.44%
controls:0.05%
cases:0.08%
controls:0.00%
—
—
cases:0.05%
controls:0.00%
cases:0.05%
controls:0.04%
cases:0.09%
controls:0.12%
51
344
19329
193376
85
91
19294
193629
16
7
19363
193713
—
9
5
17462
192682
8
73
15429
178771
8
141
8576
113330
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
29584-0 [3016018]
8.5e-01
2.6e+00
3.9e+00
1.0e+50
—
9.4e-01
3.0e-01
cases:0.39%
controls:0.17%
cases:0.86%
controls:0.06%
cases:0.19%
controls:0.00%
cases:0.03%
controls:0.00%
—
—
cases:0.16%
controls:0.06%
cases:0.27%
controls:0.20%
76
324
19304
193396
167
124
19212
193596
36
7
19343
193713
6
0
19373
193720
—
25
113
15412
178731
23
225
8561
113246
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
E87.1 [45542779]
4.2e-01
7.4e-01
1.6e+00
4.1e+00
1.0e+00
4.9e-01
-3.2e-01
cases:1.60%
controls:1.06%
cases:0.82%
controls:0.39%
cases:0.29%
controls:0.06%
cases:0.27%
controls:0.00%
cases:0.14%
controls:0.05%
cases:0.73%
controls:0.45%
cases:1.16%
controls:1.60%
310
2046
19070
191674
158
760
19221
192960
57
116
19322
193604
52
9
19327
193711
25
101
17446
192586
112
796
15325
178048
100
1811
8484
111660
Emergency Room Visit
ER [9203]
ER [9203]
1.9e-01
4.1e-01
1.6e+00
4.6e+00
8.7e-01
3.7e-01
2.1e-01
cases:49.07%
controls:44.27%
cases:22.98%
controls:16.47%
cases:11.04%
controls:2.37%
cases:8.70%
controls:0.09%
cases:5.48%
controls:2.37%
cases:22.99%
controls:17.03%
cases:48.56%
controls:43.46%
9510
85758
9870
107962
4454
31904
14925
161816
2140
4593
17239
189127
1686
184
17693
193536
957
4572
16514
188115
3549
30450
11888
148394
4168
49317
4416
64154
Other and unspecified convulsions
R56.8 [45602033]
R56.8 [45602033]
5.7e-01
1.3e+00
2.7e+00
—
1.7e+00
1.1e+00
1.1e+00
cases:0.75%
controls:0.42%
cases:0.49%
controls:0.14%
cases:0.19%
controls:0.01%
—
—
cases:0.13%
controls:0.02%
cases:0.44%
controls:0.15%
cases:1.44%
controls:0.50%
145
823
19235
192897
95
271
19284
193449
37
26
19342
193694
—
23
48
17448
192639
68
273
15369
178571
124
564
8460
112907
Social problem NOS
Z29 [2002001483]
Z29 [2002001483]
1.0e+00
1.3e+00
1.6e+00
—
2.2e+00
1.4e+00
8.1e-01
cases:0.73%
controls:0.26%
cases:0.45%
controls:0.12%
cases:0.10%
controls:0.02%
—
—
cases:0.17%
controls:0.02%
cases:0.55%
controls:0.14%
cases:1.08%
controls:0.49%
141
500
19239
193220
87
242
19292
193478
19
40
19360
193680
—
30
37
17441
192650
85
253
15352
178591
93
551
8491
112920
Epilepsy
G40 [45595935]
G40 [45595935]
5.6e-01
1.0e+00
2.1e+00
1.0e+50
2.8e+00
1.1e+00
7.5e-01
cases:0.52%
controls:0.30%
cases:0.24%
controls:0.09%
cases:0.09%
controls:0.01%
cases:0.03%
controls:0.00%
cases:0.11%
controls:0.01%
cases:0.27%
controls:0.09%
cases:0.68%
controls:0.32%
100
573
19280
193147
46
170
19333
193550
17
21
19362
193699
5
0
19374
193720
20
14
17451
192673
42
164
15395
178680
58
365
8526
113106
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
G40.22 [2000502141]
6.6e-01
1.1e+00
2.0e+00
1.0e+50
1.9e+00
1.3e+00
1.3e+00
cases:0.54%
controls:0.28%
cases:0.47%
controls:0.16%
cases:0.16%
controls:0.02%
cases:0.30%
controls:0.00%
cases:0.18%
controls:0.03%
cases:0.58%
controls:0.16%
cases:1.12%
controls:0.31%
105
542
19275
193178
91
304
19288
193416
31
41
19348
193679
59
0
19320
193720
32
53
17439
192634
89
289
15348
178555
96
357
8488
113114
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 [3010380]
22126-7 [3010380]
3.0e-01
2.2e+00
3.1e+00
—
2.9e+00
3.7e-01
-1.9e-01
cases:0.23%
controls:0.17%
cases:0.42%
controls:0.04%
cases:0.08%
controls:0.00%
—
—
cases:0.05%
controls:0.00%
cases:0.05%
controls:0.04%
cases:0.09%
controls:0.11%
45
332
19335
193388
81
87
19298
193633
15
7
19364
193713
—
8
5
17463
192682
8
64
15429
178780
8
128
8576
113343
Hip X-ray examination
NF1AA [2001307894]
NF1AA [2001307894]
-9.6e-02
2.3e-01
1.9e+00
4.6e+00
6.5e-01
4.9e-01
4.5e-01
cases:2.27%
controls:2.49%
cases:1.04%
controls:0.83%
cases:0.64%
controls:0.09%
cases:0.25%
controls:0.00%
cases:0.20%
controls:0.10%
cases:1.34%
controls:0.83%
cases:4.38%
controls:2.85%
439
4817
18941
188903
202
1611
19177
192109
124
184
19255
193536
49
5
19330
193715
35
202
17436
192485
207
1476
15230
177368
376
3231
8208
110240
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
7.4e-01
1.2e+00
1.5e+00
2.4e+00
1.9e+00
2.5e-01
8.6e-02
cases:15.86%
controls:8.26%
cases:17.27%
controls:5.65%
cases:3.00%
controls:0.66%
cases:0.23%
controls:0.02%
cases:4.33%
controls:0.67%
cases:8.09%
controls:6.40%
cases:19.65%
controls:18.33%
3074
15992
16306
177728
3346
10943
16033
182777
581
1274
18798
192446
45
41
19334
193679
756
1285
16715
191402
1249
11453
14188
167391
1687
20804
6897
92667
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
Z50.9 [45595525]
5.8e-01
8.9e-01
1.1e+00
2.6e+00
1.3e+00
9.5e-01
6.7e-01
cases:1.04%
controls:0.59%
cases:0.59%
controls:0.24%
cases:0.11%
controls:0.04%
cases:0.05%
controls:0.00%
cases:0.14%
controls:0.04%
cases:0.65%
controls:0.25%
cases:1.68%
controls:0.87%
202
1136
19178
192584
114
470
19265
193250
22
71
19357
193649
9
7
19370
193713
24
72
17447
192615
100
452
15337
178392
144
984
8440
112487
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
1.6e-01
4.8e-01
1.7e+00
4.6e+00
1.1e+00
1.3e-01
-2.1e-02
cases:3.04%
controls:2.61%
cases:1.99%
controls:1.24%
cases:0.79%
controls:0.15%
cases:0.40%
controls:0.00%
cases:0.45%
controls:0.14%
cases:1.65%
controls:1.44%
cases:4.60%
controls:4.69%
590
5061
18790
188659
385
2410
18994
191310
153
292
19226
193428
78
8
19301
193712
79
278
17392
192409
254
2579
15183
176265
395
5327
8189
108144
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
13969-1 [3005785]
9.3e-02
4.3e-01
1.5e+00
4.2e+00
1.1e+00
3.6e-01
3.4e-01
cases:4.35%
controls:3.98%
cases:2.07%
controls:1.36%
cases:0.77%
controls:0.17%
cases:0.50%
controls:0.01%
cases:0.50%
controls:0.16%
cases:1.96%
controls:1.37%
cases:5.77%
controls:4.19%
843
7707
18537
186013
402
2643
18977
191077
150
335
19229
193385
96
14
19283
193706
88
314
17383
192373
302
2458
15135
176386
495
4749
8089
108722
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
2.1e-01
5.0e-01
1.3e+00
3.9e+00
1.3e+00
5.0e-01
3.5e-01
cases:34.73%
controls:30.17%
cases:23.74%
controls:15.92%
cases:9.35%
controls:2.71%
cases:4.76%
controls:0.10%
cases:8.91%
controls:2.70%
cases:24.80%
controls:16.66%
cases:45.75%
controls:37.33%
6730
58437
12650
135283
4600
30846
14779
162874
1811
5242
17568
188478
922
202
18457
193518
1557
5208
15914
187479
3829
29788
11608
149056
3927
42363
4657
71108
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
3.0e-01
5.3e-01
1.5e+00
4.3e+00
1.1e+00
2.5e-01
5.9e-02
cases:3.95%
controls:2.94%
cases:2.11%
controls:1.25%
cases:0.71%
controls:0.16%
cases:0.51%
controls:0.01%
cases:0.48%
controls:0.16%
cases:1.83%
controls:1.42%
cases:4.88%
controls:4.61%
766
5705
18614
188015
408
2426
18971
191294
138
301
19241
193419
98
14
19281
193706
83
301
17388
192386
282
2544
15155
176300
419
5235
8165
108236
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
-8.7e-02
2.0e-01
1.1e+00
4.3e+00
1.6e+00
4.9e-01
2.9e-01
cases:4.02%
controls:4.37%
cases:2.45%
controls:2.01%
cases:0.82%
controls:0.28%
cases:0.90%
controls:0.01%
cases:1.42%
controls:0.28%
cases:3.06%
controls:1.89%
cases:6.45%
controls:4.93%
779
8463
18601
185257
474
3900
18905
189820
159
545
19220
193175
174
24
19205
193696
248
538
17223
192149
473
3387
14964
175457
554
5596
8030
107875
Cells panel - Urine sediment
58434-2 [40761535]
58434-2 [40761535]
1.2e-01
4.7e-01
1.2e+00
4.0e+00
1.2e+00
6.1e-01
4.9e-01
cases:4.33%
controls:3.85%
cases:2.06%
controls:1.29%
cases:0.62%
controls:0.18%
cases:0.30%
controls:0.01%
cases:0.58%
controls:0.18%
cases:2.15%
controls:1.18%
cases:5.42%
controls:3.40%
839
7454
18541
186266
399
2503
18980
191217
120
357
19259
193363
59
11
19320
193709
102
338
17369
192349
332
2116
15105
176728
465
3854
8119
109617
Acute cystitis
N30.0 [45601724]
N30.0 [45601724]
2.4e-01
5.9e-01
1.4e+00
4.2e+00
7.1e-01
4.9e-01
3.1e-01
cases:5.06%
controls:4.03%
cases:3.00%
controls:1.69%
cases:0.79%
controls:0.20%
cases:0.71%
controls:0.01%
cases:0.44%
controls:0.21%
cases:3.04%
controls:1.90%
cases:8.31%
controls:6.23%
980
7805
18400
185915
582
3275
18797
190445
153
391
19226
193329
137
20
19242
193700
76
412
17395
192275
470
3390
14967
175454
713
7066
7871
106405
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
7.5e-01
1.2e+00
1.3e+00
1.1e+00
1.4e+00
1.2e+00
1.0e+00
cases:28.85%
controls:16.02%
cases:29.41%
controls:11.43%
cases:15.34%
controls:4.77%
cases:5.99%
controls:2.06%
cases:16.99%
controls:4.82%
cases:33.65%
controls:13.26%
cases:52.78%
controls:29.00%
5591
31035
13789
162685
5699
22138
13680
171582
2972
9245
16407
184475
1161
3988
18218
189732
2969
9293
14502
183394
5194
23714
10243
155130
4531
32903
4053
80568
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
4.2e-02
9.9e-02
1.8e+00
4.8e+00
1.0e+00
3.0e-01
8.0e-02
cases:5.89%
controls:5.67%
cases:1.48%
controls:1.34%
cases:0.85%
controls:0.14%
cases:0.38%
controls:0.00%
cases:0.36%
controls:0.13%
cases:1.69%
controls:1.26%
cases:5.22%
controls:4.84%
1142
10975
18238
182745
286
2593
19093
191127
165
275
19214
193445
73
6
19306
193714
63
253
17408
192434
261
2256
15176
176588
448
5487
8136
107984
Functional capacity evaluation
443351003 [40481051]
443351003 [40481051]
6.5e-01
1.1e+00
1.1e+00
2.0e+00
1.2e+00
1.0e+00
7.6e-01
cases:11.55%
controls:6.39%
cases:8.82%
controls:3.11%
cases:2.71%
controls:0.90%
cases:1.23%
controls:0.16%
cases:3.04%
controls:0.91%
cases:8.84%
controls:3.34%
cases:16.52%
controls:8.49%
2239
12375
17141
181345
1710
6034
17669
187686
525
1742
18854
191978
238
317
19141
193403
531
1762
16940
190925
1364
5982
14073
172862
1418
9629
7166
103842
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
F06.9 [45561999]
F06.9 [45561999]
1.7e+00
2.1e+00
—
—
2.4e+00
1.7e+00
1.0e+00
cases:0.13%
controls:0.02%
cases:0.11%
controls:0.01%
—
—
—
—
cases:0.03%
controls:0.00%
cases:0.06%
controls:0.01%
cases:0.08%
controls:0.03%
25
47
19355
193673
21
25
19358
193695
—
—
5
5
17466
192682
9
19
15428
178825
7
33
8577
113438
Anxiety disorder, unspecified
F41.9 [45542849]
F41.9 [45542849]
2.8e-01
8.0e-01
1.4e+00
4.0e+00
1.2e+00
5.5e-01
-4.3e-01
cases:0.63%
controls:0.48%
cases:0.46%
controls:0.21%
cases:0.13%
controls:0.03%
cases:0.13%
controls:0.00%
cases:0.12%
controls:0.04%
cases:0.39%
controls:0.23%
cases:0.44%
controls:0.68%
122
922
19258
192798
89
401
19290
193319
26
67
19353
193653
26
5
19353
193715
21
68
17450
192619
60
403
15377
178441
38
769
8546
112702
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
3.4e-01
5.3e-01
1.7e+00
4.1e+00
1.5e+00
1.4e-01
-3.0e-01
cases:2.00%
controls:1.43%
cases:1.36%
controls:0.80%
cases:0.61%
controls:0.11%
cases:0.50%
controls:0.01%
cases:0.44%
controls:0.10%
cases:1.07%
controls:0.93%
cases:2.29%
controls:3.07%
388
2778
18992
190942
264
1557
19115
192163
119
213
19260
193507
96
16
19283
193704
76
193
17395
192494
165
1662
15272
177182
197
3483
8387
109988
Other specified urinary incontinence
N39.4 [45577525]
N39.4 [45577525]
3.3e-01
5.9e-01
6.9e-01
4.0e+00
1.1e+00
7.8e-01
4.1e-01
cases:3.20%
controls:2.32%
cases:1.94%
controls:1.08%
cases:0.43%
controls:0.21%
cases:0.72%
controls:0.01%
cases:0.57%
controls:0.20%
cases:2.58%
controls:1.20%
cases:4.62%
controls:3.12%
620
4492
18760
189228
375
2099
19004
191621
83
415
19296
193305
139
26
19240
193694
100
384
17371
192303
399
2148
15038
176696
397
3537
8187
109934
Cerebral infarction, unspecified
I63.9 [45596216]
I63.9 [45596216]
1.1e-01
3.1e-01
1.3e+00
4.6e+00
1.2e+00
3.8e-01
-4.1e-03
cases:3.99%
controls:3.61%
cases:1.84%
controls:1.35%
cases:0.82%
controls:0.22%
cases:1.45%
controls:0.01%
cases:0.74%
controls:0.22%
cases:2.23%
controls:1.54%
cases:4.79%
controls:4.81%
774
6991
18606
186729
356
2623
19023
191097
158
418
19221
193302
281
29
19098
193691
129
421
17342
192266
345
2753
15092
176091
411
5454
8173
108017
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
1.5e-01
5.1e-01
1.4e+00
4.9e+00
1.1e+00
1.5e-01
-2.5e-01
cases:6.26%
controls:5.44%
cases:3.08%
controls:1.87%
cases:0.80%
controls:0.20%
cases:0.56%
controls:0.00%
cases:0.64%
controls:0.21%
cases:2.15%
controls:1.86%
cases:5.06%
controls:6.38%
1214
10529
18166
183191
596
3617
18783
190103
156
394
19223
193326
108
8
19271
193712
112
405
17359
192282
332
3322
15105
175522
434
7245
8150
106226
olanzapine and samidorphan
N05AH53 [955100]
N05AH53 [955100]
9.9e-01
1.3e+00
2.0e+00
—
—
1.6e+00
2.0e+00
cases:0.15%
controls:0.06%
cases:0.10%
controls:0.03%
cases:0.07%
controls:0.01%
—
—
—
—
cases:0.14%
controls:0.03%
cases:0.50%
controls:0.07%
30
111
19350
193609
19
50
19360
193670
13
18
19366
193702
—
—
21
51
15416
178793
43
81
8541
113390
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
3.4e-01
5.1e-01
1.7e+00
4.0e+00
1.3e+00
1.6e-01
-2.3e-01
cases:1.98%
controls:1.41%
cases:1.25%
controls:0.75%
cases:0.56%
controls:0.10%
cases:0.41%
controls:0.01%
cases:0.33%
controls:0.09%
cases:0.98%
controls:0.84%
cases:2.23%
controls:2.79%
383
2736
18997
190984
243
1462
19136
192258
108
196
19271
193524
79
15
19300
193705
58
179
17413
192508
152
1509
15285
177335
191
3164
8393
110307
Inpatient Visit
IP [9201]
IP [9201]
2.3e-02
2.0e-01
1.1e+00
4.9e+00
1.4e+00
3.0e-01
-1.0e-01
cases:12.61%
controls:12.35%
cases:6.95%
controls:5.75%
cases:2.05%
controls:0.73%
cases:4.43%
controls:0.03%
cases:3.05%
controls:0.75%
cases:7.84%
controls:5.90%
cases:15.56%
controls:16.99%
2443
23926
16937
169794
1346
11136
18033
182584
397
1406
18982
192314
858
66
18521
193654
532
1452
16939
191235
1210
10556
14227
168288
1336
19276
7248
94195
Limited function/disability NOS
A28 [2002000162]
A28 [2002000162]
8.1e-01
1.1e+00
1.3e+00
1.2e+00
1.4e+00
1.1e+00
7.1e-01
cases:15.35%
controls:7.45%
cases:15.18%
controls:5.39%
cases:8.26%
controls:2.33%
cases:2.97%
controls:0.90%
cases:9.16%
controls:2.32%
cases:17.35%
controls:6.37%
cases:26.25%
controls:14.89%
2974
14439
16406
179281
2941
10439
16438
183281
1601
4519
17778
189201
575
1736
18804
191984
1600
4468
15871
188219
2678
11398
12759
167446
2253
16891
6331
96580
Acute renal failure, unspecified
N17.9 [45567829]
N17.9 [45567829]
1.7e-01
5.4e-01
1.8e+00
4.1e+00
1.4e+00
1.7e-01
-6.4e-02
cases:0.70%
controls:0.59%
cases:0.48%
controls:0.28%
cases:0.24%
controls:0.04%
cases:0.31%
controls:0.01%
cases:0.21%
controls:0.05%
cases:0.44%
controls:0.37%
cases:1.25%
controls:1.33%
135
1135
19245
192585
93
543
19286
193177
46
78
19333
193642
61
10
19318
193710
36
103
17435
192584
68
667
15369
178177
107
1506
8477
111965
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
6.0e-02
3.2e-01
1.5e+00
4.4e+00
1.2e+00
2.3e-01
9.0e-02
cases:18.24%
controls:17.36%
cases:11.16%
controls:8.37%
cases:5.10%
controls:1.18%
cases:4.30%
controls:0.06%
cases:3.96%
controls:1.17%
cases:11.04%
controls:8.97%
cases:24.86%
controls:23.22%
3535
33631
15845
160089
2163
16211
17216
177509
989
2292
18390
191428
833
108
18546
193612
691
2252
16780
190435
1705
16049
13732
162795
2134
26351
6450
87120
escitalopram; oral
N06AB10 [21604718]
N06AB10 [21604718]
7.9e-01
1.0e+00
1.0e+00
2.0e+00
8.9e-01
1.0e+00
1.0e+00
cases:5.65%
controls:2.64%
cases:4.49%
controls:1.67%
cases:1.58%
controls:0.58%
cases:0.22%
controls:0.03%
cases:1.34%
controls:0.55%
cases:4.75%
controls:1.78%
cases:8.29%
controls:3.07%
1095
5106
18285
188614
871
3241
18508
190479
307
1130
19072
192590
42
57
19337
193663
234
1063
17237
191624
733
3176
14704
175668
712
3486
7872
109985
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
2.8e-01
4.5e-01
1.5e+00
4.1e+00
1.2e+00
2.8e-01
1.4e-01
cases:2.98%
controls:2.28%
cases:1.26%
controls:0.81%
cases:0.42%
controls:0.10%
cases:0.28%
controls:0.00%
cases:0.33%
controls:0.10%
cases:1.15%
controls:0.87%
cases:3.19%
controls:2.79%
578
4419
18802
189301
244
1567
19135
192153
81
189
19298
193531
55
9
19324
193711
58
194
17413
192493
178
1560
15259
177284
274
3171
8310
110300
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
2.7e-01
4.0e-01
1.4e+00
4.1e+00
1.2e+00
4.2e-01
8.6e-02
cases:10.74%
controls:8.43%
cases:6.05%
controls:4.13%
cases:2.30%
controls:0.59%
cases:1.74%
controls:0.03%
cases:1.99%
controls:0.61%
cases:6.45%
controls:4.32%
cases:12.05%
controls:11.16%
2081
16328
17299
177392
1173
8004
18206
185716
445
1150
18934
192570
337
56
19042
193664
347
1174
17124
191513
995
7730
14442
171114
1034
12667
7550
100804
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
2.0e-01
4.7e-01
1.3e+00
3.7e+00
1.3e+00
4.7e-01
3.1e-01
cases:16.84%
controls:14.23%
cases:11.83%
controls:7.71%
cases:4.42%
controls:1.26%
cases:2.09%
controls:0.05%
cases:4.32%
controls:1.27%
cases:12.76%
controls:8.39%
cases:27.00%
controls:21.31%
3264
27558
16116
166162
2292
14945
17087
178775
856
2434
18523
191286
405
98
18974
193622
754
2446
16717
190241
1970
15005
13467
163839
2318
24185
6266
89286
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
G45.9 [45542892]
2.2e-01
3.7e-01
1.3e+00
4.6e+00
9.8e-01
2.7e-01
3.4e-03
cases:3.21%
controls:2.59%
cases:1.26%
controls:0.87%
cases:0.40%
controls:0.11%
cases:0.46%
controls:0.00%
cases:0.29%
controls:0.11%
cases:1.19%
controls:0.90%
cases:2.99%
controls:2.98%
623
5009
18757
188711
245
1692
19134
192028
78
219
19301
193501
90
9
19289
193711
51
211
17420
192476
183
1615
15254
177229
257
3386
8327
110085
Internal Medicine
11 [38004456]
11 [38004456]
9.0e-02
3.3e-01
1.3e+00
4.6e+00
8.8e-01
3.9e-01
1.1e-01
cases:36.53%
controls:34.46%
cases:18.29%
controls:13.86%
cases:8.01%
controls:2.26%
cases:9.13%
controls:0.10%
cases:5.34%
controls:2.28%
cases:19.32%
controls:13.92%
cases:36.00%
controls:33.58%
7079
66761
12301
126959
3545
26846
15834
166874
1552
4374
17827
189346
1770
194
17609
193526
933
4396
16538
188291
2983
24900
12454
153944
3090
38098
5494
75373
Hallucinations, unspecified
R44.3 [45563307]
R44.3 [45563307]
6.5e-01
2.1e+00
3.3e+00
1.0e+50
2.3e+00
6.4e-01
2.9e-02
cases:0.13%
controls:0.07%
cases:0.20%
controls:0.03%
cases:0.07%
controls:0.00%
cases:0.06%
controls:0.00%
cases:0.05%
controls:0.00%
cases:0.06%
controls:0.03%
cases:0.15%
controls:0.15%
26
136
19354
193584
39
49
19340
193671
14
5
19365
193715
12
0
19367
193720
8
9
17463
192678
10
61
15427
178783
13
167
8571
113304
Body temperature
8310-5 [3020891]
8310-5 [3020891]
2.6e-03
3.2e-01
1.6e+00
4.4e+00
1.4e+00
1.5e-01
5.9e-02
cases:1.38%
controls:1.37%
cases:0.95%
controls:0.70%
cases:0.43%
controls:0.09%
cases:0.32%
controls:0.00%
cases:0.39%
controls:0.09%
cases:0.95%
controls:0.82%
cases:2.73%
controls:2.57%
267
2662
19113
191058
185
1352
19194
192368
84
175
19295
193545
62
8
19317
193712
68
181
17403
192506
147
1467
15290
177377
234
2920
8350
110551
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
1.1e-01
4.4e-01
1.4e+00
4.1e+00
8.4e-01
4.3e-01
3.6e-01
cases:2.63%
controls:2.36%
cases:1.35%
controls:0.87%
cases:0.47%
controls:0.11%
cases:0.29%
controls:0.00%
cases:0.22%
controls:0.09%
cases:1.41%
controls:0.92%
cases:4.38%
controls:3.08%
509
4567
18871
189153
261
1691
19118
192029
92
219
19287
193501
56
9
19323
193711
38
182
17433
192505
217
1649
15220
177195
376
3500
8208
109971
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
4.1e-01
5.7e-01
1.5e+00
4.2e+00
9.8e-01
2.2e-01
-4.5e-02
cases:2.47%
controls:1.66%
cases:1.26%
controls:0.72%
cases:0.40%
controls:0.09%
cases:0.27%
controls:0.00%
cases:0.22%
controls:0.08%
cases:0.99%
controls:0.80%
cases:2.35%
controls:2.46%
479
3216
18901
190504
244
1390
19135
192330
78
179
19301
193541
53
8
19326
193712
39
161
17432
192526
153
1427
15284
177417
202
2789
8382
110682
Internal fixation of fracture of upper femur with screws and sideplate
NFJ52 [2001307953]
NFJ52 [2001307953]
3.4e-01
3.4e-01
3.6e+00
—
2.1e+00
1.2e+00
7.5e-01
cases:0.18%
controls:0.12%
cases:0.06%
controls:0.04%
cases:0.09%
controls:0.00%
—
—
cases:0.03%
controls:0.00%
cases:0.12%
controls:0.04%
cases:0.38%
controls:0.18%
34
241
19346
193479
12
85
19367
193635
18
5
19361
193715
—
6
8
17465
192679
19
68
15418
178776
33
207
8551
113264
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
76080-1 [46235759]
-1.9e-01
1.7e-01
1.8e+00
4.7e+00
1.1e+00
2.7e-01
5.8e-02
cases:1.18%
controls:1.41%
cases:0.81%
controls:0.68%
cases:0.45%
controls:0.08%
cases:0.29%
controls:0.00%
cases:0.26%
controls:0.09%
cases:0.96%
controls:0.73%
cases:2.17%
controls:2.05%
228
2740
19152
190980
157
1324
19222
192396
87
150
19292
193570
56
5
19323
193715
45
165
17426
192522
148
1309
15289
177535
186
2323
8398
111148
Dysthymia
F34.1 [45586238]
F34.1 [45586238]
3.1e-01
7.1e-01
1.3e+00
3.6e+00
1.2e+00
7.4e-01
4.7e-01
cases:0.26%
controls:0.19%
cases:0.16%
controls:0.08%
cases:0.06%
controls:0.02%
cases:0.09%
controls:0.00%
cases:0.07%
controls:0.02%
cases:0.19%
controls:0.09%
cases:0.33%
controls:0.20%
51
376
19329
193344
31
153
19348
193567
12
33
19367
193687
18
5
19361
193715
12
38
17459
192649
30
166
15407
178678
28
232
8556
113239
Norclozapine [Moles/volume] in Serum or Plasma
14851-0 [3008832]
14851-0 [3008832]
1.0e+00
1.2e+00
1.1e+00
—
2.3e+00
1.6e+00
1.4e+00
cases:0.10%
controls:0.03%
cases:0.09%
controls:0.03%
cases:0.03%
controls:0.01%
—
—
cases:0.05%
controls:0.00%
cases:0.13%
controls:0.03%
cases:0.16%
controls:0.04%
19
67
19361
193653
17
51
19362
193669
5
16
19374
193704
—
8
9
17463
192678
20
45
15417
178799
14
46
8570
113425
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
2.6e-01
4.5e-01
1.5e+00
4.0e+00
1.2e+00
2.1e-01
-4.5e-02
cases:4.75%
controls:3.71%
cases:2.50%
controls:1.60%
cases:0.86%
controls:0.20%
cases:0.56%
controls:0.01%
cases:0.60%
controls:0.19%
cases:2.23%
controls:1.82%
cases:5.57%
controls:5.81%
920
7183
18460
186537
485
3107
18894
190613
167
387
19212
193333
109
20
19270
193700
104
360
17367
192327
344
3255
15093
175589
478
6594
8106
106877
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
2.0e-01
3.7e-01
1.2e+00
4.5e+00
8.7e-01
4.0e-01
1.2e-01
cases:3.42%
controls:2.82%
cases:1.29%
controls:0.89%
cases:0.42%
controls:0.12%
cases:0.33%
controls:0.00%
cases:0.32%
controls:0.13%
cases:1.44%
controls:0.97%
cases:3.53%
controls:3.14%
663
5466
18717
188254
250
1729
19129
191991
81
242
19298
193478
63
7
19316
193713
56
260
17415
192427
222
1735
15215
177109
303
3563
8281
109908
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
72160-5 [43054903]
5.4e-01
1.2e+00
1.4e+00
2.5e+00
1.8e+00
1.8e-01
5.9e-02
cases:29.00%
controls:19.21%
cases:26.16%
controls:9.44%
cases:3.83%
controls:1.02%
cases:0.37%
controls:0.03%
cases:5.60%
controls:1.02%
cases:11.65%
controls:9.92%
cases:28.31%
controls:27.12%
5621
37221
13759
156499
5069
18283
14310
175437
743
1971
18636
191749
71
59
19308
193661
978
1959
16493
190728
1799
17745
13638
161099
2430
30775
6154
82696
Decubitus ulcer and pressure area
L89 [45601235]
L89 [45601235]
4.1e-01
9.7e-02
1.1e+00
3.4e+00
1.0e+00
6.6e-01
9.5e-01
cases:0.40%
controls:0.27%
cases:0.21%
controls:0.19%
cases:0.15%
controls:0.05%
cases:0.14%
controls:0.00%
cases:0.11%
controls:0.04%
cases:0.46%
controls:0.24%
cases:1.75%
controls:0.68%
78
518
19302
193202
41
372
19338
193348
30
103
19349
193617
28
9
19351
193711
20
81
17451
192606
71
427
15366
178417
150
777
8434
112694
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
3.7e-01
8.5e-01
1.1e+00
3.4e+00
1.4e+00
2.9e-01
9.1e-02
cases:25.64%
controls:19.19%
cases:20.44%
controls:9.93%
cases:4.71%
controls:1.58%
cases:1.59%
controls:0.06%
cases:6.30%
controls:1.59%
cases:13.19%
controls:10.20%
cases:25.92%
controls:24.20%
4970
37179
14410
156541
3961
19233
15418
174487
912
3069
18467
190651
309
107
19070
193613
1100
3067
16371
189620
2036
18249
13401
160595
2225
27464
6359
86007
Lifestyle advice and guidance
OAB48 [2001308646]
OAB48 [2001308646]
—
2.3e+00
—
1.0e+50
—
3.1e+00
2.1e+00
—
—
cases:0.09%
controls:0.01%
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.32%
controls:0.02%
cases:0.58%
controls:0.07%
—
17
17
19362
193703
—
35
0
19344
193720
—
50
27
15387
178817
50
78
8534
113393
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
1.5e-01
4.2e-01
1.4e+00
4.3e+00
9.4e-01
2.4e-01
6.5e-02
cases:27.22%
controls:24.38%
cases:16.80%
controls:11.71%
cases:6.54%
controls:1.63%
cases:4.68%
controls:0.07%
cases:4.05%
controls:1.61%
cases:14.93%
controls:12.13%
cases:32.25%
controls:30.84%
5276
47232
14104
146488
3256
22691
16123
171029
1268
3152
18111
190568
906
128
18473
193592
707
3108
16764
189579
2304
21698
13133
157146
2768
34991
5816
78480
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
40988-8 [3044254]
-1.5e-01
1.9e-01
1.8e+00
4.6e+00
1.1e+00
2.6e-01
4.5e-02
cases:1.08%
controls:1.26%
cases:0.75%
controls:0.62%
cases:0.42%
controls:0.07%
cases:0.27%
controls:0.00%
cases:0.23%
controls:0.08%
cases:0.88%
controls:0.68%
cases:1.99%
controls:1.91%
210
2434
19170
191286
146
1210
19233
192510
81
141
19298
193579
52
5
19327
193715
41
151
17430
192536
136
1216
15301
177628
171
2163
8413
111308
Retention of urine
R33 [45587507]
R33 [45587507]
3.2e-01
6.2e-01
1.3e+00
3.8e+00
9.8e-01
5.2e-01
7.1e-02
cases:3.17%
controls:2.32%
cases:1.80%
controls:0.98%
cases:0.61%
controls:0.17%
cases:0.34%
controls:0.01%
cases:0.47%
controls:0.18%
cases:1.83%
controls:1.10%
cases:3.55%
controls:3.32%
614
4495
18766
189225
349
1895
19030
191825
118
334
19261
193386
66
15
19313
193705
82
340
17389
192347
283
1971
15154
176873
305
3763
8279
109708
Palliative care
Z51.5 [45547323]
Z51.5 [45547323]
2.5e-01
4.3e-01
1.3e+00
3.7e+00
8.8e-01
5.2e-01
6.2e-01
cases:0.30%
controls:0.23%
cases:0.80%
controls:0.52%
cases:1.05%
controls:0.29%
cases:0.92%
controls:0.02%
cases:0.74%
controls:0.31%
cases:2.03%
controls:1.22%
cases:5.86%
controls:3.23%
58
451
19322
193269
156
1016
19223
192704
203
555
19176
193165
178
43
19201
193677
130
599
17341
192088
313
2173
15124
176671
503
3668
8081
109803
Other symptoms and signs involving cognitive functions and awareness
R41 [45544146]
R41 [45544146]
1.8e+00
2.4e+00
3.3e+00
—
-1.0e+50
-1.2e-01
—
cases:0.75%
controls:0.12%
cases:0.55%
controls:0.05%
cases:0.08%
controls:0.00%
—
—
cases:0.00%
controls:0.00%
cases:0.05%
controls:0.06%
—
—
145
240
19235
193480
107
98
19272
193622
16
6
19363
193714
—
0
6
17471
192681
8
104
15429
178740
—
Mixed cortical and subcortical vascular dementia without additional symptoms
F01.30 [2000501593]
F01.30 [2000501593]
9.8e-01
1.3e+00
1.9e+00
—
2.3e+00
9.8e-01
2.7e-01
cases:0.21%
controls:0.08%
cases:0.26%
controls:0.07%
cases:0.11%
controls:0.02%
—
—
cases:0.14%
controls:0.01%
cases:0.25%
controls:0.09%
cases:0.30%
controls:0.23%
41
154
19339
193566
51
135
19328
193585
21
33
19358
193687
—
25
27
17446
192660
38
166
15399
178678
26
262
8558
113209
Memory test
SPAT1053 [2001700154]
SPAT1053 [2001700154]
1.2e+00
2.0e+00
1.5e+00
1.3e+00
8.7e-01
1.1e+00
8.3e-01
cases:20.14%
controls:7.28%
cases:14.38%
controls:2.30%
cases:1.01%
controls:0.24%
cases:0.04%
controls:0.01%
cases:0.54%
controls:0.23%
cases:6.32%
controls:2.14%
cases:14.57%
controls:6.94%
3904
14098
15476
179622
2786
4446
16593
189274
196
459
19183
193261
7
19
19372
193701
95
442
17376
192245
976
3833
14461
175011
1251
7880
7333
105591
Persistent delusional disorder, unspecified
F22.9 [45542837]
F22.9 [45542837]
9.0e-01
1.2e+00
1.9e+00
—
2.1e+00
1.3e+00
5.3e-01
cases:0.17%
controls:0.07%
cases:0.10%
controls:0.03%
cases:0.04%
controls:0.01%
—
—
cases:0.06%
controls:0.01%
cases:0.16%
controls:0.04%
cases:0.16%
controls:0.10%
32
130
19348
193590
20
58
19359
193662
8
12
19371
193708
—
10
14
17461
192673
25
79
15412
178765
14
109
8570
113362
Chronic ischaemic heart disease, unspecified
I25.9 [45552784]
I25.9 [45552784]
5.9e-02
2.2e-01
1.1e+00
4.9e+00
9.1e-01
3.0e-01
8.2e-02
cases:4.56%
controls:4.31%
cases:2.07%
controls:1.67%
cases:0.78%
controls:0.27%
cases:1.75%
controls:0.01%
cases:0.70%
controls:0.28%
cases:2.57%
controls:1.90%
cases:6.15%
controls:5.69%
884
8348
18496
185372
402
3235
18977
190485
152
528
19227
193192
340
26
19039
193694
123
547
17348
192140
396
3406
15041
175438
528
6461
8056
107010
citalopram; oral, parenteral
N06AB04 [21604712]
N06AB04 [21604712]
6.8e-01
9.0e-01
9.4e-01
2.2e+00
8.2e-01
8.5e-01
9.5e-01
cases:6.08%
controls:3.17%
cases:4.85%
controls:2.02%
cases:1.51%
controls:0.60%
cases:0.16%
controls:0.02%
cases:1.33%
controls:0.59%
cases:4.52%
controls:1.98%
cases:7.63%
controls:3.10%
1178
6147
18202
187573
939
3914
18440
189806
293
1153
19086
192567
31
33
19348
193687
232
1139
17239
191548
697
3546
14740
175298
655
3517
7929
109954
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
2.6e-01
4.1e-01
1.4e+00
4.1e+00
1.1e+00
1.7e-01
-4.1e-02
cases:4.22%
controls:3.28%
cases:2.08%
controls:1.39%
cases:0.73%
controls:0.17%
cases:0.51%
controls:0.01%
cases:0.53%
controls:0.17%
cases:1.89%
controls:1.61%
cases:4.97%
controls:5.17%
817
6363
18563
187357
404
2697
18975
191023
142
337
19237
193383
98
16
19281
193704
93
332
17378
192355
292
2873
15145
175971
427
5868
8157
107603
Specific gravity of Urine by Refractometry
5810-7 [3019150]
5810-7 [3019150]
1.6e-01
4.5e-01
1.1e+00
3.7e+00
1.2e+00
4.1e-01
2.8e-01
cases:10.54%
controls:9.13%
cases:7.70%
controls:5.06%
cases:2.59%
controls:0.84%
cases:1.21%
controls:0.03%
cases:2.71%
controls:0.83%
cases:8.06%
controls:5.48%
cases:17.35%
controls:13.63%
2042
17679
17338
176041
1492
9811
17887
183909
502
1624
18877
192096
234
60
19145
193660
474
1599
16997
191088
1244
9797
14193
169047
1489
15470
7095
98001
cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]
14656-3 [3000081]
1.0e+00
1.1e+00
1.1e+00
—
2.2e+00
1.6e+00
1.4e+00
cases:0.11%
controls:0.04%
cases:0.10%
controls:0.03%
cases:0.03%
controls:0.01%
—
—
cases:0.05%
controls:0.01%
cases:0.15%
controls:0.03%
cases:0.19%
controls:0.05%
22
78
19358
193642
20
64
19359
193656
6
20
19373
193700
—
9
11
17462
192676
23
55
15414
178789
16
54
8568
113417
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
2.6e-01
4.4e-01
1.5e+00
4.0e+00
1.2e+00
1.9e-01
-3.5e-02
cases:4.71%
controls:3.68%
cases:2.47%
controls:1.60%
cases:0.87%
controls:0.20%
cases:0.55%
controls:0.01%
cases:0.61%
controls:0.19%
cases:2.21%
controls:1.84%
cases:5.60%
controls:5.79%
913
7129
18467
186591
479
3098
18900
190622
169
390
19210
193330
106
20
19273
193700
106
371
17365
192316
341
3287
15096
175557
481
6570
8103
106901
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
2.6e-01
4.4e-01
1.7e+00
3.7e+00
8.8e-01
2.8e-01
7.7e-02
cases:4.81%
controls:3.75%
cases:1.71%
controls:1.11%
cases:0.66%
controls:0.12%
cases:0.23%
controls:0.01%
cases:0.28%
controls:0.12%
cases:1.44%
controls:1.09%
cases:3.84%
controls:3.57%
932
7266
18448
186454
332
2144
19047
191576
128
226
19251
193494
44
11
19335
193709
49
224
17422
192463
223
1956
15214
176888
330
4050
8254
109421
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
2.6e-01
4.4e-01
1.5e+00
4.0e+00
1.2e+00
1.9e-01
-3.7e-02
cases:4.70%
controls:3.68%
cases:2.47%
controls:1.60%
cases:0.87%
controls:0.20%
cases:0.55%
controls:0.01%
cases:0.61%
controls:0.19%
cases:2.21%
controls:1.84%
cases:5.59%
controls:5.79%
911
7128
18469
186592
478
3098
18901
190622
168
389
19211
193331
106
20
19273
193700
106
371
17365
192316
341
3283
15096
175561
480
6569
8104
106902
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
1.6e-01
3.6e-01
1.3e+00
4.0e+00
1.1e+00
3.3e-01
-3.8e-03
cases:6.92%
controls:5.96%
cases:5.27%
controls:3.75%
cases:2.18%
controls:0.58%
cases:1.12%
controls:0.02%
cases:1.83%
controls:0.60%
cases:5.73%
controls:4.17%
cases:10.75%
controls:10.79%
1342
11545
18038
182175
1021
7260
18358
186460
422
1130
18957
192590
217
41
19162
193679
319
1151
17152
191536
884
7462
14553
171382
923
12242
7661
101229
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
2.5e-01
4.2e-01
1.4e+00
4.0e+00
1.1e+00
1.9e-01
-3.6e-02
cases:4.72%
controls:3.70%
cases:2.42%
controls:1.60%
cases:0.84%
controls:0.20%
cases:0.52%
controls:0.01%
cases:0.60%
controls:0.19%
cases:2.19%
controls:1.82%
cases:5.57%
controls:5.76%
914
7158
18466
186562
469
3099
18910
190621
163
386
19216
193334
101
18
19278
193702
105
375
17366
192312
338
3249
15099
175595
478
6539
8106
106932
Schizoaffective disorder, unspecified
F25.9 [45605490]
F25.9 [45605490]
1.4e+00
1.4e+00
1.5e+00
—
1.9e+00
1.3e+00
1.2e+00
cases:0.14%
controls:0.04%
cases:0.10%
controls:0.02%
cases:0.04%
controls:0.01%
—
—
cases:0.06%
controls:0.01%
cases:0.10%
controls:0.03%
cases:0.14%
controls:0.04%
28
69
19352
193651
19
45
19360
193675
7
15
19372
193705
—
11
18
17460
192669
16
50
15421
178794
12
47
8572
113424
Support of social functional capacity
SPAT1234 [2001700335]
SPAT1234 [2001700335]
8.5e-01
1.1e+00
1.2e+00
5.6e-01
1.2e+00
1.3e+00
1.2e+00
cases:3.75%
controls:1.64%
cases:3.33%
controls:1.16%
cases:1.89%
controls:0.60%
cases:0.30%
controls:0.17%
cases:1.92%
controls:0.59%
cases:4.39%
controls:1.29%
cases:8.62%
controls:2.79%
727
3186
18653
190534
645
2240
18734
191480
366
1168
19013
192552
59
338
19320
193382
336
1140
17135
191547
677
2313
14760
176531
740
3171
7844
110300
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
3.9e-01
8.4e-01
1.1e+00
3.3e+00
1.4e+00
2.0e-01
-5.8e-02
cases:29.12%
controls:21.75%
cases:23.77%
controls:11.82%
cases:5.77%
controls:1.92%
cases:1.79%
controls:0.07%
cases:7.48%
controls:1.90%
cases:14.65%
controls:12.36%
cases:28.19%
controls:29.39%
5643
42128
13737
151592
4606
22900
14773
170820
1118
3715
18261
190005
346
134
19033
193586
1307
3661
16164
189026
2261
22102
13176
156742
2420
33346
6164
80125
Urine culture
117010004 [4024509]
117010004 [4024509]
4.3e-02
4.6e-01
1.2e+00
3.3e+00
1.8e+00
4.2e-01
-8.6e-02
cases:0.22%
controls:0.21%
cases:0.84%
controls:0.53%
cases:0.35%
controls:0.10%
cases:0.09%
controls:0.00%
cases:0.65%
controls:0.10%
cases:1.33%
controls:0.88%
cases:2.36%
controls:2.57%
42
402
19338
193318
162
1028
19217
192692
68
202
19311
193518
17
6
19362
193714
113
202
17358
192485
206
1572
15231
177272
203
2919
8381
110552
Lactate [Moles/volume] in Cerebral spinal fluid
2520-5 [3035999]
2520-5 [3035999]
2.9e-01
1.7e+00
3.1e+00
—
2.4e+00
7.8e-01
7.8e-02
cases:0.21%
controls:0.16%
cases:0.26%
controls:0.05%
cases:0.08%
controls:0.00%
—
—
cases:0.05%
controls:0.00%
cases:0.08%
controls:0.04%
cases:0.15%
controls:0.14%
41
306
19339
193414
50
89
19329
193631
16
7
19363
193713
—
9
9
17462
192678
13
69
15424
178775
13
159
8571
113312
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
1.7e-01
4.1e-01
1.2e+00
3.0e+00
1.8e+00
5.3e-01
2.0e-01
cases:2.61%
controls:2.22%
cases:1.44%
controls:0.96%
cases:0.37%
controls:0.11%
cases:0.08%
controls:0.00%
cases:0.73%
controls:0.13%
cases:1.80%
controls:1.07%
cases:4.33%
controls:3.57%
506
4298
18874
189422
280
1861
19099
191859
72
222
19307
193498
16
8
19363
193712
127
244
17344
192443
278
1907
15159
176937
372
4049
8212
109422
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
6.6e-01
1.3e+00
1.2e+00
1.8e+00
1.5e+00
4.4e-01
3.3e-01
cases:13.59%
controls:7.49%
cases:12.28%
controls:3.56%
cases:1.67%
controls:0.50%
cases:0.11%
controls:0.02%
cases:2.07%
controls:0.48%
cases:5.69%
controls:3.75%
cases:14.13%
controls:10.58%
2634
14500
16746
179220
2379
6892
17000
186828
323
978
19056
192742
21
36
19358
193684
361
932
17110
191755
878
6707
14559
172137
1213
12001
7371
101470
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
NFB20 [2001307920]
NFB20 [2001307920]
5.6e-01
6.2e-01
2.9e+00
—
1.1e+00
1.1e+00
9.9e-01
cases:1.15%
controls:0.66%
cases:0.51%
controls:0.28%
cases:0.46%
controls:0.03%
—
—
cases:0.08%
controls:0.03%
cases:0.85%
controls:0.30%
cases:3.41%
controls:1.30%
222
1271
19158
192449
99
535
19280
193185
90
52
19289
193668
—
14
50
17457
192637
131
532
15306
178312
293
1477
8291
111994
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
2.0e-01
3.7e-01
1.3e+00
3.9e+00
1.1e+00
3.2e-01
-3.8e-02
cases:7.22%
controls:6.01%
cases:5.00%
controls:3.51%
cases:1.96%
controls:0.55%
cases:1.07%
controls:0.02%
cases:1.65%
controls:0.57%
cases:5.28%
controls:3.88%
cases:9.67%
controls:10.01%
1399
11647
17981
182073
968
6802
18411
186918
379
1070
19000
192650
208
41
19171
193679
289
1093
17182
191594
815
6939
14622
171905
830
11357
7754
102114
Weakness/tiredness general
A04 [2002000145]
A04 [2002000145]
5.1e-01
7.2e-01
1.3e+00
1.7e+00
1.5e+00
8.3e-01
5.2e-01
cases:6.23%
controls:3.84%
cases:3.95%
controls:1.96%
cases:1.74%
controls:0.47%
cases:0.74%
controls:0.13%
cases:2.11%
controls:0.46%
cases:4.90%
controls:2.20%
cases:10.43%
controls:6.47%
1207
7445
18173
186275
766
3804
18613
189916
338
912
19041
192808
143
253
19236
193467
368
892
17103
191795
756
3938
14681
174906
895
7343
7689
106128
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
N05BA06 [21604571]
4.7e-01
6.2e-01
8.2e-01
1.7e+00
6.6e-01
1.3e+00
1.6e+00
cases:1.97%
controls:1.25%
cases:1.67%
controls:0.90%
cases:0.73%
controls:0.32%
cases:0.06%
controls:0.01%
cases:0.64%
controls:0.33%
cases:3.54%
controls:1.01%
cases:8.46%
controls:1.91%
382
2416
18998
191304
324
1748
19055
191972
141
622
19238
193098
12
22
19367
193698
111
636
17360
192051
547
1811
14890
177033
726
2172
7858
111299
In Home Supportive Care Agency
253Z00000X [38004206]
253Z00000X [38004206]
6.8e-01
9.9e-01
1.1e+00
7.6e-01
1.1e+00
1.2e+00
1.2e+00
cases:2.80%
controls:1.44%
cases:2.94%
controls:1.11%
cases:1.78%
controls:0.59%
cases:0.67%
controls:0.31%
cases:1.79%
controls:0.59%
cases:4.07%
controls:1.21%
cases:8.46%
controls:2.80%
543
2784
18837
190936
569
2156
18810
191564
345
1140
19034
192580
129
603
19250
193117
312
1129
17159
191558
628
2169
14809
176675
726
3174
7858
110297
Volume depletion
E86 [45581386]
E86 [45581386]
6.0e-01
1.1e+00
2.1e+00
—
1.5e+00
9.8e-01
7.5e-01
cases:0.74%
controls:0.41%
cases:0.55%
controls:0.18%
cases:0.22%
controls:0.03%
—
—
cases:0.10%
controls:0.02%
cases:0.63%
controls:0.24%
cases:1.85%
controls:0.88%
143
785
19237
192935
107
358
19272
193362
42
51
19337
193669
—
18
43
17453
192644
97
423
15340
178421
159
999
8425
112472
Mononuclear cells/Leukocytes in Cerebral spinal fluid
26492-9 [3033306]
26492-9 [3033306]
1.4e+00
2.6e+00
3.1e+00
1.0e+50
—
7.0e-01
6.5e-01
cases:0.24%
controls:0.06%
cases:0.34%
controls:0.03%
cases:0.06%
controls:0.00%
cases:0.04%
controls:0.00%
—
—
cases:0.05%
controls:0.03%
cases:0.16%
controls:0.09%
47
116
19333
193604
65
50
19314
193670
11
5
19368
193715
8
0
19371
193720
—
8
46
15429
178798
14
97
8570
113374
Screening of depression or other psychiatric problem
SPAT1246 [2001700347]
SPAT1246 [2001700347]
1.5e+00
2.0e+00
1.5e+00
—
2.3e+00
1.2e+00
5.2e-01
cases:1.35%
controls:0.31%
cases:0.69%
controls:0.09%
cases:0.04%
controls:0.01%
—
—
cases:0.06%
controls:0.01%
cases:0.27%
controls:0.08%
cases:0.49%
controls:0.29%
262
591
19118
193129
134
179
19245
193541
7
15
19372
193705
—
11
12
17460
192675
41
140
15396
178704
42
331
8542
113140
Organic hallucinosis
F06.0 [45552430]
F06.0 [45552430]
1.2e+00
2.0e+00
2.3e+00
—
2.2e+00
1.5e+00
6.7e-01
cases:0.13%
controls:0.04%
cases:0.11%
controls:0.02%
cases:0.04%
controls:0.00%
—
—
cases:0.03%
controls:0.00%
cases:0.06%
controls:0.01%
cases:0.09%
controls:0.05%
25
72
19355
193648
22
30
19357
193690
7
7
19372
193713
—
5
6
17466
192681
10
26
15427
178818
8
54
8576
113417
Infectious disease other/NOS
A78 [2002000212]
A78 [2002000212]
6.9e-01
4.9e-01
1.9e+00
—
2.0e+00
1.3e+00
1.2e+00
cases:0.21%
controls:0.10%
cases:0.08%
controls:0.05%
cases:0.04%
controls:0.01%
—
—
cases:0.03%
controls:0.00%
cases:0.21%
controls:0.06%
cases:0.62%
controls:0.19%
40
201
19340
193519
16
98
19363
193622
7
11
19372
193709
—
6
9
17465
192678
32
100
15405
178744
53
216
8531
113255
Nursing episode
950 [44777714]
950 [44777714]
5.8e-01
9.3e-01
1.1e+00
1.3e+00
1.1e+00
1.1e+00
9.2e-01
cases:10.80%
controls:6.32%
cases:10.04%
controls:4.22%
cases:5.09%
controls:1.73%
cases:1.36%
controls:0.37%
cases:4.96%
controls:1.76%
cases:13.14%
controls:4.89%
cases:24.78%
controls:11.65%
2094
12251
17286
181469
1946
8184
17433
185536
987
3352
18392
190368
263
717
19116
193003
867
3389
16604
189298
2028
8739
13409
170105
2127
13221
6457
100250
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
1.1e-01
3.4e-01
1.3e+00
3.9e+00
1.0e+00
2.9e-01
4.9e-02
cases:11.97%
controls:10.86%
cases:7.77%
controls:5.67%
cases:3.12%
controls:0.85%
cases:1.54%
controls:0.03%
cases:2.36%
controls:0.85%
cases:7.82%
controls:5.99%
cases:15.97%
controls:15.32%
2319
21031
17061
172689
1505
10988
17874
182732
605
1639
18774
192081
298
62
19081
193658
412
1640
17059
191047
1207
10710
14230
168134
1371
17386
7213
96085
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
N02BA01 [21604305]
4.9e-01
8.3e-01
1.1e+00
1.6e+00
1.1e+00
9.8e-01
7.6e-01
cases:7.23%
controls:4.57%
cases:6.18%
controls:2.78%
cases:3.78%
controls:1.23%
cases:0.36%
controls:0.07%
cases:3.83%
controls:1.26%
cases:7.85%
controls:3.08%
cases:13.94%
controls:7.05%
1402
8861
17978
184859
1198
5388
18181
188332
732
2390
18647
191330
70
137
19309
193583
670
2430
16801
190257
1212
5516
14225
173328
1197
7997
7387
105474
Neurosurgery
14 [38004459]
14 [38004459]
3.9e-01
6.8e-01
1.0e+00
3.0e+00
1.1e+00
7.6e-01
2.0e-01
cases:4.26%
controls:2.92%
cases:2.10%
controls:1.07%
cases:0.51%
controls:0.18%
cases:0.11%
controls:0.01%
cases:0.48%
controls:0.17%
cases:2.07%
controls:0.98%
cases:2.97%
controls:2.45%
826
5653
18554
188067
407
2073
18972
191647
98
345
19281
193375
21
10
19358
193710
84
323
17387
192364
319
1755
15118
177089
255
2782
8329
110689
Postmenopausal osteoporosis with pathological fracture
M80.0 [45572553]
M80.0 [45572553]
2.2e-01
3.7e-01
8.5e-01
4.4e+00
9.8e-01
7.6e-01
1.9e-01
cases:0.79%
controls:0.64%
cases:0.46%
controls:0.32%
cases:0.12%
controls:0.05%
cases:0.25%
controls:0.00%
cases:0.15%
controls:0.06%
cases:0.71%
controls:0.33%
cases:1.10%
controls:0.91%
154
1240
19226
192480
89
616
19290
193104
24
103
19355
193617
48
6
19331
193714
26
108
17445
192579
109
590
15328
178254
94
1028
8490
112443
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.2 [45591172]
G40.2 [45591172]
8.1e-01
9.0e-01
1.7e+00
—
2.8e+00
1.3e+00
1.1e+00
cases:0.38%
controls:0.17%
cases:0.14%
controls:0.06%
cases:0.03%
controls:0.00%
—
—
cases:0.10%
controls:0.01%
cases:0.24%
controls:0.06%
cases:0.57%
controls:0.19%
74
329
19306
193391
28
114
19351
193606
5
9
19374
193711
—
17
11
17454
192676
37
112
15400
178732
49
221
8535
113250
Fall involving bed
W06 [45575895]
W06 [45575895]
3.5e-01
8.9e-01
2.2e+00
—
1.9e+00
1.2e+00
8.0e-01
cases:0.19%
controls:0.14%
cases:0.17%
controls:0.07%
cases:0.07%
controls:0.01%
—
—
cases:0.05%
controls:0.01%
cases:0.27%
controls:0.08%
cases:0.70%
controls:0.31%
37
262
19343
193458
32
132
19347
193588
14
16
19365
193704
—
9
15
17462
192672
41
141
15396
178703
60
357
8524
113114
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.9e-02
2.0e-01
1.0e+00
4.0e+00
1.5e+00
3.0e-01
-7.5e-02
cases:10.71%
controls:10.53%
cases:3.23%
controls:2.65%
cases:0.89%
controls:0.33%
cases:0.67%
controls:0.01%
cases:1.35%
controls:0.32%
cases:3.50%
controls:2.61%
cases:7.65%
controls:8.20%
2076
20398
17304
173322
625
5132
18754
188588
173
630
19206
193090
129
24
19250
193696
235
614
17236
192073
541
4671
14896
174173
657
9304
7927
104167
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
1.1e-01
3.3e-01
1.3e+00
3.9e+00
1.0e+00
3.0e-01
9.7e-02
cases:16.62%
controls:15.14%
cases:10.16%
controls:7.52%
cases:3.95%
controls:1.15%
cases:2.05%
controls:0.04%
cases:3.06%
controls:1.15%
cases:10.38%
controls:7.94%
cases:22.08%
controls:20.46%
3220
29329
16160
164391
1969
14566
17410
179154
766
2225
18613
191495
397
85
18982
193635
534
2208
16937
190479
1603
14197
13834
164647
1895
23212
6689
90259
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
1.1e-01
3.3e-01
1.3e+00
3.9e+00
1.0e+00
2.8e-01
1.1e-02
cases:14.43%
controls:13.17%
cases:9.77%
controls:7.20%
cases:3.98%
controls:1.12%
cases:2.05%
controls:0.04%
cases:3.18%
controls:1.14%
cases:10.16%
controls:7.85%
cases:20.04%
controls:19.86%
2797
25511
16583
168209
1893
13942
17486
179778
772
2179
18607
191541
397
82
18982
193638
555
2200
16916
190487
1569
14046
13868
164798
1720
22532
6864
90939
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
1.2e-01
3.5e-01
1.1e+00
3.6e+00
1.2e+00
3.0e-01
1.8e-01
cases:12.57%
controls:11.32%
cases:8.73%
controls:6.34%
cases:3.19%
controls:1.04%
cases:1.53%
controls:0.04%
cases:3.35%
controls:1.01%
cases:9.00%
controls:6.86%
cases:19.06%
controls:16.40%
2437
21932
16943
171788
1692
12291
17687
181429
619
2017
18760
191703
297
79
19082
193641
586
1944
16885
190743
1390
12266
14047
166578
1636
18605
6948
94866
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
8.4e-02
3.0e-01
1.1e+00
3.5e+00
1.5e+00
3.0e-01
9.8e-02
cases:48.67%
controls:46.57%
cases:37.97%
controls:31.27%
cases:18.19%
controls:6.81%
cases:15.39%
controls:0.52%
cases:24.01%
controls:6.82%
cases:39.46%
controls:32.53%
cases:59.84%
controls:57.48%
9432
90218
9948
103502
7359
60576
12020
133144
3525
13199
15854
180521
2982
1016
16397
192704
4195
13147
13276
179540
6092
58180
9345
120664
5137
65222
3447
48249
Liquor cerebri shunt X-ray examinatin without contrast
AA7AA [2001300207]
AA7AA [2001300207]
6.6e-01
1.9e+00
—
—
—
2.8e+00
2.2e+00
cases:0.07%
controls:0.04%
cases:0.08%
controls:0.01%
—
—
—
—
—
—
cases:0.06%
controls:0.00%
cases:0.10%
controls:0.01%
14
72
19366
193648
16
25
19363
193695
—
—
—
10
7
15427
178837
9
13
8575
113458
Dizziness and giddiness
R42 [45568132]
R42 [45568132]
4.0e-01
5.3e-01
9.6e-01
3.9e+00
7.9e-01
2.3e-01
-1.2e-01
cases:10.34%
controls:7.17%
cases:4.03%
controls:2.41%
cases:0.75%
controls:0.29%
cases:0.72%
controls:0.01%
cases:0.60%
controls:0.27%
cases:3.14%
controls:2.51%
cases:7.54%
controls:8.42%
2004
13886
17376
179834
781
4676
18598
189044
145
560
19234
193160
139
27
19240
193693
104
524
17367
192163
485
4490
14952
174354
647
9551
7937
103920
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
1.9e-02
3.1e-01
1.5e+00
4.1e+00
1.2e+00
2.6e-02
-2.5e-01
cases:2.87%
controls:2.82%
cases:2.19%
controls:1.61%
cases:0.99%
controls:0.22%
cases:0.68%
controls:0.01%
cases:0.69%
controls:0.22%
cases:1.92%
controls:1.87%
cases:4.85%
controls:6.14%
557
5465
18823
188255
424
3118
18955
190602
191
419
19188
193301
131
22
19248
193698
120
417
17351
192270
296
3343
15141
175501
416
6969
8168
106502
Unspecified osteoporosis with pathological fracture
M80.9 [45553292]
M80.9 [45553292]
3.5e-01
4.5e-01
1.1e+00
4.3e+00
8.6e-01
6.1e-01
2.1e-01
cases:0.68%
controls:0.48%
cases:0.34%
controls:0.22%
cases:0.10%
controls:0.03%
cases:0.22%
controls:0.00%
cases:0.09%
controls:0.04%
cases:0.41%
controls:0.22%
cases:0.90%
controls:0.73%
131
924
19249
192796
66
422
19313
193298
20
65
19359
193655
43
6
19336
193714
16
75
17455
192612
63
397
15374
178447
77
826
8507
112645
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
1.2e-01
3.4e-01
1.2e+00
3.8e+00
1.0e+00
2.7e-01
1.5e-02
cases:15.96%
controls:14.40%
cases:11.15%
controls:8.22%
cases:4.47%
controls:1.33%
cases:2.19%
controls:0.05%
cases:3.60%
controls:1.33%
cases:11.52%
controls:9.04%
cases:22.16%
controls:21.91%
3094
27896
16286
165824
2161
15927
17218
177793
866
2571
18513
191149
424
96
18955
193624
629
2556
16842
190131
1778
16160
13659
162684
1902
24859
6682
88612
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
8.6e-02
4.2e-01
1.1e+00
3.2e+00
1.1e+00
4.5e-01
4.9e-01
cases:6.92%
controls:6.39%
cases:3.81%
controls:2.53%
cases:1.21%
controls:0.40%
cases:0.52%
controls:0.02%
cases:1.25%
controls:0.40%
cases:3.49%
controls:2.25%
cases:7.58%
controls:4.78%
1342
12385
18038
181335
739
4895
18640
188825
234
772
19145
192948
101
43
19278
193677
219
774
17252
191913
538
4019
14899
174825
651
5425
7933
108046
Outpatient Hospital
22 [8756]
22 [8756]
-6.6e-03
1.9e-01
1.2e+00
3.8e+00
1.3e+00
3.3e-01
3.3e-02
cases:32.56%
controls:32.70%
cases:10.68%
controls:9.03%
cases:4.01%
controls:1.26%
cases:2.94%
controls:0.07%
cases:4.22%
controls:1.24%
cases:11.46%
controls:8.49%
cases:24.37%
controls:23.77%
6310
63355
13070
130365
2069
17501
17310
176219
777
2439
18602
191281
570
127
18809
193593
737
2390
16734
190297
1769
15189
13668
163655
2092
26975
6492
86496
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
4.8e-01
9.5e-01
1.0e+00
2.5e+00
1.5e+00
3.1e-01
-2.7e-03
cases:18.01%
controls:11.96%
cases:14.77%
controls:6.26%
cases:2.89%
controls:1.03%
cases:0.41%
controls:0.03%
cases:4.26%
controls:1.03%
cases:8.63%
controls:6.51%
cases:16.40%
controls:16.44%
3490
23174
15890
170546
2862
12127
16517
181593
560
2001
18819
191719
80
63
19299
193657
744
1981
16727
190706
1332
11634
14105
167210
1408
18654
7176
94817
Cerebral infarction due to thrombosis of cerebral arteries
I63.3 [45562366]
I63.3 [45562366]
1.0e-01
8.1e-02
9.4e-01
4.5e+00
1.3e+00
2.1e-01
-1.2e-01
cases:1.20%
controls:1.08%
cases:0.42%
controls:0.39%
cases:0.14%
controls:0.05%
cases:0.34%
controls:0.00%
cases:0.22%
controls:0.06%
cases:0.49%
controls:0.39%
cases:1.12%
controls:1.26%
232
2091
19148
191629
82
756
19297
192964
27
106
19352
193614
66
7
19313
193713
39
121
17432
192566
75
703
15362
178141
96
1435
8488
112036
Prevention and treatment of malnutrition
OAB73 [2001308651]
OAB73 [2001308651]
-1.7e-01
8.0e-01
2.1e+00
—
1.8e+00
1.4e+00
1.3e+00
cases:0.04%
controls:0.05%
cases:0.09%
controls:0.04%
cases:0.06%
controls:0.01%
—
—
cases:0.05%
controls:0.01%
cases:0.17%
controls:0.04%
cases:0.41%
controls:0.11%
8
95
19372
193625
18
81
19361
193639
11
13
19368
193707
—
8
14
17463
192673
26
71
15411
178773
35
124
8549
113347
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
8.9e-02
3.7e-01
1.1e+00
3.7e+00
1.1e+00
3.4e-01
1.1e-01
cases:15.92%
controls:14.76%
cases:11.28%
controls:8.08%
cases:3.81%
controls:1.29%
cases:1.66%
controls:0.04%
cases:3.69%
controls:1.28%
cases:11.89%
controls:8.77%
cases:24.51%
controls:22.58%
3086
28601
16294
165119
2185
15651
17194
178069
738
2505
18641
191215
322
85
19057
193635
644
2473
16827
190214
1836
15693
13601
163151
2104
25626
6480
87845
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
7.4e-02
3.1e-01
1.3e+00
3.9e+00
9.8e-01
2.5e-01
-4.3e-03
cases:12.25%
controls:11.48%
cases:8.21%
controls:6.15%
cases:3.31%
controls:0.93%
cases:1.68%
controls:0.03%
cases:2.50%
controls:0.95%
cases:8.33%
controls:6.62%
cases:16.69%
controls:16.75%
2374
22235
17006
171485
1591
11923
17788
181797
642
1799
18737
191921
325
67
19054
193653
437
1839
17034
190848
1286
11848
14151
166996
1433
19010
7151
94461
Microorganisms panel - Urine sediment
58435-9 [40761536]
58435-9 [40761536]
-6.5e-02
2.3e-01
1.3e+00
3.6e+00
1.1e+00
3.1e-01
1.9e-01
cases:3.42%
controls:3.64%
cases:2.07%
controls:1.65%
cases:0.88%
controls:0.25%
cases:0.40%
controls:0.01%
cases:0.72%
controls:0.24%
cases:2.06%
controls:1.51%
cases:4.26%
controls:3.56%
663
7056
18717
186664
401
3193
18978
190527
171
475
19208
193245
78
21
19301
193699
125
466
17346
192221
318
2705
15119
176139
366
4041
8218
109430
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
E11.8 [45561951]
1.5e-01
2.6e-01
8.0e-01
4.2e+00
9.8e-01
3.1e-01
1.9e-03
cases:4.07%
controls:3.51%
cases:2.54%
controls:1.97%
cases:0.91%
controls:0.41%
cases:1.76%
controls:0.03%
cases:1.02%
controls:0.39%
cases:3.10%
controls:2.29%
cases:5.53%
controls:5.52%
789
6803
18591
186917
492
3816
18887
189904
177
800
19202
192920
342
52
19037
193668
179
745
17292
191942
479
4104
14958
174740
475
6268
8109
107203
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
3.3e-02
2.5e-01
1.7e+00
4.3e+00
7.2e-01
1.5e-01
-1.9e-01
cases:3.75%
controls:3.63%
cases:1.52%
controls:1.19%
cases:0.67%
controls:0.13%
cases:0.44%
controls:0.01%
cases:0.27%
controls:0.13%
cases:1.54%
controls:1.33%
cases:3.81%
controls:4.59%
726
7032
18654
186688
295
2301
19084
191419
129
248
19250
193472
86
12
19293
193708
48
259
17423
192428
238
2380
15199
176464
327
5206
8257
108265
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
1.6e-02
3.5e-01
1.3e+00
3.8e+00
1.1e+00
2.7e-01
7.9e-04
cases:1.69%
controls:1.67%
cases:1.11%
controls:0.79%
cases:0.39%
controls:0.11%
cases:0.24%
controls:0.01%
cases:0.29%
controls:0.10%
cases:1.16%
controls:0.89%
cases:2.68%
controls:2.68%
328
3227
19052
190493
215
1523
19164
192197
75
215
19304
193505
47
11
19332
193709
51
192
17420
192495
179
1589
15258
177255
230
3038
8354
110433
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
6.3e-02
2.3e-01
1.5e+00
4.0e+00
1.2e+00
6.5e-02
-1.7e-01
cases:4.40%
controls:4.14%
cases:2.77%
controls:2.21%
cases:1.23%
controls:0.29%
cases:0.90%
controls:0.02%
cases:0.86%
controls:0.26%
cases:2.57%
controls:2.41%
cases:6.55%
controls:7.70%
852
8016
18528
185704
537
4284
18842
189436
238
553
19141
193167
174
33
19205
193687
150
504
17321
192183
397
4316
15040
174528
562
8736
8022
104735
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
14685-2 [3009035]
5.0e-01
9.4e-01
1.2e+00
2.5e+00
1.5e+00
-6.5e-02
-1.2e-01
cases:14.24%
controls:9.17%
cases:7.98%
controls:3.26%
cases:1.13%
controls:0.33%
cases:0.10%
controls:0.01%
cases:1.44%
controls:0.31%
cases:3.06%
controls:3.26%
cases:9.45%
controls:10.51%
2760
17762
16620
175958
1546
6321
17833
187399
219
633
19160
193087
20
17
19359
193703
251
604
17220
192083
472
5825
14965
173019
811
11921
7773
101550
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
64799-0 [40767503]
-2.2e-01
5.2e-02
1.6e+00
3.6e+00
1.5e+00
2.7e-01
1.9e-01
cases:0.57%
controls:0.70%
cases:0.38%
controls:0.36%
cases:0.23%
controls:0.05%
cases:0.12%
controls:0.00%
cases:0.17%
controls:0.04%
cases:0.46%
controls:0.35%
cases:1.25%
controls:1.04%
110
1365
19270
192355
73
693
19306
193027
44
92
19335
193628
23
6
19356
193714
30
77
17441
192610
71
627
15366
178217
107
1177
8477
112294
Limited function/disability (Z)
Z28 [2002001482]
Z28 [2002001482]
8.9e-01
1.5e+00
2.0e+00
—
—
1.3e+00
9.4e-01
cases:0.23%
controls:0.09%
cases:0.14%
controls:0.03%
cases:0.05%
controls:0.01%
—
—
—
—
cases:0.17%
controls:0.05%
cases:0.41%
controls:0.16%
44
180
19336
193540
28
65
19351
193655
9
12
19370
193708
—
—
27
83
15410
178761
35
181
8549
113290
Osteoporosis, unspecified
M81.9 [45591963]
M81.9 [45591963]
2.0e-01
3.1e-01
9.2e-01
4.1e+00
9.5e-01
3.3e-01
9.3e-02
cases:1.43%
controls:1.18%
cases:0.77%
controls:0.57%
cases:0.23%
controls:0.09%
cases:0.38%
controls:0.01%
cases:0.25%
controls:0.10%
cases:0.84%
controls:0.61%
cases:1.83%
controls:1.67%
278
2281
19102
191439
149
1095
19230
192625
44
175
19335
193545
74
12
19305
193708
43
184
17428
192503
130
1089
15307
177755
157
1895
8427
111576
Base excess in Blood by calculation
11555-0 [3012501]
11555-0 [3012501]
-2.8e-01
2.4e-01
1.2e+00
3.3e+00
1.3e+00
4.4e-01
3.8e-01
cases:0.70%
controls:0.92%
cases:0.37%
controls:0.29%
cases:0.15%
controls:0.05%
cases:0.10%
controls:0.00%
cases:0.17%
controls:0.04%
cases:0.44%
controls:0.28%
cases:1.08%
controls:0.75%
135
1778
19245
191942
71
561
19308
193159
30
92
19349
193628
19
7
19360
193713
29
85
17442
192602
68
506
15369
178338
93
846
8491
112625
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
11557-6 [3013290]
-2.8e-01
2.4e-01
1.2e+00
3.3e+00
1.3e+00
4.4e-01
3.8e-01
cases:0.70%
controls:0.92%
cases:0.37%
controls:0.29%
cases:0.15%
controls:0.05%
cases:0.10%
controls:0.00%
cases:0.17%
controls:0.04%
cases:0.44%
controls:0.28%
cases:1.08%
controls:0.75%
135
1778
19245
191942
71
560
19308
193160
30
92
19349
193628
19
7
19360
193713
29
85
17442
192602
68
506
15369
178338
93
846
8491
112625
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
1.5e-01
3.9e-01
1.1e+00
3.3e+00
1.1e+00
3.6e-01
2.0e-01
cases:9.79%
controls:8.52%
cases:7.39%
controls:5.15%
cases:2.36%
controls:0.83%
cases:0.86%
controls:0.03%
cases:2.48%
controls:0.82%
cases:7.77%
controls:5.55%
cases:16.16%
controls:13.61%
1898
16497
17482
177223
1432
9975
17947
183745
458
1607
18921
192113
166
60
19213
193660
434
1575
17037
191112
1199
9917
14238
168927
1387
15443
7197
98028
Senility
R54 [45568140]
R54 [45568140]
8.0e-01
9.0e-01
1.9e+00
1.0e+50
2.0e+00
1.0e+00
4.0e-01
cases:0.20%
controls:0.09%
cases:0.13%
controls:0.05%
cases:0.09%
controls:0.01%
cases:0.12%
controls:0.00%
cases:0.08%
controls:0.01%
cases:0.23%
controls:0.09%
cases:0.42%
controls:0.28%
38
171
19342
193549
26
106
19353
193614
17
26
19362
193694
24
0
19355
193720
14
20
17457
192667
36
154
15401
178690
36
320
8548
113151
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
4.1e-01
8.9e-01
1.1e+00
2.4e+00
1.3e+00
3.4e-01
1.7e-01
cases:24.58%
controls:17.73%
cases:19.75%
controls:9.20%
cases:4.27%
controls:1.50%
cases:0.53%
controls:0.05%
cases:5.27%
controls:1.43%
cases:12.98%
controls:9.60%
cases:27.00%
controls:23.70%
4764
34346
14616
159374
3827
17828
15552
175892
828
2904
18551
190816
102
96
19277
193624
921
2755
16550
189932
2003
17170
13434
161674
2318
26893
6266
86578
Other function in accordance with SHToL (Finnish classification of nursing interventions)
SPAT1292 [2001700393]
SPAT1292 [2001700393]
3.7e-01
8.8e-01
1.3e+00
1.3e+00
1.2e+00
9.8e-01
6.1e-01
cases:4.27%
controls:3.00%
cases:3.32%
controls:1.40%
cases:2.05%
controls:0.59%
cases:0.86%
controls:0.23%
cases:1.89%
controls:0.60%
cases:3.91%
controls:1.50%
cases:6.79%
controls:3.80%
827
5809
18553
187911
643
2713
18736
191007
397
1139
18982
192581
167
443
19212
193277
330
1159
17141
191528
604
2683
14833
176161
583
4312
8001
109159
Subcortical vascular dementia
F01.2 [45581393]
F01.2 [45581393]
2.5e-01
6.2e-01
2.3e+00
—
2.6e+00
1.7e+00
5.3e-01
cases:0.08%
controls:0.06%
cases:0.09%
controls:0.05%
cases:0.07%
controls:0.01%
—
—
cases:0.17%
controls:0.01%
cases:0.45%
controls:0.08%
cases:0.49%
controls:0.29%
16
125
19364
193595
17
91
19362
193629
14
14
19365
193706
—
29
25
17442
192662
70
145
15367
178699
42
329
8542
113142
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
1.0e-01
3.4e-02
1.5e+00
4.4e+00
7.5e-01
-5.0e-02
-7.9e-02
cases:4.11%
controls:3.74%
cases:1.04%
controls:1.01%
cases:0.49%
controls:0.11%
cases:0.24%
controls:0.00%
cases:0.23%
controls:0.11%
cases:0.89%
controls:0.93%
cases:2.57%
controls:2.78%
797
7240
18583
186480
202
1952
19177
191768
94
218
19285
193502
47
6
19332
193714
40
209
17431
192478
137
1667
15300
177177
221
3156
8363
110315
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
-1.0e-01
2.4e-01
1.6e+00
4.1e+00
1.1e+00
-1.3e-02
-2.6e-01
cases:1.57%
controls:1.74%
cases:1.08%
controls:0.85%
cases:0.50%
controls:0.10%
cases:0.35%
controls:0.01%
cases:0.34%
controls:0.11%
cases:0.97%
controls:0.98%
cases:2.71%
controls:3.51%
305
3364
19075
190356
209
1642
19170
192078
97
199
19282
193521
67
11
19312
193709
59
209
17412
192478
150
1760
15287
177084
233
3981
8351
109490
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
1.4e-01
3.7e-01
1.1e+00
3.4e+00
1.1e+00
3.0e-01
1.4e-01
cases:33.43%
controls:30.43%
cases:21.01%
controls:15.55%
cases:6.94%
controls:2.45%
cases:2.95%
controls:0.10%
cases:7.03%
controls:2.46%
cases:20.48%
controls:16.06%
cases:39.59%
controls:36.38%
6478
58940
12902
134780
4072
30130
15307
163590
1344
4749
18035
188971
572
187
18807
193533
1228
4740
16243
187947
3162
28729
12275
150115
3398
41283
5186
72188
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
3.1e-02
2.6e-01
1.3e+00
3.9e+00
9.5e-01
1.7e-01
5.2e-02
cases:8.73%
controls:8.48%
cases:4.92%
controls:3.86%
cases:2.03%
controls:0.56%
cases:1.00%
controls:0.02%
cases:1.48%
controls:0.58%
cases:4.86%
controls:4.13%
cases:11.60%
controls:11.08%
1691
16432
17689
177288
954
7468
18425
186252
394
1091
18985
192629
193
40
19186
193680
259
1116
17212
191571
750
7388
14687
171456
996
12571
7588
100900
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
3.7e-01
8.1e-01
1.2e+00
2.1e+00
1.8e+00
3.2e-01
6.5e-02
cases:19.73%
controls:14.57%
cases:15.56%
controls:7.57%
cases:2.83%
controls:0.87%
cases:0.25%
controls:0.03%
cases:4.72%
controls:0.84%
cases:10.55%
controls:7.90%
cases:22.29%
controls:21.17%
3824
28223
15556
165497
3016
14674
16363
179046
549
1691
18830
192029
48
60
19331
193660
824
1610
16647
191077
1628
14122
13809
164722
1913
24024
6671
89447
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
2.3e-01
2.5e-01
1.1e+00
3.9e+00
7.2e-01
2.6e-01
-3.2e-02
cases:3.29%
controls:2.62%
cases:1.47%
controls:1.15%
cases:0.46%
controls:0.15%
cases:0.21%
controls:0.00%
cases:0.29%
controls:0.14%
cases:1.57%
controls:1.21%
cases:3.52%
controls:3.63%
637
5083
18743
188637
284
2223
19095
191497
89
286
19290
193434
41
8
19338
193712
50
269
17421
192418
242
2165
15195
176679
302
4119
8282
109352
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
1.5e-01
6.9e-01
9.7e-01
4.0e+00
1.0e+00
2.0e-01
-3.4e-01
cases:4.63%
controls:4.01%
cases:2.24%
controls:1.14%
cases:0.35%
controls:0.13%
cases:0.17%
controls:0.00%
cases:0.36%
controls:0.13%
cases:1.40%
controls:1.15%
cases:2.76%
controls:3.82%
897
7760
18483
185960
435
2213
18944
191507
68
258
19311
193462
33
6
19346
193714
63
245
17408
192442
216
2057
15221
176787
237
4332
8347
109139
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
6.1e-01
1.3e+00
2.4e+00
—
1.5e+00
6.9e-01
-4.9e-02
cases:1.82%
controls:0.99%
cases:1.05%
controls:0.28%
cases:0.28%
controls:0.03%
—
—
cases:0.14%
controls:0.03%
cases:0.53%
controls:0.27%
cases:0.85%
controls:0.89%
352
1923
19028
191797
203
535
19176
193185
55
52
19324
193668
—
24
58
17447
192629
82
479
15355
178365
73
1013
8511
112458
Melaena
K92.1 [45533624]
K92.1 [45533624]
2.2e-01
1.6e-01
1.4e+00
3.8e+00
1.1e+00
1.1e-01
-1.7e-01
cases:1.39%
controls:1.12%
cases:0.49%
controls:0.41%
cases:0.18%
controls:0.05%
cases:0.13%
controls:0.00%
cases:0.15%
controls:0.05%
cases:0.52%
controls:0.47%
cases:1.39%
controls:1.65%
270
2166
19110
191554
94
798
19285
192922
35
88
19344
193632
26
6
19353
193714
26
93
17445
192594
81
837
15356
178007
119
1867
8465
111604
Fracture of lumbar vertebra
S32.0 [45583057]
S32.0 [45583057]
2.0e-01
6.5e-01
1.4e+00
3.9e+00
7.1e-01
5.4e-01
1.1e-01
cases:0.83%
controls:0.68%
cases:0.51%
controls:0.26%
cases:0.17%
controls:0.04%
cases:0.21%
controls:0.00%
cases:0.11%
controls:0.05%
cases:0.51%
controls:0.30%
cases:1.12%
controls:1.00%
161
1317
19219
192403
98
513
19281
193207
33
85
19346
193635
41
8
19338
193712
19
103
17452
192584
79
532
15358
178312
96
1139
8488
112332
Multi-infarct dementia without information on additional symptoms
F01.19 [2000501586]
F01.19 [2000501586]
2.1e-01
1.4e+00
2.9e+00
—
—
2.2e+00
-1.5e-01
cases:0.05%
controls:0.04%
cases:0.07%
controls:0.02%
cases:0.05%
controls:0.00%
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.06%
controls:0.07%
10
81
19370
193639
13
33
19366
193687
9
5
19370
193715
—
—
22
28
15415
178816
5
77
8579
113394
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
19232-8 [3007628]
2.4e-01
3.7e-01
1.2e+00
3.8e+00
8.4e-01
1.5e-01
-5.4e-02
cases:1.78%
controls:1.40%
cases:1.31%
controls:0.91%
cases:0.54%
controls:0.16%
cases:0.27%
controls:0.01%
cases:0.34%
controls:0.15%
cases:1.26%
controls:1.09%
cases:2.87%
controls:3.02%
344
2703
19036
191017
254
1755
19125
191965
104
301
19275
193419
52
12
19327
193708
60
287
17411
192400
195
1947
15242
176897
246
3428
8338
110043
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
-9.9e-02
2.4e-01
1.6e+00
4.0e+00
1.1e+00
-2.3e-03
-2.7e-01
cases:1.59%
controls:1.76%
cases:1.09%
controls:0.86%
cases:0.51%
controls:0.10%
cases:0.34%
controls:0.01%
cases:0.33%
controls:0.11%
cases:0.98%
controls:0.99%
cases:2.73%
controls:3.53%
309
3406
19071
190314
211
1661
19168
192059
99
200
19280
193520
66
12
19313
193708
58
209
17413
192478
152
1765
15285
177079
234
4000
8350
109471
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
-3.9e-02
2.6e-01
1.6e+00
4.0e+00
1.0e+00
-4.1e-02
-4.0e-01
cases:2.21%
controls:2.29%
cases:1.59%
controls:1.24%
cases:0.74%
controls:0.15%
cases:0.53%
controls:0.01%
cases:0.44%
controls:0.16%
cases:1.32%
controls:1.37%
cases:3.23%
controls:4.74%
428
4444
18952
189276
309
2400
19070
191320
144
298
19235
193422
102
19
19277
193701
77
300
17394
192387
203
2450
15234
176394
277
5377
8307
108094
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
5.1e-02
3.2e-01
1.1e+00
3.7e+00
1.1e+00
2.9e-01
8.6e-02
cases:16.44%
controls:15.75%
cases:11.27%
controls:8.46%
cases:3.98%
controls:1.37%
cases:1.94%
controls:0.05%
cases:3.99%
controls:1.35%
cases:11.59%
controls:8.93%
cases:23.66%
controls:22.14%
3187
30516
16193
163204
2184
16391
17195
177329
772
2662
18607
191058
375
99
19004
193621
697
2596
16774
190091
1789
15967
13648
162877
2031
25118
6553
88353
Bacteria identified in Cerebral spinal fluid by Culture
606-4 [3016914]
606-4 [3016914]
6.0e-01
1.2e+00
2.3e+00
1.0e+50
2.4e+00
5.8e-01
3.9e-01
cases:0.37%
controls:0.20%
cases:0.22%
controls:0.07%
cases:0.06%
controls:0.01%
cases:0.04%
controls:0.00%
cases:0.07%
controls:0.01%
cases:0.11%
controls:0.06%
cases:0.35%
controls:0.24%
72
394
19308
193326
42
133
19337
193587
12
12
19367
193708
8
0
19371
193720
12
12
17459
192675
17
110
15420
178734
30
270
8554
113201
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
9.5e-02
2.2e-01
7.2e-01
4.3e+00
8.3e-01
4.0e-01
-1.4e-01
cases:7.67%
controls:7.02%
cases:4.39%
controls:3.55%
cases:1.40%
controls:0.69%
cases:3.29%
controls:0.04%
cases:1.58%
controls:0.69%
cases:5.56%
controls:3.81%
cases:8.35%
controls:9.45%
1486
13605
17894
180115
851
6872
18528
186848
272
1338
19107
192382
637
87
18742
193633
276
1333
17195
191354
859
6821
14578
172023
717
10728
7867
102743
Nutrition survey
SPAT1139 [2001700240]
SPAT1139 [2001700240]
7.8e-01
1.1e+00
1.4e+00
7.2e-01
1.4e+00
1.1e+00
6.8e-01
cases:1.32%
controls:0.61%
cases:1.15%
controls:0.38%
cases:0.66%
controls:0.16%
cases:0.13%
controls:0.07%
cases:0.66%
controls:0.16%
cases:1.28%
controls:0.44%
cases:2.20%
controls:1.13%
256
1185
19124
192535
223
743
19156
192977
128
316
19251
193404
26
127
19353
193593
115
315
17356
192372
198
782
15239
178062
189
1279
8395
112192
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
1.0e-01
3.6e-01
1.1e+00
3.5e+00
1.1e+00
2.7e-01
7.0e-02
cases:20.59%
controls:18.98%
cases:15.59%
controls:11.45%
cases:5.50%
controls:1.91%
cases:2.35%
controls:0.07%
cases:5.59%
controls:1.88%
cases:16.03%
controls:12.72%
cases:31.75%
controls:30.26%
3990
36776
15390
156944
3021
22173
16358
171547
1066
3693
18313
190027
456
143
18923
193577
977
3626
16494
189061
2475
22753
12962
156091
2725
34334
5859
79137
Communicating hydrocephalus
G91.0 [45533173]
G91.0 [45533173]
1.0e+00
1.7e+00
—
—
—
1.8e+00
1.9e+00
cases:0.15%
controls:0.05%
cases:0.09%
controls:0.02%
—
—
—
—
—
—
cases:0.08%
controls:0.01%
cases:0.23%
controls:0.04%
30
106
19350
193614
18
32
19361
193688
—
—
—
13
25
15424
178819
20
41
8564
113430
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
8.7e-02
2.1e-01
1.1e+00
3.6e+00
1.2e+00
1.8e-01
-4.5e-02
cases:11.16%
controls:10.32%
cases:5.08%
controls:4.16%
cases:1.62%
controls:0.53%
cases:0.80%
controls:0.02%
cases:1.83%
controls:0.54%
cases:5.20%
controls:4.37%
cases:12.79%
controls:13.30%
2163
19999
17217
173721
984
8052
18395
185668
314
1027
19065
192693
155
44
19224
193676
319
1049
17152
191638
802
7817
14635
171027
1098
15097
7486
98374
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
9.4e-02
2.0e-01
1.3e+00
4.2e+00
8.5e-01
8.5e-02
-8.1e-02
cases:2.09%
controls:1.91%
cases:1.04%
controls:0.85%
cases:0.38%
controls:0.10%
cases:0.29%
controls:0.00%
cases:0.21%
controls:0.09%
cases:1.00%
controls:0.92%
cases:2.89%
controls:3.12%
405
3693
18975
190027
201
1641
19178
192079
74
202
19305
193518
56
8
19323
193712
37
175
17434
192512
155
1651
15282
177193
248
3545
8336
109926
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
8.3e-02
3.4e-01
1.1e+00
3.5e+00
1.1e+00
2.6e-01
5.5e-02
cases:19.87%
controls:18.58%
cases:15.19%
controls:11.26%
cases:5.40%
controls:1.89%
cases:2.32%
controls:0.07%
cases:5.47%
controls:1.85%
cases:15.66%
controls:12.52%
cases:31.03%
controls:29.87%
3850
35991
15530
157729
2944
21819
16435
171901
1047
3653
18332
190067
450
140
18929
193580
956
3565
16515
189122
2418
22398
13019
156446
2664
33898
5920
79573
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
8.7e-02
3.5e-01
1.1e+00
3.5e+00
1.1e+00
2.6e-01
6.2e-02
cases:20.66%
controls:19.27%
cases:15.53%
controls:11.51%
cases:5.45%
controls:1.91%
cases:2.33%
controls:0.07%
cases:5.57%
controls:1.88%
cases:15.97%
controls:12.74%
cases:31.62%
controls:30.29%
4004
37325
15376
156395
3010
22299
16369
171421
1056
3703
18323
190017
452
142
18927
193578
974
3627
16497
189060
2466
22779
12971
156065
2714
34369
5870
79102
Occupational Medicine Clinic/Center
261QX0100X [38004267]
261QX0100X [38004267]
4.6e-01
1.0e+00
9.2e-01
—
3.3e+00
1.2e+00
3.6e-01
cases:0.88%
controls:0.56%
cases:0.50%
controls:0.18%
cases:0.08%
controls:0.03%
—
—
cases:0.59%
controls:0.02%
cases:0.65%
controls:0.19%
cases:1.14%
controls:0.80%
171
1080
19209
192640
97
356
19282
193364
15
60
19364
193660
—
103
41
17368
192646
100
342
15337
178502
98
908
8486
112563
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
9.3e-02
2.5e-01
1.3e+00
4.3e+00
8.0e-01
1.0e-01
-6.4e-02
cases:2.09%
controls:1.91%
cases:1.03%
controls:0.80%
cases:0.35%
controls:0.10%
cases:0.27%
controls:0.00%
cases:0.19%
controls:0.09%
cases:0.96%
controls:0.87%
cases:2.77%
controls:2.95%
406
3705
18974
190015
199
1554
19180
192166
67
190
19312
193530
52
7
19327
193713
34
168
17437
192519
148
1549
15289
177295
238
3348
8346
110123
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
51484-4 [3030981]
5.6e-02
2.3e-01
1.2e+00
3.9e+00
1.2e+00
1.8e-01
-2.0e-01
cases:2.53%
controls:2.40%
cases:1.75%
controls:1.40%
cases:0.77%
controls:0.23%
cases:0.43%
controls:0.01%
cases:0.74%
controls:0.22%
cases:2.02%
controls:1.70%
cases:4.33%
controls:5.26%
491
4648
18889
189072
340
2713
19039
191007
150
441
19229
193279
84
17
19295
193703
130
433
17341
192254
312
3035
15125
175809
372
5963
8212
107508
Acute subendocardial infarction unspecified coronary artery status
I21.49 [2000502437]
I21.49 [2000502437]
-1.7e-01
-1.3e-02
1.1e+00
4.5e+00
8.0e-01
-1.2e-01
-2.0e-01
cases:1.39%
controls:1.64%
cases:0.60%
controls:0.61%
cases:0.27%
controls:0.09%
cases:0.36%
controls:0.00%
cases:0.18%
controls:0.08%
cases:0.64%
controls:0.72%
cases:1.96%
controls:2.39%
270
3183
19110
190537
117
1185
19262
192535
53
180
19326
193540
70
8
19309
193712
32
159
17439
192528
99
1288
15338
177556
168
2707
8416
110764
melatonin; oral
N05CH01 [21604659]
N05CH01 [21604659]
3.7e-01
6.3e-01
8.7e-01
1.8e+00
9.5e-01
9.6e-01
8.1e-01
cases:6.02%
controls:4.24%
cases:5.59%
controls:3.06%
cases:2.67%
controls:1.14%
cases:0.31%
controls:0.05%
cases:2.96%
controls:1.16%
cases:8.98%
controls:3.65%
cases:15.70%
controls:7.67%
1167
8211
18213
185509
1084
5931
18295
187789
517
2201
18862
191519
60
104
19319
193616
517
2236
16954
190451
1387
6519
14050
172325
1348
8702
7236
104769
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
F10.1 [45595844]
7.2e-01
1.3e+00
2.1e+00
—
1.2e+00
1.0e+00
2.9e-01
cases:0.96%
controls:0.47%
cases:0.58%
controls:0.16%
cases:0.18%
controls:0.02%
—
—
cases:0.10%
controls:0.03%
cases:0.51%
controls:0.19%
cases:0.73%
controls:0.55%
187
914
19193
192806
112
315
19267
193405
34
41
19345
193679
—
17
55
17454
192632
78
333
15359
178511
63
626
8521
112845
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
7.2e-02
1.8e-01
1.3e+00
4.2e+00
8.2e-01
2.6e-02
-8.8e-02
cases:2.04%
controls:1.90%
cases:0.99%
controls:0.83%
cases:0.38%
controls:0.10%
cases:0.24%
controls:0.00%
cases:0.19%
controls:0.09%
cases:0.93%
controls:0.90%
cases:2.74%
controls:2.98%
396
3690
18984
190030
192
1612
19187
192108
74
197
19305
193523
46
7
19333
193713
34
165
17437
192522
143
1614
15294
177230
235
3383
8349
110088
Hypertensive heart disease with (congestive) heart failure
I11.0 [45538369]
I11.0 [45538369]
4.5e-02
5.5e-02
1.0e+00
4.8e+00
9.7e-01
8.7e-02
-4.6e-01
cases:0.51%
controls:0.49%
cases:0.28%
controls:0.26%
cases:0.14%
controls:0.05%
cases:0.38%
controls:0.00%
cases:0.18%
controls:0.07%
cases:0.47%
controls:0.43%
cases:0.99%
controls:1.56%
99
946
19281
192774
54
511
19325
193209
27
99
19352
193621
74
6
19305
193714
31
130
17440
192557
72
765
15365
178079
85
1768
8499
111703
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
30934-4 [3011960]
2.3e-01
3.4e-01
8.5e-01
3.2e+00
1.1e+00
3.8e-01
2.2e-01
cases:6.08%
controls:4.90%
cases:2.55%
controls:1.82%
cases:0.65%
controls:0.28%
cases:0.30%
controls:0.01%
cases:0.84%
controls:0.29%
cases:2.54%
controls:1.76%
cases:5.44%
controls:4.42%
1179
9496
18201
184224
494
3529
18885
190191
126
540
19253
193180
58
23
19321
193697
147
553
17324
192134
392
3144
15045
175700
467
5021
8117
108450
Superficial injury of scalp
S00.0 [45548998]
S00.0 [45548998]
7.2e-01
8.9e-01
1.6e+00
1.0e+50
1.6e+00
9.4e-01
5.4e-01
cases:0.71%
controls:0.35%
cases:0.31%
controls:0.13%
cases:0.09%
controls:0.02%
cases:0.09%
controls:0.00%
cases:0.07%
controls:0.02%
cases:0.43%
controls:0.17%
cases:1.23%
controls:0.72%
137
672
19243
193048
61
250
19318
193470
18
35
19361
193685
18
0
19361
193720
13
30
17458
192657
66
299
15371
178545
106
820
8478
112651
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
965
501
14.52
307.65
1.0
1.0
54.28
36.00
ng/l
17.10
732
301
6543
25474
2.34
307.65
1.9
1.8
1179.61
1146.03
nmol/l
2.00
4852
18831
955
503
14.30
307.65
1.0
1.0
406.36
287.37
ng/l
15.19
732
308
965
500
14.55
307.65
1.0
1.0
566.08
784.80
ng/l
17.27
726
292
993
1931
3.84
284.33
1.2
1.3
476.45
602.50
mg/l
7.46
914
1855
900
1637
4.09
281.56
1.3
1.4
294.29
1104.95
e6/l
4.35
687
1328
893
1623
4.09
279.62
1.2
1.3
9.00
25.33
e6/l
1.65
654
1236
7650
37871
1.79
279.40
2.0
1.8
20.44
20.20
nmol/l
0.57
6810
31403
903
1678
4.00
274.63
1.2
1.2
3.88
3.83
mmol/l
0.48
860
1580
9871
53886
1.72
242.40
2.7
2.4
91.39
93.98
pmol/l
6.16
5402
28338
5420
25694
1.74
214.39
2.9
3.1
2.46
2.47
mmol/l
12.71
4858
22683
551
1017
3.97
168.24
3.4
4.0
314.82
328.48
umol/l
1.22
455
856
7511
40489
1.57
168.16
2.7
3.5
2.35
2.35
mmol/l
0.20
6729
35948
3572
16390
1.70
149.36
2.0
1.9
—
—
—
0
0
11840
72032
1.55
142.48
6.5
5.9
3018.30
1845.57
e6/l
1.33
361
1152
5089
25956
1.57
137.37
1.9
1.8
4413628.94
27779036.05
pmol/l
6.31
4124
20469
3730
17767
1.64
133.09
2.0
1.9
—
—
—
0
0
4694
23727
1.57
130.38
2.0
2.0
—
—
—
0
0
3521
35866
0.63
123.91
1.8
1.9
1.20
1.26
mmol/l
6.66
3073
28577
9235
54216
1.46
122.01
4.1
4.9
34.49
34.14
g/l
7.14
8393
50105
8084
46375
1.46
119.28
2.3
2.4
78.00
81.28
nmol/l
19.11
7079
40114
4156
39710
0.67
101.99
2.9
3.5
60.66
52.64
mg/l
0.78
2723
25693
7058
40278
1.43
101.01
2.6
2.2
—
—
—
0
0
9256
55458
1.41
100.32
5.0
6.6
1.21
1.21
mmol/l
12.00
8407
50614
4200
39905
0.67
99.30
2.9
3.4
6.86
6.67
mmol/l
2.40
3456
32592
10144
62025
1.41
95.63
5.8
7.3
1.22
1.21
mmol/l
29.46
8672
52788
4371
40848
0.69
92.61
3.5
4.2
9.86
9.78
mg/mmol
0.03
2783
25454
4479
24249
1.43
81.24
5.3
5.1
1.02
1.14
kg/l
0.80
3080
16744
10702
68154
1.32
61.71
30.2
29.8
329.79
330.06
g/l
2.34
10555
67606
1286
14412
0.61
60.60
1.2
1.3
17.57
15.35
u/ml
0.36
364
4715
13710
91303
1.35
51.39
22.3
22.0
32.01
28.81
mg/l
19.57
12261
79242
167
320
3.76
48.59
1.2
1.2
47.63
65.98
%
—
8
44
1471
15315
0.66
48.57
1.2
1.3
41.81
43.53
iu/ml
0.14
462
4610
11065
71767
1.28
48.55
5.6
5.5
2.01
114.57
0.50
21
118
5802
34861
1.28
46.94
2.4
2.5
2.82
3.07
mg/l
12.59
4865
29759
1316
13722
0.66
43.31
4.6
5.5
34.78
34.15
%
1.07
732
8581
1089
11780
0.64
42.67
1.3
1.3
492.23
505.46
titre
0.10
229
2868
6174
37756
1.26
41.86
2.3
2.2
274.42
219.04
u/l
4.04
5783
35351
8699
55573
1.24
38.87
4.9
4.7
5.44
3.04
estimate
0.51
1746
12717
4191
24631
1.28
38.64
4.6
4.6
200.15
411.59
ng/l
4.59
3828
22055
10749
70298
1.24
38.52
4.0
4.5
15.24
15.27
pmol/l
0.70
9584
62391
10143
65970
1.24
37.90
4.8
5.2
7.07
6.90
mmol/l
9.72
9693
63086
10634
82185
0.81
37.71
3.8
4.7
1.20
1.24
mmol/l
10.41
9167
72133
986
4561
1.58
36.31
1.2
1.3
—
—
—
0
0
12645
84447
1.26
36.19
5.5
5.7
2.03
2.11
mu/l
4.47
11466
75610
7457
47174
1.23
35.08
4.9
4.8
53.40
95.47
ng/l
2.87
6075
38990
8699
55960
1.22
34.52
4.9
4.8
0.64
0.38
estimate
0.17
1629
11949
6445
40278
1.23
33.61
5.2
4.9
0.97
0.89
estimate
0.06
1331
9916
730
8204
0.62
33.49
1.3
1.3
—
—
—
0
0
8522
54840
1.22
33.08
4.8
4.7
0.00
0.00
estimate
0.03
1645
12223
11178
85511
0.81
32.66
4.4
5.5
1.46
1.45
mmol/l
1.02
9815
76193
736
8208
0.62
32.62
1.4
1.5
—
—
—
0
0
13950
94799
1.26
30.14
27.6
27.4
139.68
139.43
mmol/l
19.84
13597
92825
13957
94859
1.26
30.07
27.7
27.7
4.01
4.02
mmol/l
4.07
13588
92771
3386
28985
0.79
29.01
2.5
3.1
354.10
364.86
umol/l
6.06
2776
24457
14008
95459
1.25
27.70
32.2
33.4
7.23
7.06
e9/l
6.76
13499
92452
14001
95445
1.25
27.28
32.6
33.9
38.19
38.87
%
34.98
13665
93866
14000
95446
1.25
27.18
32.2
33.3
4.23
4.30
e12/l
54.97
13481
92397
13999
95445
1.25
27.11
32.2
33.3
92.06
92.07
fl
0.05
13681
93913
14000
95455
1.25
27.08
32.5
33.6
127.39
129.83
g/l
68.51
13668
93965
13998
95440
1.25
27.08
32.2
33.4
236.05
237.82
e9/l
2.32
13516
92886
13980
95308
1.25
27.03
29.1
30.1
86.35
87.17
umol/l
1.69
13646
93778
498
5826
0.60
26.90
2.0
1.9
1.79
1.39
g/l
1.12
412
5207
11376
86312
0.83
26.42
4.5
5.6
4.29
4.32
mmol/l
2.05
10052
77624
230
747
2.22
26.08
2.2
2.3
—
—
—
0
0
4321
26455
1.22
25.79
4.6
4.4
0.21
0.29
0.21
57
398
1594
8690
1.34
24.30
5.0
6.3
24.39
24.50
mmol/l
0.52
1536
8309
2179
12428
1.29
23.99
3.4
3.3
235.66
276.59
ng/l
3.81
2023
11491
1794
16236
0.77
23.59
1.5
1.5
2.77
2.74
g/l
0.12
851
8841
1620
14815
0.76
22.98
2.9
4.0
14.69
24.75
ug/l
1.24
1327
12469
100
230
3.12
22.41
1.2
1.3
34.80
25.26
%
—
5
35
6279
49614
0.85
21.27
2.6
3.0
—
—
estimate
—
0
0
377
4457
0.60
21.22
2.5
4.2
173.55
97.69
u/ml
0.92
354
4277
567
2616
1.57
21.11
4.5
6.2
11.34
11.33
mmol/l
0.02
520
2341
567
2616
1.57
21.11
4.5
6.2
104.76
104.80
mmol/l
0.07
520
2342
712
7295
0.68
20.60
2.9
2.8
10.65
10.73
g/l
0.16
620
6665
11480
86438
0.85
20.58
22.2
22.4
67.45
68.11
ml/min/173m2
3.28
10764
81390
3387
28172
0.83
20.55
2.3
2.6
—
—
—
0
0
468
5179
0.64
19.85
1.4
1.5
37.86
18.43
iu/ml
—
9
113
98
1751
0.40
19.30
1.5
1.8
3.13
3.24
mmol/l
0.40
78
1296
6707
43535
1.16
19.16
4.7
4.5
163.39
136.06
e6/l
0.94
4893
32082
6230
40209
1.17
19.16
3.9
3.8
116.82
101.36
e6/l
0.25
4854
31470
760
3813
1.44
18.95
4.4
5.4
1.40
1.35
mmol/l
0.54
683
3390
10501
70542
1.16
18.85
27.9
27.5
14.04
14.09
%
3.21
10357
69518
1364
12449
0.76
18.80
3.0
3.2
5.51
5.04
e9/l
0.55
1097
10114
9017
59955
1.16
18.33
20.4
21.5
1.42
1.40
inr
2.41
7825
50882
1054
5637
1.36
18.10
1.5
1.5
1.66
1.64
%
0.34
876
4513
308
3676
0.59
18.03
1.8
1.6
8.62
8.10
iu/ml
0.10
80
850
398
4459
0.63
17.85
1.2
1.3
255.58
258.60
u/ml
0.03
356
4067
228
2939
0.55
17.77
1.9
3.0
189.63
1104.98
u/ml
2.60
200
2658
6937
53915
0.87
17.53
4.9
6.0
0.20
0.20
e9/l
0.31
5774
45771
1951
16903
0.80
17.29
2.8
3.9
249.03
250.66
u/l
0.14
1753
15895
188
2540
0.52
17.19
1.6
2.0
3.02
3.25
ratio
2.25
165
2080
5589
44069
0.86
17.08
11.8
13.5
0.00
0.00
e9/l
0.61
4461
35555
6779
52673
0.87
16.77
4.7
5.9
0.04
0.04
e9/l
1.73
5631
44017
813
7868
0.73
16.77
1.3
1.3
—
—
—
0
0
169
582
2.09
16.75
1.1
1.1
—
—
—
0
0
6744
52409
0.87
16.69
4.7
5.9
0.64
0.64
e9/l
0.25
5599
43711
186
2496
0.53
16.64
1.3
1.3
3.25
4.74
u/ml
1.11
31
398
187
2495
0.53
16.42
1.3
1.2
4.03
4.39
u/ml
0.07
22
262
198
731
1.95
16.25
1.1
1.1
—
3.94
—
0
11
3252
20125
1.19
16.10
3.5
3.5
2.60
2.61
e6/l
0.01
1663
10505
6356
49513
0.87
16.04
5.1
6.3
23.82
24.87
%
11.12
5908
46327
304
3522
0.61
15.80
1.5
1.5
16.87
16.50
iu/ml
—
9
82
276
3262
0.60
15.57
1.5
1.5
—
—
—
0
0
934
8745
0.75
15.40
2.7
3.0
57.76
56.13
ml/min/173m2
0.78
403
4152
6905
53374
0.87
15.25
4.9
6.0
1.71
1.84
e9/l
4.31
5808
45714
208
2616
0.56
14.91
1.3
1.2
23.59
40.11
u/ml
0.36
14
131
370
4047
0.65
14.90
1.5
1.7
38.74
38.45
u/l
0.08
290
3400
44
1008
0.31
14.84
1.9
1.4
—
—
—
0
0
1447
12748
0.79
14.75
4.3
6.0
11.38
12.05
mmol/l
2.63
1332
11968
6227
48380
0.87
14.62
5.0
6.1
60.58
59.60
%
7.95
5819
45657
5039
32493
1.15
14.61
3.7
3.7
1368.66
227.41
estimate
0.39
33
224
186
2378
0.55
14.17
4.0
3.5
1.79
1.49
%
0.38
148
2076
167
2196
0.54
14.03
1.3
1.2
2.01
6.23
u/ml
1.57
15
154
2097
17637
0.83
13.52
3.7
5.2
1.02
1.05
mmol/l
2.98
1850
16112
11926
88650
0.88
13.22
5.4
6.6
2.40
2.43
mmol/l
3.01
10600
79494
87
251
2.48
13.09
1.1
1.2
0.52
0.52
ratio
0.00
52
155
91
269
2.43
13.02
1.8
2.0
—
—
—
0
0
214
2569
0.59
12.92
1.6
1.7
12.74
13.07
mg/l
0.21
185
2339
4244
27258
1.15
12.65
3.5
3.7
0.14
0.08
0.78
184
1118
1709
10167
1.22
12.62
1.6
1.6
—
—
—
0
0
129
1773
0.52
12.59
1.1
1.1
—
—
—
0
0
576
2965
1.40
12.55
1.4
1.4
—
—
—
0
0
576
2965
1.40
12.55
1.4
1.4
—
—
—
0
0
11605
79419
1.13
12.53
6.2
8.7
81.52
84.22
u/l
4.33
10781
74838
143
1898
0.53
12.45
3.9
3.8
207.71
2014.21
iu/ml
1.19
21
272
7761
59108
0.89
12.40
6.5
9.1
4.72
4.46
e9/l
11.83
6553
50443
89
267
2.39
12.36
1.8
2.0
—
—
—
0
0
222
2605
0.60
12.25
1.2
1.3
—
—
—
0
0
4972
32344
1.14
12.18
5.2
4.8
0.00
0.00
estimate
2.22
1403
10826
107
1539
0.49
12.04
2.9
3.6
58.78
58.96
%
0.02
73
1290
115
393
2.10
11.79
1.1
1.1
39.59
48.33
mg/l
1.11
95
340
241
1052
1.65
11.48
1.2
1.2
311.78
307.99
nmol/l
0.09
187
771
153
1943
0.56
11.47
1.7
1.8
16.59
24.77
ug/l
4.12
148
1891
68
1129
0.43
11.40
1.2
1.2
15.00
36.37
u/ml
—
5
61
3439
21898
1.15
11.40
3.4
3.4
1.51
1.34
e6/l
0.58
1869
12315
2020
12327
1.19
11.39
2.5
2.6
5.62
6.31
ug/l
1.01
1529
10507
188
2252
0.59
11.31
1.1
1.1
100.00
143.22
titre
0.93
16
171
308
3296
0.66
11.24
1.3
1.2
0.49
1.05
u/ml
1.48
32
299
209
2425
0.61
11.05
1.2
1.3
150.77
276.12
titre
1.70
26
188
111
1530
0.52
11.00
2.1
2.4
1.20
0.49
mmol/l
0.88
94
1471
542
5226
0.73
10.93
2.7
2.7
—
—
—
0
0
134
500
1.92
10.84
1.2
1.2
0.74
0.98
promille
1.30
112
376
102
1433
0.51
10.74
1.2
1.3
—
—
—
0
0
218
948
1.65
10.58
1.4
1.3
—
—
—
0
0
218
2478
0.62
10.57
2.2
2.1
211.03
216.53
%
0.38
200
2342
266
2889
0.65
10.47
1.8
2.0
3.65
3.67
g/l
0.08
247
2746
301
3184
0.67
10.39
2.2
2.5
1.74
1.88
mg/l
1.78
237
2771
235
2616
0.64
10.39
1.9
1.9
89.33
88.76
%
0.17
218
2516
1332
11411
0.82
10.27
2.2
2.2
0.00
0.01
estimate
2.03
222
1910
58
977
0.42
10.14
1.2
1.2
84.20
79.63
u/ml
—
5
35
165
678
1.75
9.88
1.2
1.2
2.02
2.35
mmol/l
4.04
154
614
129
1631
0.56
9.60
1.4
1.5
268.06
285.72
pmol/l
0.09
124
1580
1155
9954
0.82
9.44
1.8
2.0
187.27
171.75
ug/g
0.49
867
7663
263
2797
0.67
9.37
1.7
1.5
1.14
1.16
g/l
0.77
241
2645
102
365
2.00
9.36
1.0
1.1
277.43
323.50
mg/l
1.30
88
322
4191
27357
1.13
9.22
4.5
4.3
0.95
0.41
estimate
0.71
1232
9448
258
2735
0.67
9.06
1.7
1.5
0.23
0.23
g/l
0.45
236
2573
619
5690
0.77
8.93
2.0
2.2
0.00
0.20
estimate
0.57
183
1378
1016
5940
1.24
8.86
4.1
4.7
0.91
0.85
%
4.13
971
5633
1095
6456
1.23
8.81
4.0
4.6
1.63
1.52
%
2.00
1051
6144
107
1373
0.55
8.46
1.5
1.6
0.66
0.89
g/l
1.75
84
1050
2104
13203
1.16
8.32
4.7
7.0
119.49
118.69
g/l
1.08
2055
12888
88
1190
0.53
8.32
2.3
4.0
50.82
68.25
u/ml
0.37
81
1161
147
1713
0.61
8.05
1.3
1.2
65.63
46.02
u/ml
0.60
15
182
120
1462
0.58
7.87
1.4
1.3
0.12
0.33
nmol/l
—
9
110
532
4902
0.77
7.85
2.3
3.1
364.71
2799.88
u/ml
2.45
430
4191
1090
9278
0.83
7.83
3.0
3.9
5.19
5.15
kpa
0.54
978
8782
5263
35046
1.11
7.78
3.7
3.7
0.59
0.50
e6/l
1.60
3982
26712
268
2724
0.70
7.57
1.4
1.5
30.33
30.96
g/l
0.39
237
2448
123
1469
0.60
7.48
1.9
2.0
543.25
2358.44
u/ml
—
8
111
119
1431
0.59
7.44
1.4
1.3
0.66
2.07
nmol/l
0.58
111
1365
94
359
1.88
7.26
2.5
2.1
61.37
52.33
umol/l
1.62
76
295
227
2356
0.68
7.23
1.3
1.3
—
—
—
0
0
93
355
1.88
7.20
1.1
1.1
—
—
—
0
0
30
572
0.37
7.18
1.6
1.4
1.10
1.65
u/ml
0.25
25
350
42
117
2.57
6.97
1.1
1.2
25.75
48.58
%
1.43
12
50
703
6174
0.81
6.94
2.1
2.1
10.86
11.13
nmol/l
0.32
578
5201
84
316
1.90
6.81
3.0
2.8
27.81
29.41
umol/l
0.69
58
239
57
827
0.49
6.81
1.2
1.2
—
—
—
0
0
269
2678
0.71
6.78
1.5
1.5
37.26
5.01
iu/ml
1.00
88
612
19
437
0.31
6.73
1.2
1.3
1.59
1.54
g/l
0.24
19
437
114
1341
0.60
6.58
1.2
1.2
2.80
5.01
u/ml
—
5
40
187
1975
0.67
6.57
1.3
1.4
—
—
—
0
0
466
4258
0.78
6.50
1.1
1.1
66.96
122.95
u/ml
4.01
148
1370
51
162
2.25
6.44
13.2
12.2
0.67
0.66
mmol/l
0.06
46
149
398
3705
0.76
6.42
1.8
1.6
—
—
—
0
0
100
1206
0.59
6.39
1.1
1.2
—
108.97
—
0
8
825
4890
1.22
6.38
1.8
2.1
942.06
584.53
ug/l
0.73
774
4653
109
1279
0.61
6.25
1.3
1.3
0.19
0.20
nmol/l
0.88
89
1048
6647
45086
1.09
6.20
2.9
3.2
137.61
158.65
ug/l
10.32
5918
40613
104
1227
0.60
6.11
1.3
1.3
150.18
161.39
au/ml
0.54
32
364
575
5086
0.80
6.10
2.6
3.1
25.00
24.90
mmol/l
0.23
557
4999
658
5735
0.81
6.07
2.8
3.2
54.32
78.57
mg/l
1.32
541
4839
2337
18451
0.89
6.03
1.2
1.3
1.67
1.67
u/ml
0.00
510
4276
18
32
4.02
6.01
1.1
1.2
1.75
2.14
%
—
8
21
274
2664
0.73
6.01
1.4
1.4
—
—
—
0
0
2645
20734
0.90
6.01
2.2
2.8
0.81
0.81
mmol/l
0.04
2370
19160
453
2528
1.29
5.98
4.1
3.9
32.22
30.20
mg/l
0.52
358
1846
134
1483
0.64
5.97
1.1
1.1
—
0.79
—
0
11
23
50
3.29
5.87
1.0
1.2
53.55
45.03
%
0.26
11
31
194
948
1.47
5.86
1.2
1.3
—
—
—
0
0
4300
28675
1.10
5.85
3.0
2.9
5.80
5.09
e6/l
2.90
3952
26064
174
1819
0.68
5.85
2.1
2.3
0.95
1.04
g/24h
0.19
75
1032
191
932
1.47
5.81
1.2
1.3
—
—
—
0
0
20
40
3.58
5.75
1.1
1.3
14.70
14.34
%
—
10
29
661
5723
0.82
5.73
2.8
3.2
44.73
51.86
mg/l
0.61
548
4827
406
3711
0.78
5.73
1.5
1.7
—
—
—
0
0
1606
12916
0.88
5.59
2.2
2.6
65.31
65.67
g/l
1.08
1367
11559
315
1689
1.34
5.58
7.6
11.5
8.43
7.32
mmol/l
1.63
258
1394
57
202
2.02
5.55
1.6
1.9
1.20
1.19
mmol/l
0.54
52
195
41
616
0.47
5.51
1.2
1.1
0.26
0.88
u/ml
4.05
22
348
87
1042
0.59
5.48
1.2
1.5
—
—
—
0
0
87
1042
0.59
5.48
1.2
1.5
—
—
—
0
0
87
1042
0.59
5.48
1.2
1.5
—
—
—
0
0
62
813
0.54
5.46
3.3
3.7
—
—
—
0
0
235
1208
1.40
5.43
1.6
1.5
—
—
—
0
0
12
312
0.27
5.42
1.3
1.3
0.53
0.61
ratio
—
7
106
1899
12177
1.13
5.41
2.5
3.1
4.12
4.34
kpa
5.81
1825
11833
155
1630
0.68
5.41
3.1
3.6
29.62
48.22
u/ml
2.13
148
1580
88
1047
0.60
5.41
1.5
1.7
4.36
4.81
mg/l
0.57
78
991
89
1053
0.60
5.35
1.3
1.3
11.50
12.95
u/l
0.44
68
825
468
2662
1.26
5.35
1.2
1.2
—
—
—
0
0
96
1114
0.61
5.33
1.1
1.2
252.40
284.50
u/ml
0.57
57
645
44
637
0.49
5.33
1.1
1.1
—
—
—
0
0
1013
8389
0.85
5.32
5.0
7.6
24.19
24.29
mmol/l
0.37
961
8101
241
2342
0.73
5.32
1.4
1.5
3605.82
2588.34
e6/l
0.39
170
1654
238
2316
0.73
5.30
1.3
1.4
—
—
—
0
0
43
626
0.49
5.29
1.1
1.6
—
—
—
0
0
43
626
0.49
5.29
1.1
1.6
—
—
—
0
0
43
626
0.49
5.29
1.1
1.6
—
—
—
0
0
766
4595
1.20
5.29
3.0
3.7
1.45
1.42
mmol/l
0.29
749
4494
232
2260
0.73
5.21
1.3
1.5
—
—
—
0
0
471
2691
1.26
5.20
1.2
1.2
—
—
—
0
0
91
384
1.70
5.19
1.4
1.5
95.30
94.25
umol/l
0.02
57
220
432
2449
1.27
5.10
1.4
2.0
25.16
32.81
umol/l
11.23
355
2091
172
1747
0.70
5.00
1.3
1.4
6.37
6.41
mmol/l
0.06
153
1645
19
373
0.36
4.99
1.1
1.1
0.20
0.29
u/ml
0.33
13
210
63
241
1.87
4.98
1.2
1.1
—
—
—
0
0
108
1199
0.64
4.96
1.4
1.3
—
—
nmol/l
—
0
0
2486
16263
1.11
4.96
4.4
6.4
1.22
0.98
mmol/l
1.98
1928
13259
215
2096
0.73
4.88
1.4
1.5
48979.21
66308.42
e6/l
0.49
126
1184
248
2365
0.75
4.86
1.3
1.3
38.10
38.79
u/l
0.03
216
2021
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
619
5300
0.83
4.83
2.1
2.6
0.37
0.35
iu/ml
0.66
338
2933
45
624
0.51
4.82
1.1
1.5
—
—
—
0
0
120
1289
0.66
4.73
1.1
1.2
60.98
61.51
u/l
0.03
99
1128
547
4728
0.82
4.72
3.4
4.2
24.97
24.92
mmol/l
0.11
455
4234
28
454
0.44
4.70
1.1
1.7
—
—
—
0
0
28
454
0.44
4.70
1.1
1.7
—
—
—
0
0
10580
73505
1.07
4.68
4.1
4.8
15.62
15.86
mm/h
0.71
9533
67415
349
3162
0.78
4.66
1.7
1.6
36.98
32.24
u/ml
0.28
44
467
6183
46250
0.93
4.66
3.1
3.5
2189.92
2006.64
ng/l
1.88
5337
40910
121
1292
0.67
4.64
1.1
1.3
232.02
272.82
pmol/l
1.43
97
1055
24
411
0.42
4.63
1.4
1.2
—
—
—
0
0
96
426
1.61
4.57
1.8
2.4
4.87
4.98
kpa
0.44
96
426
96
426
1.61
4.57
1.8
2.4
9.53
10.05
kpa
1.23
96
426
186
1834
0.72
4.57
1.3
1.3
424.66
433.03
u/l
0.03
168
1734
164
819
1.44
4.53
1.9
1.8
8.46
8.13
mmol/l
0.39
164
819
42
144
2.09
4.52
2.0
2.4
135.91
127.73
nmol/l
0.21
33
125
34
503
0.48
4.46
2.1
2.2
14.31
30.32
iu/ml
—
8
94
54
691
0.56
4.45
2.1
2.2
30.58
129.80
ug/min
1.99
12
164
109
1176
0.66
4.42
1.2
1.5
—
—
—
0
0
103
1120
0.66
4.35
1.2
1.5
—
—
—
0
0
39
541
0.51
4.23
1.0
1.0
284.72
292.96
mg/l
0.30
32
479
2485
16385
1.10
4.21
4.5
6.4
4.96
5.06
kpa
5.78
2369
15641
978
7972
0.87
4.20
2.9
3.7
1.98
2.10
mmol/l
0.46
688
5875
2483
16375
1.10
4.19
4.5
6.4
11.53
11.72
kpa
1.07
2366
15622
72
839
0.61
4.17
1.1
1.1
116.47
114.71
%
0.19
58
727
611
5155
0.84
4.10
2.7
3.1
3.76
7.27
ratio
0.78
385
3088
31
458
0.48
4.09
1.2
1.7
—
—
—
0
0
21
357
0.42
4.03
1.0
1.8
267366.80
41325.09
u/ml
—
5
58
35
492
0.51
3.98
1.0
1.0
3.12
1.53
u/ml
0.33
12
224
139
1402
0.71
3.97
1.2
1.3
—
—
—
0
0
516
4404
0.83
3.96
2.4
2.9
1187.55
678.29
mg/l
0.26
176
1832
5
150
0.24
3.91
1.4
1.1
—
—
—
0
0
5764
39392
1.07
3.90
5.3
6.6
6.12
4.76
ug/l
0.55
4979
34756
92
998
0.66
3.89
1.7
1.8
169.78
186.69
pmol/l
1.24
83
902
212
1996
0.76
3.89
1.2
1.2
—
—
—
0
0
57
690
0.59
3.88
1.1
1.1
39.07
28.12
u/l
0.62
46
589
48
608
0.56
3.87
1.0
1.1
—
—
—
0
0
2220
14618
1.10
3.87
4.5
6.5
94.97
95.08
%
0.26
2131
14056
58
696
0.59
3.82
1.1
1.1
102.12
86.93
u/l
0.71
49
597
12
255
0.34
3.81
1.0
1.0
0.15
0.19
u/ml
—
5
121
11884
86666
0.94
3.76
7.0
7.9
41.49
40.85
mmol/mol
9.31
10654
78607
61
716
0.61
3.69
1.3
1.4
—
—
—
0
0
2977
22711
0.92
3.66
3.2
3.7
0.87
0.87
ug/l
0.12
2163
16990
509
3056
1.20
3.61
1.2
1.2
—
—
—
0
0
14
266
0.38
3.53
1.1
1.4
125.59
145.82
pmol/l
0.27
14
266
162
1561
0.74
3.53
1.2
1.3
—
—
—
0
0
160
1544
0.74
3.52
1.2
1.3
—
—
—
0
0
79
863
0.65
3.50
3.1
3.0
32.97
31.79
mg/l
0.11
64
656
57
670
0.61
3.49
1.1
1.2
94.15
91.57
%
0.42
47
610
94
988
0.68
3.44
1.1
1.2
3.57
5.30
u/ml
0.37
28
343
116
1172
0.71
3.41
2.0
2.1
617.61
804.82
mg
1.04
116
1156
106
1088
0.69
3.41
1.2
1.2
—
—
—
0
0
126
1254
0.72
3.39
1.2
1.3
—
—
—
0
0
158
1517
0.74
3.38
3.2
3.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
95
455
1.49
3.35
1.1
1.1
—
—
—
0
0
19
310
0.44
3.35
1.2
1.1
—
—
—
0
0
368
3183
0.82
3.32
1.4
1.4
—
—
—
0
0
1860
12241
1.10
3.30
3.8
6.2
1.47
1.38
mmol/l
3.21
1803
11937
101
1037
0.69
3.27
2.2
2.2
609.17
647.31
ml
0.46
60
657
34
450
0.54
3.26
1.5
1.8
5521.14
4146.19
e6/l
0.10
21
297
4622
31517
1.07
3.24
4.8
5.4
22.31
22.64
%
0.75
2355
18017
28
392
0.51
3.22
1.5
1.7
11170.00
18649.58
e6/l
0.39
15
212
0
60
0.00
3.22
0.0
1.0
—
—
—
0
0
2692
18022
1.08
3.19
2.1
2.3
1.72
1.79
%
2.54
2243
15805
152
1451
0.75
3.15
1.2
1.3
21.87
13.00
u/l
1.39
134
1327
801
6479
0.88
3.14
1.9
2.3
4.09
4.17
g/l
2.33
672
5764
802
6483
0.88
3.11
1.9
2.3
7.62
7.52
g/l
0.89
673
5761
800
6466
0.88
3.10
1.9
2.3
3.82
3.71
g/l
0.94
671
5748
13318
93733
1.07
3.08
10.9
13.9
22.48
23.45
u/l
2.23
12635
89990
90
931
0.69
3.07
1.2
1.4
—
—
—
0
0
2946
22339
0.93
3.06
1.6
1.7
1.78
1.61
mg/l
1.23
2311
17884
5184
35529
1.06
3.06
2.3
2.6
179.22
64.86
u/l
0.47
4761
32619
157
1483
0.75
3.04
1.2
1.4
—
—
—
0
0
189
1740
0.77
3.02
1.6
1.7
4.21
4.30
mmol/24h
0.16
143
1459
144
1375
0.75
3.01
1.1
1.2
—
9.74
u/ml
—
0
12
170
1586
0.76
3.01
1.2
1.3
—
—
—
0
0
1613
10594
1.10
3.00
3.0
2.6
0.55
0.51
e6/l
0.31
1567
10250
42
510
0.59
2.99
2.2
1.8
455.94
500.60
e6/l
0.27
36
428
9
177
0.36
2.98
10.4
13.2
5.27
5.26
mmol/l
—
9
177
107
1066
0.72
2.95
1.1
1.1
96.43
473.51
iu/ml
0.72
15
179
118
1156
0.73
2.94
1.1
1.0
—
—
—
0
0
159
1488
0.76
2.90
1.2
1.4
—
—
—
0
0
90
920
0.70
2.90
1.1
1.2
—
—
—
0
0
46
541
0.61
2.89
1.2
1.4
21.26
17.98
%
0.34
41
482
94
953
0.70
2.89
1.1
1.2
4.20
4.87
u/ml
0.23
40
424
441
3698
0.85
2.86
2.4
3.0
7.48
7.76
kpa
2.98
429
3605
159
1484
0.76
2.85
1.2
1.4
—
—
—
0
0
43
511
0.60
2.83
1.4
1.5
5.27
6.08
u/l
0.94
38
415
55
243
1.62
2.81
1.3
1.4
0.22
0.30
mmol/l
—
9
50
31
400
0.55
2.78
1.1
1.7
93.38
98.09
%
0.40
26
381
1142
8979
0.90
2.77
5.2
7.9
92.95
93.67
%
2.35
1136
8945
72
760
0.68
2.77
1.1
1.2
—
—
—
0
0
33
417
0.56
2.75
1.1
1.1
—
—
—
0
0
62
673
0.66
2.75
1.1
1.1
—
—
—
0
0
6
136
0.32
2.73
1.3
1.4
—
—
—
0
0
70
740
0.67
2.72
1.4
1.5
—
—
—
0
0
70
740
0.67
2.72
1.4
1.5
—
—
—
0
0
85
864
0.70
2.68
1.0
1.1
—
—
—
0
0
683
4308
1.14
2.67
3.7
3.4
0.78
0.82
nmol/l
1.93
550
3490
44
508
0.62
2.60
2.1
1.9
216.62
240.84
e6/l
0.53
39
460
81
825
0.70
2.59
1.2
1.5
—
—
—
0
0
108
1049
0.73
2.59
1.3
1.2
67.88
44.94
u/ml
—
9
66
96
488
1.41
2.58
1.2
1.3
—
—
—
0
0
4076
30430
0.94
2.58
2.7
3.1
35.44
36.84
u/l
0.35
3779
28292
1591
10521
1.09
2.57
3.3
4.1
1.23
1.23
mmol/l
2.56
1295
8995
24
325
0.53
2.56
1.4
1.2
44.29
36.59
u/l
0.33
17
265
20
287
0.50
2.56
2.8
2.2
3.80
691.26
ug/l
1.04
20
287
162
1483
0.78
2.54
1.4
1.5
73.99
63.27
%
4.34
102
917
2115
14155
1.08
2.54
2.8
3.6
1.93
1.81
mmol/l
0.81
1837
12265
59
635
0.66
2.54
1.1
1.1
—
—
—
0
0
2173
14558
1.08
2.54
2.8
3.6
5.84
5.82
kpa
0.66
2099
14190
59
634
0.66
2.52
1.1
1.1
—
—
—
0
0
56
608
0.66
2.52
2.2
1.7
—
—
—
0
0
238
1380
1.24
2.52
1.3
1.3
276.59
273.63
mosm/kgh2o
0.88
170
1000
221
1949
0.81
2.51
1.2
1.2
—
—
—
0
0
65
684
0.68
2.50
1.3
1.4
61.02
67.39
%
0.68
47
556
0
48
0.00
2.48
0.0
12.6
—
211.30
—
0
37
38
158
1.72
2.47
3.2
2.9
0.34
0.56
u/field
1.07
38
158
219
1927
0.81
2.44
1.2
1.4
25.46
13.02
u/ml
—
5
43
79
798
0.71
2.44
1.2
1.5
—
—
—
0
0
44
498
0.63
2.41
2.3
2.5
40.45
35.94
%
0.77
29
299
10
182
0.39
2.40
1.2
1.2
—
—
—
0
0
10
182
0.39
2.40
2.0
2.7
764.20
1206.01
u/l
—
10
169
139
1286
0.77
2.39
1.3
1.4
14.12
13.61
u/l
0.44
131
1228
59
624
0.67
2.35
1.1
1.1
—
—
—
0
0
7
137
0.36
2.32
1.7
1.7
—
—
—
0
0
380
3161
0.86
2.30
1.4
1.4
—
—
—
0
0
754
5994
0.89
2.30
2.0
2.4
2.99
2.96
g/l
0.35
625
5273
71
722
0.70
2.30
1.6
1.5
4.41
7.17
u/l
0.98
49
565
74
746
0.71
2.28
1.3
1.2
8.06
8.01
mmol/l
0.05
67
577
465
2894
1.15
2.26
1.3
1.4
60.94
60.10
mmol/l
0.20
380
2346
5
111
0.32
2.19
3.4
2.5
163.20
407.43
umol/l
—
5
104
56
588
0.68
2.18
1.7
1.8
38.59
39.40
g/l
0.58
56
588
59
609
0.69
2.11
1.1
1.1
—
—
—
0
0
74
734
0.72
2.10
1.1
1.2
197.69
125.56
titre
0.34
13
133
206
1204
1.23
2.09
2.4
2.3
1.98
1.75
u/field
0.35
120
631
1182
7796
1.09
2.08
2.5
3.6
24.12
24.17
mmol/l
0.17
1146
7671
398
3270
0.87
2.08
2.5
3.0
87.62
88.67
%
2.16
386
3178
31
364
0.61
2.04
1.1
1.2
140.29
154.53
mmol/24h
0.34
31
364
313
2614
0.85
2.04
1.5
1.6
—
—
—
0
0
68
680
0.71
2.04
1.0
1.1
1.43
4.46
eliau/ml
2.75
12
136
441
3587
0.88
2.00
1.1
1.1
—
—
—
0
0
2872
19581
1.06
1.98
1.7
1.9
29.52
30.05
s
4.65
2768
19037
171
1503
0.81
1.96
1.5
1.6
7.05
4.99
mg/l
0.71
133
1177
100
540
1.33
1.94
1.2
1.3
1.27
1.17
nmol/l
0.31
77
387
33
375
0.63
1.91
2.8
2.3
0.63
0.62
mmol/l
0.13
33
375
174
1010
1.23
1.91
1.1
1.1
34.64
35.22
mmol/l
0.12
139
854
1142
7557
1.09
1.89
5.6
8.4
15.76
15.70
%
0.34
1095
7291
9
145
0.44
1.88
1.1
1.0
—
—
—
0
0
2056
13904
1.06
1.87
9.9
9.0
—
—
—
0
0
892
6945
0.91
1.86
4.1
4.2
1.02
1.02
ratio
4.59
794
6305
69
354
1.39
1.86
1.1
1.1
25.00
502.08
ng/l
2.05
13
101
980
7596
0.92
1.85
1.5
1.7
1.59
1.57
g/l
0.30
792
6476
95
514
1.32
1.84
1.1
1.1
—
—
—
0
0
77
737
0.75
1.79
1.1
1.2
84.66
99.10
u/l
0.66
65
624
2753
20573
0.95
1.78
2.3
2.7
19.89
20.73
%
2.77
2425
18878
27
315
0.61
1.77
1.3
1.4
0.13
0.14
nmol/l
0.12
17
211
215
1823
0.84
1.74
2.2
2.2
29.81
26.66
mg/l
0.35
69
626
283
1739
1.17
1.72
1.1
1.1
8.50
13.16
eliau/ml
—
6
76
362
2942
0.88
1.68
2.0
2.3
92.57
104.84
ug/min
0.26
188
1637
58
573
0.72
1.67
1.3
1.4
3.50
3.45
%
0.02
12
124
29
327
0.63
1.66
1.3
1.4
13.51
15.28
g/l
0.49
20
252
332
2711
0.87
1.66
1.6
1.6
—
—
—
0
0
723
5648
0.91
1.65
1.8
2.3
10.45
10.26
g/l
0.49
585
4851
41
428
0.68
1.63
1.1
1.1
83.83
81.75
—
6
33
1885
12773
1.06
1.63
4.5
4.0
—
—
—
0
0
422
3388
0.89
1.62
1.4
1.4
—
—
—
0
0
16
208
0.55
1.60
1.1
1.2
—
—
—
0
0
22
262
0.60
1.60
1.3
1.4
67.64
321.24
nmol/24h
1.46
22
262
24
279
0.61
1.58
1.2
1.2
—
2093931.13
—
0
8
58
299
1.39
1.57
1.3
1.4
17.50
16.89
pmol/l
0.30
43
236
1134
7569
1.08
1.55
3.6
4.3
44.39
45.41
%
0.74
1117
7468
49
490
0.71
1.55
6.1
6.3
25.71
127.83
ug/l
0.91
27
309
1327
8909
1.07
1.54
2.7
3.2
127.87
125.54
g/l
3.76
1297
8647
113
643
1.26
1.54
2.3
2.1
1.97
2.42
u/field
0.35
78
424
12
168
0.51
1.53
1.0
1.1
—
—
—
0
0
26
294
0.63
1.53
1.2
1.3
28.74
47.61
g/l
0.51
18
245
77
718
0.77
1.53
1.1
1.2
27.44
30.80
u/l
0.24
63
597
27
302
0.64
1.52
1.4
1.5
19.88
10.30
%
—
8
151
35
370
0.68
1.51
1.2
1.2
—
—
—
0
0
544
3524
1.11
1.49
2.0
2.3
126.20
125.28
g/l
0.39
457
2708
19
228
0.60
1.45
1.1
1.3
0.33
0.32
g/l
0.42
14
178
32
341
0.67
1.45
1.3
1.4
31.02
29.77
umol/l
0.30
32
319
197
1650
0.85
1.43
1.3
1.4
—
—
—
0
0
64
603
0.76
1.40
1.0
1.1
1.90
10.51
nmol/l
—
8
133
70
651
0.77
1.39
4.7
5.3
64.84
120.40
u/ml
0.46
14
201
1098
8364
0.93
1.39
4.3
6.6
24.82
24.76
mmol/l
0.16
1085
8283
32
337
0.68
1.38
1.3
1.4
—
—
—
0
0
0
29
0.00
1.37
0.0
1.1
—
—
—
0
0
56
295
1.36
1.36
1.1
1.1
1.04
1.19
u/l
1.57
23
140
54
519
0.74
1.36
1.1
1.1
—
—
—
0
0
18
215
0.60
1.36
1.1
1.3
112.36
112.85
%
0.04
11
188
65
608
0.76
1.36
4.9
3.2
1.37
1.22
%
0.24
65
608
211
1748
0.86
1.35
1.3
1.3
0.86
0.83
nmol/l
0.18
176
1435
0
30
0.00
1.35
0.0
1.0
—
—
—
0
0
5
12
2.98
1.31
1.4
1.3
—
—
—
0
0
713
5505
0.92
1.31
1.9
2.5
1.25
1.07
g/l
0.45
566
4584
1551
10542
1.06
1.25
2.8
3.6
89.72
98.73
ng/l
4.08
1258
8719
62
571
0.78
1.19
1.3
1.3
447.70
279.59
ug/l
0.17
34
307
1116
7529
1.06
1.18
2.2
2.6
1.12
1.13
%
0.13
1109
7496
48
254
1.35
1.17
1.1
1.1
—
—
—
0
0
133
1127
0.84
1.17
1.4
1.5
18.20
26.58
%
3.39
85
697
5
82
0.44
1.15
1.0
1.0
—
—
—
0
0
18
204
0.63
1.14
6.8
7.6
7.44
5.58
kpa
0.68
18
204
38
372
0.73
1.13
1.8
1.9
373.20
329.57
mu/l
0.31
30
289
18
78
1.65
1.12
1.1
1.0
—
—
—
0
0
19
212
0.64
1.12
1.7
1.7
9.98
10.25
ug/l
0.10
19
212
566
4376
0.92
1.12
1.9
2.4
0.00
0.00
g/l
0.08
470
3785
43
411
0.75
1.10
1.3
1.4
—
—
—
0
0
23
245
0.67
1.10
7.2
7.8
5.63
5.92
kpa
1.13
18
204
436
3405
0.91
1.09
1.2
1.3
—
—
—
0
0
47
252
1.33
1.08
1.1
1.1
—
—
—
0
0
11
139
0.57
1.07
3.2
1.5
64.00
64.29
pmol/l
0.00
11
107
6
91
0.47
1.06
1.0
1.1
—
—
—
0
0
67
601
0.80
1.06
2.1
1.8
88.99
100.14
umol/l
1.45
67
601
17
74
1.64
1.05
1.1
1.0
—
—
—
0
0
9
32
2.01
1.05
1.7
1.6
521.00
350.87
nmol/l
—
9
32
145
1206
0.86
1.04
1.3
1.4
157348.27
190793.09
e6/l
0.17
89
805
5
79
0.45
1.03
2.6
2.5
—
106.99
—
0
14
51
280
1.30
1.01
1.3
1.3
23.82
32.38
%
1.20
34
175
88
761
0.83
1.00
1.2
1.2
199.56
181.33
miu/ml
0.09
11
150
0
21
0.00
1.00
0.0
1.3
—
—
—
0
0
0
21
0.00
1.00
0.0
7.5
—
—
—
0
0
208
1312
1.13
1.00
1.9
1.6
29.80
26.02
u/ml
0.52
54
254
0
22
0.00
1.00
0.0
1.0
—
0.01
—
0
7
0
22
0.00
1.00
0.0
1.0
—
0.64
—
0
8
0
22
0.00
1.00
0.0
1.0
—
0.05
—
0
6
0
22
0.00
1.00
0.0
1.0
—
—
—
0
0
1100
7477
1.05
0.95
2.2
2.6
0.65
0.63
%
1.48
1094
7451
592
4531
0.93
0.94
1.8
2.4
0.02
0.05
g/l
1.33
500
4015
49
448
0.78
0.94
1.1
1.2
40.45
40.37
g/l
0.02
28
209
113
944
0.85
0.90
1.1
1.1
74.75
28.44
au/ml
—
8
73
36
192
1.34
0.89
1.1
1.3
91.11
105.12
ug/l
0.25
20
121
31
299
0.74
0.89
1.2
1.3
2.68
845.09
u/l
—
8
108
209
1671
0.89
0.88
1.3
1.4
—
—
—
0
0
448
3453
0.93
0.88
3.6
3.8
8.20
7.68
mmol/l
2.52
438
3376
19
199
0.68
0.87
1.2
1.2
72.00
80.78
%
—
5
104
125
1031
0.87
0.85
2.6
3.1
31.21
38.06
mg/l
0.30
88
766
8
102
0.56
0.84
6.9
5.1
45.38
52.38
ug/min
—
8
88
64
372
1.23
0.84
1.1
1.1
—
—
—
0
0
42
232
1.29
0.83
1.1
1.1
—
—
—
0
0
21
212
0.71
0.81
1.2
1.4
85.80
73.38
%
1.08
14
181
54
310
1.25
0.80
1.3
1.2
—
—
—
0
0
464
3555
0.93
0.80
1.3
1.4
255.90
256.82
ug/g
0.03
263
2226
403
3103
0.93
0.79
1.6
1.6
21531.85
14599.31
e6/l
1.25
273
2160
0
20
0.00
0.79
0.0
1.1
—
8.24
—
0
20
0
20
0.00
0.79
0.0
1.1
—
0.49
—
0
14
38
209
1.30
0.79
1.0
1.1
—
—
—
0
0
64
553
0.83
0.78
1.4
1.4
45.18
36.13
iu/l
0.92
54
464
41
372
0.79
0.78
1.0
1.1
7.15
12.85
iu/ml
—
8
73
1209
9003
0.96
0.78
5.0
7.8
1.38
1.29
%
3.64
1202
8932
1020
6968
1.05
0.77
3.0
3.5
25.34
25.11
mmol/l
1.35
978
6775
16
167
0.68
0.75
1.0
1.2
—
—
—
0
0
260
2031
0.91
0.74
2.6
2.5
1.20
1.20
mmol/l
0.04
254
2016
29
273
0.76
0.74
4.7
5.8
10.17
8.38
mmol/l
2.78
29
273
263
2053
0.91
0.73
2.6
2.5
106.46
105.49
mmol/l
2.02
257
2037
263
2053
0.91
0.73
2.6
2.5
4.15
4.12
mmol/l
0.45
257
2038
39
218
1.28
0.73
1.4
1.2
1.46
46.30
mg/l
0.79
32
163
1495
10313
1.04
0.73
2.2
2.5
54.98
49.85
u/l
0.11
1229
8602
539
4086
0.94
0.70
1.9
2.4
0.00
0.00
g/l
-0.00
469
3775
22
214
0.73
0.70
1.2
1.3
36.74
82.38
mu/l
1.64
15
149
12277
88323
0.98
0.70
5.2
6.2
6.20
6.14
mmol/l
3.81
10763
78161
70
592
0.84
0.70
1.9
2.2
—
—
—
0
0
11
122
0.64
0.69
1.2
3.1
—
—
—
0
0
37
334
0.79
0.69
1.2
1.2
1.38
1.47
mmol/l
0.20
23
209
29
270
0.77
0.69
1.3
1.3
1.16
1.18
mmol/l
0.51
29
270
20
197
0.73
0.69
1.2
1.3
82.67
78.01
%
—
6
106
18
180
0.71
0.68
1.1
1.2
16.30
17.94
u/l
—
10
120
16
163
0.70
0.67
5.3
7.0
10.89
10.14
%
0.37
16
163
325
2154
1.08
0.67
1.9
1.9
1.76
1.71
mmol/l
0.47
319
2088
99
811
0.87
0.67
1.1
1.2
103.27
100.38
pmol/l
0.23
99
811
25
236
0.76
0.66
1.2
1.1
240.69
278.84
pmol/l
0.34
16
163
29
268
0.77
0.66
1.1
1.2
—
—
—
0
0
22
211
0.74
0.65
1.4
1.5
—
—
—
0
0
5
20
1.79
0.65
1.0
1.1
—
—
—
0
0
60
510
0.84
0.65
1.1
1.2
—
—
—
0
0
296
2281
0.93
0.64
1.6
1.7
25.02
13.12
iu/l
0.21
106
755
43
249
1.23
0.63
1.1
1.1
—
—
—
0
0
3015
22001
0.97
0.62
2.2
2.7
2.18
2.24
g/l
7.13
2670
20052
9
101
0.64
0.61
1.0
1.0
—
—
—
0
0
0
16
0.00
0.61
0.0
2.4
—
3.24
—
0
16
231
1793
0.92
0.61
5.0
5.8
13.05
12.78
mg/l
0.37
203
1624
24
224
0.77
0.60
1.1
1.2
—
—
—
0
0
65
395
1.18
0.60
1.7
1.8
12.60
13.99
nmol/l
0.96
60
358
0
17
0.00
0.59
0.0
1.2
—
—
—
0
0
82
509
1.15
0.58
1.2
1.3
—
—
—
0
0
60
504
0.85
0.58
1.1
1.2
—
—
—
0
0
531
3993
0.95
0.56
3.4
3.6
1.74
1.63
mmol/l
1.60
518
3906
1180
8713
0.97
0.55
5.1
8.0
0.68
0.63
%
4.79
1170
8647
98
789
0.89
0.54
1.7
1.8
—
—
—
0
0
24
132
1.30
0.54
4.3
5.8
—
—
—
0
0
349
2346
1.06
0.53
1.3
1.4
0.32
0.28
mg/l
0.55
158
888
27
243
0.79
0.53
1.2
1.2
36.31
336.49
u/l
0.87
16
166
59
361
1.17
0.52
1.3
1.4
70.65
61.96
%
1.28
43
312
22
202
0.78
0.51
1.1
1.2
—
—
—
0
0
146
1144
0.91
0.51
1.3
1.5
—
—
—
0
0
3811
27656
0.98
0.50
3.6
4.3
80.27
81.74
%
2.98
3711
27108
40
341
0.84
0.49
1.5
1.7
114.88
115.70
ug/l
0.01
34
289
78
491
1.14
0.49
1.0
1.1
—
—
—
0
0
1950
14252
0.97
0.48
2.1
2.5
64.39
67.18
e9/l
3.09
1403
10626
49
410
0.85
0.48
1.3
1.2
6.54
14.97
umol/l
2.36
36
284
33
286
0.82
0.48
1.2
1.3
—
—
—
0
0
24
215
0.80
0.47
1.1
1.1
—
—
—
0
0
16
150
0.76
0.45
1.1
1.3
—
4639.62
—
0
26
18
99
1.30
0.42
1.1
1.1
1.79
1.67
umol/24h
0.33
18
99
0
11
0.00
0.42
0.0
1.0
—
—
—
0
0
0
12
0.00
0.42
0.0
2.3
—
2.49
—
0
12
0
12
0.00
0.42
0.0
1.2
—
241.41
—
0
12
67
540
0.89
0.41
1.1
2.4
58.33
66.62
mg/l
0.70
42
354
0
13
0.00
0.41
0.0
1.2
—
1.69
—
0
13
8
43
1.33
0.40
1.1
1.0
—
—
—
0
0
7
75
0.67
0.40
1.1
1.1
—
—
—
0
0
59
371
1.14
0.40
1.1
1.1
—
—
—
0
0
0
14
0.00
0.40
0.0
1.0
—
0.01
—
0
14
0
14
0.00
0.40
0.0
4.6
—
—
—
0
0
0
14
0.00
0.40
0.0
1.0
—
0.10
—
0
5
14
131
0.76
0.39
1.4
1.6
—
—
—
0
0
71
567
0.89
0.39
1.3
1.3
4.16
3.21
mmol/l
1.03
61
521
21
185
0.81
0.38
1.0
1.2
—
—
—
0
0
9
49
1.31
0.37
1.0
1.0
—
—
—
0
0
49
398
0.88
0.36
1.3
1.4
15.05
21.58
%
1.19
38
329
742
5145
1.03
0.35
2.0
1.9
—
—
—
0
0
672
4956
0.97
0.35
1.2
1.3
46.36
58.49
au/ml
0.68
35
325
162
1083
1.07
0.34
1.3
1.4
314.55
440.19
titre
0.41
22
106
11
58
1.36
0.34
1.7
1.8
19.93
17.80
umol/l
0.18
11
58
18
158
0.81
0.32
1.1
1.4
12.00
16.34
mm/h
1.03
18
158
386
2869
0.96
0.32
3.6
4.4
4.99
5.01
kpa
0.14
372
2788
386
2867
0.96
0.31
3.6
4.4
2.55
2.79
mmol/l
0.83
265
1981
31
190
1.17
0.31
1.1
1.2
—
—
—
0
0
157
1054
1.07
0.31
1.3
1.4
46.25
66.19
titre
—
8
84
79
617
0.91
0.31
1.1
1.2
9.38
9.86
mmol/l
0.50
74
572
15
133
0.81
0.30
1.9
1.5
—
—
—
0
0
198
1342
1.06
0.29
3.4
3.6
11.26
12.26
index
0.92
99
699
7
40
1.25
0.29
1.1
1.1
210.14
264.33
nmol/l
—
7
40
38
308
0.88
0.29
1.6
1.6
0.46
0.39
ug/l
0.30
19
183
32
262
0.87
0.28
1.2
1.2
0.76
1.60
mmol/l
1.00
18
168
114
872
0.93
0.28
1.8
1.7
110.93
110.72
ng/l
0.01
114
872
8
45
1.27
0.28
1.0
1.0
—
—
—
0
0
25
208
0.86
0.27
1.1
1.1
—
—
—
0
0
169
1268
0.95
0.24
2.6
2.9
—
—
—
0
0
567
4155
0.97
0.23
1.1
1.1
0.99
1.17
u/ml
—
7
46
7
67
0.75
0.23
1.0
1.0
13.73
28.48
iu/ml
—
7
67
0
8
0.00
0.22
0.0
1.1
—
—
—
0
0
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
0
8
0.00
0.22
0.0
6.7
—
8.88
—
0
8
5
30
1.19
0.21
1.2
1.2
—
—
—
0
0
0
9
0.00
0.21
0.0
1.2
—
70.20
—
0
9
8
74
0.77
0.21
3.6
5.0
—
—
—
0
0
94
634
1.06
0.19
1.7
2.1
19.60
28.95
umol/l
—
9
64
37
291
0.91
0.19
1.0
1.1
—
—
—
0
0
1588
11488
0.99
0.19
1.6
2.0
0.19
0.19
g/l
0.55
1395
10562
6
37
1.16
0.19
1.0
1.1
—
—
—
0
0
20
163
0.88
0.18
2.5
2.4
0.70
0.65
ug/l
0.25
20
163
12
71
1.21
0.18
1.1
1.1
—
—
—
0
0
12
71
1.21
0.18
1.0
1.1
0.86
1.11
u/field
—
7
45
24
152
1.13
0.18
1.2
1.1
—
—
—
0
0
14
85
1.18
0.17
1.1
1.1
9.93
11.33
u/l
0.18
14
85
11
65
1.21
0.17
1.1
1.2
—
—
—
0
0
20
126
1.13
0.16
1.1
1.1
—
—
—
0
0
412
3008
0.98
0.16
2.5
2.7
16.11
15.70
%
2.19
401
2944
26
168
1.11
0.15
1.3
1.8
1.49
1.11
ug/l
0.38
26
157
8270
59278
0.99
0.14
4.3
6.4
12.63
12.60
umol/l
0.07
7703
56416
786
5542
1.01
0.14
2.0
2.0
—
—
—
0
0
10
60
1.19
0.13
1.1
1.1
121.60
107.20
titre
—
10
60
10
60
1.19
0.13
1.6
1.3
1.20
1.06
u/field
—
5
35
55
416
0.94
0.13
3.7
6.6
24.49
24.79
mmol/l
0.29
49
374
16
101
1.13
0.13
1.1
1.0
—
—
—
0
0
19
151
0.90
0.13
1.3
1.1
—
—
—
0
0
7579
54002
1.01
0.12
3.0
3.3
50.53
58.69
u/l
10.19
6784
48788
22
143
1.10
0.11
1.2
1.1
—
—
—
0
0
12
98
0.87
0.11
1.3
1.0
—
—
—
0
0
56
421
0.95
0.11
5.3
5.9
59.67
72.42
%
2.05
43
319
1291
9155
1.01
0.10
1.8
2.2
408.52
393.41
nmol/l
1.71
1120
8339
1731
12447
0.99
0.09
2.1
2.6
8.99
10.31
umol/l
1.69
1448
10935
12
96
0.89
0.08
1.8
1.4
—
—
—
0
0
7
49
1.02
0.08
1.1
1.1
1994.00
343.25
u/l
—
7
40
10
63
1.13
0.07
1.4
1.1
—
—
—
0
0
43
294
1.05
0.07
2.6
2.4
7.21
7.59
mmol/l
0.47
30
202
508
3664
0.99
0.06
3.4
3.8
2.14
1.84
index
0.58
246
1891
51
352
1.04
0.06
1.1
1.2
10.88
14.37
pmol/l
0.27
15
133
12
94
0.91
0.06
1.1
1.1
—
—
—
0
0
38
261
1.04
0.05
1.1
1.1
—
—
—
0
0
201
1454
0.99
0.05
1.5
1.4
—
—
—
0
0
12
79
1.09
0.04
1.2
1.0
—
—
—
0
0
123
867
1.01
0.03
2.2
1.9
326.15
306.03
mu/l
0.21
115
793
3262
23351
1.00
0.03
2.2
2.7
10.80
11.49
umol/l
7.18
2882
21419
34
251
0.97
0.03
1.2
1.1
1527.06
1606.80
miu/ml
0.16
34
251
40
294
0.97
0.03
1.1
1.3
102.04
133.25
nmol/l
0.77
25
207
885
6344
1.00
0.02
1.8
1.9
2.40
2.25
ug/l
0.10
688
5528
89
645
0.99
0.02
1.2
1.4
—
—
—
0
0
89
645
0.99
0.02
1.2
1.4
—
—
—
0
0
22
152
1.03
0.01
1.4
1.7
41.86
47.81
umol/l
0.55
22
152
20
148
0.97
0.01
1.3
1.1
—
—
—
0
0
766
5467
1.00
0.01
2.2
2.5
27.84
23.40
au/ml
0.34
30
348
730
5211
1.00
0.00
2.7
3.2
4.27
4.30
pmol/l
0.26
625
4491
16
116
0.99
0.00
1.1
1.1
—
—
—
0
0
32
232
0.99
0.00
1.2
1.1
0.64
0.67
umol/24h
0.14
18
98
42
299
1.00
0.00
1.1
1.2
—
—
—
0
0
132
947
1.00
0.00
1.2
1.2
1.12
1.49
nmol/l
5.91
118
853
44
316
1.00
0.00
2.3
1.9
14.70
44.29
u/l
2.89
38
299
18
130
0.99
0.00
1.1
1.0
—
—
—
0
0
8
64
0.89
0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
3.75
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.00
—
0
6
8
61
0.94
-0.00
1.1
1.1
6.31
6.17
mmol/l
—
8
61
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
26.40
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint G6_ALZHEIMER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ALZHEIMER | 2.419 [2.2, 2.66] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 74328 out of 110920 females with G6_ALZHEIMER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ALZHEIMER | 2.756 [2.43, 3.13] | < 0.001 |
| Birth year | 0.984 [0.98, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 42782 out of 61190 males with G6_ALZHEIMER died.
Mortality risk
Mortality risk for people of age
years, who have G6_ALZHEIMER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.184% | 0.451% |
| 5 | 1.156% | 2.751% |
| 10 | 2.546% | 6.244% |
| 15 | 4.559% | 11.313% |
| 20 | 8.12% | 18.563% |
Relationships between endpoints
↥Index endpoint: G6_ALZHEIMER – Alzheimer disease
GWS hits: 37
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data